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Abstract
Iron deficiency affects approximately 12% of women of childbearing age in 
Australia and reduces the body’s capacity to transport oxygen, impeding physical 
performance and cognitive ability. Zinc deficiency can lead to a range of non-
specific symptoms associated with weakened immunity including diarrhoea and
dermatitis. Prevalence of zinc deficiency in Australia is unknown but it has been 
suggested that iron and zinc deficiencies occur in parallel as these minerals are 
present in similar food sources and absorption of both is impaired by similar 
compounds. However, the extent of this relationship remains unknown in 
economically-developed countries. The lack of a practical zinc status biomarker 
has hindered understanding of risk factors for deficiency and of any association 
with iron status. In contrast, there are several established indicators of iron status,
and risk factors for iron deficiency are better understood. It is acknowledged blood 
loss is a major risk factor for iron deficiency, which places premenopausal women 
at increased risk. Less understood is the role of dietary intake and dietary 
composition on iron status in free-living women. Similarly, there are also little 
data exploring the influences of dietary intake and composition on zinc status. 
Single meal absorption studies have demonstrated that non-haem iron absorption 
can be enhanced through simultaneous consumption of compounds including 
ascorbic acid and meat. However, effects are weakened in whole diet absorption 
studies, and the cross-sectional studies assessing dietary intake and iron status
have produced mixed findings. It is now understood that hepcidin plays an 
important role in maintaining iron balance, with high hepcidin levels decreasing 
the amount of iron absorbed. Whether the influence of hepcidin outweighs the 
influence of absorption enhancers and inhibitors in determining iron status is 
unknown. While some studies have shown that the presence of inhibitors, 
particularly phytate, can reduce zinc absorption, there is no work investigating 
whether consumption affects zinc status in the Australian population where 
phytate intakes may be low. 
The overall aims of this thesis were to assess dietary intakes of iron and zinc; to 
investigate dietary determinants of iron and zinc status; and to identify possible 
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associations between iron and zinc intakes and biochemical status in a sample of 
Australian premenopausal women. This thesis comprises work from a cross-
sectional research program in a group of premenopausal women recruited in
Melbourne and Sydney, Australia, and has yielded four cross-sectional 
investigations into iron and zinc intakes, biochemical status, and determinants of 
biochemical status.
From 2010 – 2014, 396 women were asked to complete a demographic, blood loss 
and medical background questionnaire, complete the Dietary Questionnaire for 
Epidemiological Studies v3.1 (DQES v3.1) food frequency questionnaire (FFQ),
and provide a blood sample. Blood loss was quantified by recording volume of 
blood donation, estimation of menstrual losses, and experiences of nose bleeds.
DQES v3.1, a 140-item FFQ, was used to estimate usual dietary intakes of foods 
and nutrients. Blood samples were analysed for serum ferritin, haemoglobin, C-
reactive protein, serum zinc, and hepcidin concentrations. 
The aims of the descriptive study of iron and zinc intakes were to describe dietary 
intakes of iron and zinc and intakes including supplements, assess adequacy of 
dietary intakes of iron and zinc in comparison with nutrient reference values, and
identify the main dietary sources of iron and zinc. Mean dietary intake of iron was 
10.5 (SD 3.5) mg/d and median dietary zinc intake was 8.7 (IQR 7.0 to 11.1) mg/d. 
Thirty-one percent of women were at risk of inadequate dietary iron intakes and 
19% at risk of inadequate dietary zinc intakes. The three main food sources of iron 
were cereals and cereal products (contributing 31% of dietary iron intake), 
vegetable products and dishes (16%), and meat and poultry products and dishes 
(14%). The main sources of zinc were meat and poultry products and dishes 
(contributing 30% of dietary zinc intake), milk products and dishes (19%), and 
cereals and cereal products (17%). In addition to the proportion of women at risk 
of inadequate dietary intakes, of note was women’s reliance on plant-based 
sources of iron, which may have placed them at further risk of inadequacy due to 
reduced bioavailability of non-haem iron.
The aims of the second study were to investigate associations between dietary iron 
and zinc intakes, and to investigate associations between biochemical iron and zinc 
status as assessed using serum ferritin and serum zinc concentrations, respectively.
A positive relationship between dietary iron and zinc intakes was observed, with 
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each 1 mg/d increase in dietary iron intake associated with a 0.4 mg/d increase in 
dietary zinc intake (p < .001). Furthermore, women who did not meet Australian 
dietary zinc recommendations were more likely to present with inadequate dietary 
iron intakes; 63% of women with low zinc intakes were at risk of inadequate 
dietary iron intakes, compared with 23% of women with adequate zinc intakes.
There was less of an association between iron and zinc status. Although each 1 
μmol/L increase in serum zinc corresponded to a 6% increase in serum ferritin (p
= .019), women with low iron stores were not more likely to present with low 
serum zinc concentrations. This finding suggests there is not a clinically 
meaningful association between iron and zinc status in premenopausal women in 
Australia.
The aims of the third study were to identify dietary determinants of iron stores in 
women, after accounting for blood loss, and to determine whether iron intake 
predicts iron stores independently of circulating hepcidin concentrations. After 
accounting for blood donation and menstrual losses, each 1 mg/d increase in 
dietary iron intake was associated with a 3% increase in iron stores (p = .027). The 
source of iron was important, and each 10% increase in total meat intake was 
associated with a 1% increase in iron stores (p = .006) (e.g. an increase in the 
geometric mean of total meat intake from 92 to 101 g/d was associated with an 
increase in the serum ferritin geometric mean from 29.3 to 29.6 μg/L). Intakes of 
cereals and vegetables were not associated with iron stores. Intakes of iron 
absorption inhibitors and enhancers, including phytate and ascorbic acid, were also 
not associated with iron stores. Hepcidin was found to be a more influential 
determinant of iron stores than blood loss and dietary factors combined (R2 of 
model including hepcidin = .65; R2 of model excluding hepcidin = .17, p for 
difference < .001), and increased hepcidin concentration diminished the positive 
association between dietary iron intake and iron stores. These findings indicate 
manipulation of hepcidin production may be an important means of improving iron 
status in women with deficiency, and may be a useful adjunct to dietary advice 
recommending increased consumption of total iron and absorption enhancers and 
decreased consumption of absorption inhibitors.
The aims of the fourth study were to identify nutritional determinants of serum 
zinc after accounting for confounders of serum zinc concentration, and to 
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investigate whether sources of blood loss are determinants of serum zinc 
concentration. For each 10% increase in consumption of white meat (e.g. increase 
in geometric mean from 60 to 66 g/d) and total meat (e.g. increase in geometric 
mean from 92 to 101 g/d), serum zinc concentrations increased by 0.02 μmol/L
(white meat p = .028; total meat p = .037). Serum zinc concentration was not 
associated with consumption of red meat or dietary zinc intakes, and the negative 
association with the molar ratio of phytate:zinc did not reach statistical 
significance (p = .087). These findings tentatively suggest absorbable zinc may be 
a determinant of serum zinc concentration, but stronger evidence and appropriate 
phytate data are needed. Menstrual losses and blood donation were not associated
with serum zinc concentration. The modelling of determinants of zinc status only 
explained at most 6% of variance in serum zinc concentrations, indicating much 
more work is needed to understand factors influencing serum zinc concentrations.
In summary, although associations between dietary iron and zinc intakes and 
similarities in dietary sources of iron and zinc were observed in the current study,
associations between iron and zinc status were not clinically meaningful.
Therefore, the prevalence of zinc deficiency in the Australian population cannot be 
assumed through extrapolating data describing the prevalence of iron deficiency,
and serum ferritin cannot be used as a proxy for serum zinc concentration in 
premenopausal women in Australia. Dietary iron intake and consumption of meat 
were positive determinants of iron stores, but circulating hepcidin concentration 
was a more powerful influence. Future investigations of dietary determinants of 
iron status accordingly need to consider hepcidin, and hepcidin modifiers need to 
be identified and tested in interventions for their ability to affect iron status.
Intakes of white meat and total meat were positively associated with serum zinc 
concentrations but only a marginally negative effect of the molar ratio of 
phytate:zinc was observed. As very little variance in serum zinc concentrations 
could be explained by the identified confounders, critical areas for future research 
include furthering understanding of determinants of serum zinc concentrations to 
best identify dietary and lifestyle factors that can improve zinc concentrations.
Given that 30% of the study population had low iron stores and 17% had low 
serum zinc concentration, understanding determinants and establishing effective 
dietary interventions in premenopausal women should be considered priority 
health targets.
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Chapter 1: Introduction
Iron and zinc are the two most abundant trace minerals in the human body, with 3-
4 g of iron and 1.5-2.5 g of zinc present in the average adult (King & Cousins, 
2006; Wood & Ronnenberg, 2006). In human nutrition, zinc and iron are 
frequently assessed together (Donovan & Gibson, 1995; Gibson et al., 1999; Hunt, 
2002, 2003; Kordas & Stoltzfus, 2004; Nair et al., 2013; Sandstead, 2000) as these
minerals are found in similar food sources such as meat and legumes, and the 
absorption of both is believed to be enhanced and inhibited by similar compounds 
such as phytate (Gibson et al., 1999; Hunt, 2002; Nair et al., 2013; Sandstead, 
2000). Consequently, deficiencies of iron and zinc are thought to occur 
simultaneously. As an example, the International Zinc Nutrition Consultative 
Group (IZiNCG) has used the prevalence of iron-deficiency anaemia across 
populations as ‘suggestive evidence’ of risk of zinc deficiency, citing shared food 
sources and absorption inhibitors and enhancers as rationales (Brown et al., 2004).
Noting iron deficiency is the most prevalent nutritional disorder worldwide (World 
Health Organization, 2000b), and globally 10% of women 15-49 years of age 
present with severe iron deficiency (World Health Organization, 2015), zinc 
deficiency may be similarly widespread. 
Understanding biochemical zinc status and the association between iron status and 
zinc status has been limited by the lack of a specific, sensitive and practical 
biomarker of zinc (Brown et al., 2004). Serum zinc concentration is the most 
commonly used marker and the only marker with population reference data, but 
only recently have important confounders of serum zinc measurement been 
identified: fasting status, diurnal variation, inflammation and use of oral 
contraception each affect serum zinc concentration (Brown et al., 2004).
Furthermore, zinc in serum is present only in minute concentrations, and samples 
are easily contaminated by zinc present in dust and on equipment, raising logistic 
issues for data collection. Assessing serum zinc concentrations may advance 
understanding of the dietary determinants of zinc status and characteristics that 
place groups at risk of zinc deficiency, but there is a need for studies that account 
for the biological and logistic issues associated with measurement. Likewise, 
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studies that assess both serum zinc concentration and a marker of iron status of a 
group can confirm the proposed association between iron and zinc status.
Compared to zinc status, there are several biomarker options to assess iron status 
and knowledge of factors influencing iron status is more developed. It is 
recognised that any source of blood loss is a risk factor for impaired iron status and 
that accordingly, menstrual losses place women at increased risk of iron deficiency
(Institute of Medicine, 2001). The effect of iron bioavailability on iron status is 
less established. Although studies measuring absorption have shown iron 
bioavailability can be increased with simultaneous consumption of ascorbic acid 
(Diaz, Rosado, Allen, Abrams, & Garcia, 2003; Hallberg, Brune, & Rossander, 
1986; Hallberg & Rossander, 1982; Nair et al., 2013) or meat (Bjorn-Rasmussen & 
Hallberg, 1979; Cook & Monsen, 1976), and decreased with consumption of 
phytate (Hallberg, Brune, & Rossander, 1989; Hallberg, Rossander, & Skanberg, 
1987), the expected effects on iron status have not been consistently demonstrated. 
It has been noted that there is considerable inter-individual variation in iron 
absorption, and that individuals seem to adapt to the bioavailability of their diet 
(Collings et al., 2013). Hepcidin, a peptide produced by the liver (Park, Valore, 
Waring, & Ganz, 2001), may account for the variation in absorption between 
individuals and the observed adaptation to diet bioavailability. Increased hepcidin 
production reduces iron transport from the enterocyte into the bloodstream 
(Nemeth, Tuttle, et al., 2004), and there is evidence of a genetic link in hepcidin 
production that may explain the inter-individual variation in absorption 
(Pietrangelo, 2004). If the genetic influence on hepcidin production is sufficiently 
strong, it may explain adaptation to bioavailability, and may override dietary 
influences on iron status, potentially limiting the effectiveness of dietary 
recommendations to improve iron absorption. Whether hepcidin holds more 
influence than dietary aspects has been postulated (Demeyer, De Smet, & Ulens, 
2014) but not tested, and no studies have investigated the combined effect of 
hepcidin, diet and blood loss on any marker of iron status. 
The overall aims of this thesis were to assess dietary intakes of iron and zinc; to 
investigate dietary determinants of iron and zinc status; and to identify possible 
associations between iron and zinc intakes and biochemical status in a sample of 
premenopausal women in Australia.
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Components of this chapter have been published in Lim, K. H., Riddell, L. J., 
Nowson, C. A., Booth, A. O., & Szymlek-Gay, E. A. (2013). Iron and zinc 
nutrition in the economically-developed world: A review. Nutrients, 5(8), 3184-
3211. doi: 10.3390/nu5083184.
2.1 Iron and Zinc Physiology
The physiologies of iron and zinc in the body are interestingly contrasting. Iron in 
haemoglobin within red blood cells binds to oxygen and is crucial for transporting 
oxygen around the body; accordingly, approximately 60% of iron in the body is 
present in red cells (Institute of Medicine, 2001). Twenty-five percent of the 
body’s iron is stored as ferritin or haemosiderin, primarily in the liver, spleen and 
bone marrow, and these stores are mobilised when iron demand (i.e. losses) 
exceeds intake (Institute of Medicine, 2001). The remaining iron is used in 
myoglobin where it facilitates muscular oxygen use, and in proteins such as 
cytochromes and enzymes where it is essential for generation of cellular energy 
and enzymatic function (Institute of Medicine, 2001). In adults, iron losses consist 
of basal losses in faeces, epithelial cells, sweat and urine, and any blood losses 
given most iron is present in blood (Beard, Dawson, & Pinero, 1996; Gibson, 
2005). Estimates of the amount of iron lost through these routes are provided in 
Table 2.1. Of note are the substantial menstrual iron losses experienced by 
premenopausal women (Table 2.1) that increase women’s iron requirements and 
increase risk of impaired iron status (Institute of Medicine, 2001). Oral 
contraceptive use reduces the magnitude of menstrual loss (Institute of Medicine, 
2001) and can be used to intentionally skip menstrual cycles if the hormonal pills 
are continuously taken (i.e. the inactive pills are discarded). As iron losses are not 
actively controlled by the body, iron balance is maintained through up- or down-
regulation of absorption via the peptide, hepcidin (section 2.1.1 Iron and zinc 
regulation.).
In contrast to iron, the body does not actively maintain zinc stores (Institute of 
Medicine, 2001). Instead, when zinc demand exceeds intakes, pools of zinc are 
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rapidly redistributed, although this redistribution does not occur uniformly across 
the body (Brown et al., 2004). Over 60% of total body zinc is found in skeletal 
muscle (Brown et al., 2004), and muscular zinc levels are preserved even in severe 
zinc depletion (King, Shames, & Woodhouse, 2000). Approximately 20% of zinc 
is present in bone, and this zinc can be considered a ‘passive reserve’ as some zinc 
can be mobilised during normal bone turnover, and in states of zinc depletion less 
zinc is transferred to the bone (Brown et al., 2004). The body’s remaining zinc is 
distributed across other tissues in low concentrations, for example 3% in the liver, 
1% in the kidneys, and 1% in whole blood (Brown et al., 2004). For unknown 
reasons, the zinc in these tissues is rapidly shifted to maintain homeostasis in 
skeletal muscle, the heart (< 1% of body zinc), and skin (2% of body zinc) (Brown 
et al., 2004; King et al., 2000). While the main function of iron is oxygen 
transport, there is no analogous specific role of zinc (King, 2011). Rather, zinc is 
an essential component of the structure or function of over 300 enzymes and 
accordingly, zinc is necessary for immune function, gene expression, appetite 
regulation, and protein, lipid and carbohydrate metabolism (Gibson, 2005, 2012).
Gastrointestinal secretion of zinc represents the major route of zinc loss (Table 
2.1), and is notable as it is the body’s active means of removing excess zinc, 
distinct from the passive routes of iron loss (section 2.1.1 Iron and zinc 
regulation.). This difference in iron and zinc regulation is an important factor 
distinguishing absorption of iron and zinc. 
Table 2.1 Main routes of iron and zinc losses
Main routes of iron loss Main routes of zinc loss
Faeces (from occult blood loss and 
shed enterocytes; 0.6 mg/day)
Endogenous intestinal losses (0.5 to 3 
mg/day)
Menstrual blood (0.4 to 0.5 mg/day) Urine (0.5 to 0.7 mg/day)
Skin cells and sweat (0.2 to 0.3 
mg/day) Skin cells (0.5 to 0.7 mg/day)
Urine (0.08 mg/day) Semen (1 mg/ejaculate)
(Brown et al., 2004; Gibson, 2005; King & Cousins, 2006; Wood & Ronnenberg, 
2006).
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2.1.1 Iron and zinc regulation.
It is understood that the human body regulates iron status through absorption 
rather than active secretion of excesses: when iron status is impaired, iron
absorption increases (Hallberg, 1981; Zimmermann & Hurrell, 2007). Intestinal 
iron absorption (Figure 2.1) is at least partly controlled by hepcidin, a peptide 
produced primarily by hepatocytes (Park et al., 2001). In food, iron is present as
haem iron and inorganic non-haem iron, with haem iron present exclusively in 
meats and non-haem iron present across the food chain in plants, eggs, milk, and 
meats (Gibson, 2005). Prior to absorption, non-haem iron needs to be released 
from food and reduced from the oxidised Fe3+ form to Fe2+, then transported into 
the enterocyte via divalent metal transporter 1 (DMT1) (Andrews, 2008;
Steinbicker & Muckenthaler, 2013), and it is thought haem iron, naturally present 
as Fe2+, enters the enterocyte via the haem-folate co-transporter, haem carrier 
protein 1 (HCP1) (Laftah et al., 2009). From the enterocyte, iron is exported by 
ferroportin, oxidised and then bound to transferrin for transport (Andrews, 2008;
Steinbicker & Muckenthaler, 2013). Any iron remaining in the enterocyte is lost 
when the cell is shed from the lumen. Circulating hepcidin binds to and engulfs 
ferroportin, trapping iron in enterocytes that are subsequently shed, and in 
macrophages preventing normal iron cycling (Nemeth, Tuttle, et al., 2004). The 
influence of hepcidin on DMT1 is less explored than the influence on ferroportin, 
although there is evidence that circulating hepcidin impairs expression of DMT1 
(Brasse-Lagnel et al., 2011).
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Evidence for a strong genetic influence on hepcidin production and therefore iron 
status originates largely from research relating to haemochromatosis, a group of 
iron overload disorders caused by mutations in iron-related genes (Pietrangelo, 
2004). The most common form of haemochromatosis, classic hereditary 
haemochromatosis, is caused by autosomal recessive mutations on the HFE gene 
thought to modulate hepcidin expression, and a form of juvenile 
haemochromatosis is caused by autosomal recessive mutations in HAMP, the gene 
that directly encodes hepcidin (Pietrangelo, 2004). These mutations appear to 
down-regulate expression, leading to hepcidin deficiency and excessive iron 
absorption (Pietrangelo, 2004). Conversely, hepcidin is overexpressed in mutations 
of the TMPRSS6 gene that, in normal circumstances, expresses a protease that 
suppresses hepcidin production (Ganz & Nemeth, 2011). Autosomal recessive 
mutations in this gene can cause familial iron-refractory iron deficiency anaemia, 
in which patients have normal or high levels of circulating hepcidin but frank iron 
deficiency (Ganz & Nemeth, 2011). In addition to genetic mutations, hepcidin 
production is down-regulated in states of hypoxia and erythropoietic activity (e.g. 
Figure 2.1 Iron absorption through the enterocyte and into the bloodstream. 
Non-haem iron is reduced and the resulting Fe2+ is brought into the enterocyte 
by divalent metal transporter 1 (DMT1). Haem iron is brought into the 
enterocyte by haem carrier protein 1 (HCP1). Iron remains in the cell until 
exported into circulation by ferroportin or the enterocyte is shed from the 
body. Hepcidin binds to ferroportin, preventing export of iron in the 
enterocyte.
Figure based on Andrews (2008), Steinbicker and Muckenthaler (2013) and 
Zimmermann and Hurrell (2007).
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haemorrhage or haemolysis), and upregulated with inflammation (Ganz, 2011).
Importantly, there is evidence the presence of iron also regulates hepcidin 
production. Urinary hepcidin levels in adults increased five-fold within 24-hours 
of ingesting 65 mg iron (Nemeth, Rivera, et al., 2004), but this response has only 
been demonstrated acutely. In the same study, urinary hepcidin levels returned to 
baseline levels on the following two days, despite participants continuing 
supplementation (Nemeth, Rivera, et al., 2004), and women consuming 56 mg/d 
fortificant iron for nine weeks did not experience any change in circulating 
hepcidin levels (Karl et al., 2010). This apparent inability to maintain elevated 
hepcidin levels with continued exposure to high-dose supplements perhaps 
suggests the genetic influences on hepcidin production and thus iron status
supersedes the influence of iron intake.
In contrast to iron, the body largely regulates zinc homeostasis through 
gastrointestinal secretion and excretion of endogenous zinc (Institute of Medicine, 
2001; Sandström, 1997). The amount of zinc secreted via the intestine is positively 
associated with zinc intakes, indicating the secretions (Table 2.1) are a means to 
maintain zinc homeostasis (Institute of Medicine, 2001). For example, when zinc 
intakes are low, faecal zinc losses may total less than 1 mg/d, and when intakes are 
high losses may exceed 5 mg/d (Institute of Medicine, 2001). There is emerging 
evidence that expression of certain proteins that transport zinc from the intestinal 
lumen into the enterocyte (ZIP4, ZIP11, ZIP14) increases in states of zinc 
deficiency or restriction, but this response has only been demonstrated in cell and 
animal models (Cousins, 2010), and the field is not as established as that of 
hepcidin as a regulator of iron status.
2.2 Implications of Impaired Iron and Zinc Status
When iron losses exceed the amount of iron absorbed and this negative iron 
balance is maintained, deficiency develops over three stages: iron store depletion 
(stage 1), where the body’s iron stores are reduced but there is adequate iron to 
meet cellular needs; iron-deficient erythropoiesis (stage 2), where there is reduced 
iron available for erythropoiesis as iron stores are diminished and cellular needs
cannot be met; leading to iron-deficiency anaemia (stage 3), where stores are 
completely exhausted, and erythropoiesis and oxygen transport are severely 
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impeded (Gibson, 2005; Hallberg, 2001). Suboptimal iron status in women has 
been demonstrated to adversely affect physical performance, including diminished 
oxygen consumption (Pasricha, Low, Thompson, Farrell, & De-Regil, 2014), and 
cognitive ability (Leonard, Chalmers, Collins, & Patterson, 2014b; Murray-Kolb & 
Beard, 2007; Steinbicker & Muckenthaler, 2013). Through their meta-analysis, 
Pasricha et al. (2014) deduced that relative maximal aerobic capacity, measured as 
VO2 max adjusted for body weight, was impaired even in the early stages of iron 
deficiency (i.e. prior to developing iron-deficiency anaemia), although absolute 
VO2 max unadjusted for body weight was impaired only in those with anaemia 
(Pasricha et al., 2014). Evidence for the effect of impaired iron status on cognition 
is somewhat weaker and findings are inconsistent across different cognitive 
domains and assessment tasks. The most convincing is a randomised controlled 
trial that improved iron status using supplements and accordingly improved 
performance on memory, learning and attention tasks (Murray-Kolb & Beard, 
2007). Other interventions have also found that improvements in serum ferritin 
have led to improved attention and faster task response (Blanton, 2014; Leonard et 
al., 2014b). Cross-sectional analyses have also shown that performance on 
memory, learning and attention tasks progressively worsens with increased 
severity of iron deficiency (Murray-Kolb & Beard, 2007); increased body iron 
irrespective of haemoglobin level is associated with better performance in tests of 
spatial working memory and planning speed (Blanton, 2014); and increased body 
iron in the absence of anaemia is associated with faster planning speed (Blanton, 
Green, & Kretsch, 2013). However, body iron and serum ferritin have been 
negatively correlated with performance on memory tasks (Blanton et al., 2013),
and women with non-anaemic iron deficiency and healthy controls did not perform 
differently on tests assessing memory, response speed, or attention (Leonard et al., 
2014b). Thus, the effect of iron status on cognitive ability remains controversial.
In comparison to iron status, there is little information concerning the health 
implications of impaired zinc status. Much understanding of the health 
implications of severe zinc deficiency comes from observations of patients with 
untreated acrodermatitis enteropathica, an autosomal recessive disorder that causes 
zinc malabsorption via mutations in ZIP4 (Brown et al., 2004; Kasana, Din, & 
Maret, 2015; Van Wouwe, 1989). Reflecting the broad functions of zinc in the 
body, symptoms of severe deficiency are similarly non-specific and include a 
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‘classic triad’ of severe dermatitis, alopecia and diarrhoea (Wessells, King, & 
Brown, 2014) that occurs in just 20% of cases of deficiency (Sehgal & Jain, 2000),
and growth stunting, nail deformation and miscarriage (Van Wouwe, 1989). As 
covered in two comprehensive reviews (Fraker, King, Laakko, & Vollmer, 2000;
Shankar & Prasad, 1998), correction of even moderate zinc deficiency using 
supplementation returns production and function of immune components to normal 
(e.g. lymphocytes, macrophages) (Fraker et al., 2000; Shankar & Prasad, 1998),
demonstrating the important role of zinc in the immune system. However, this 
work is predominantly based on animal models and more human studies are 
required (Fraker et al., 2000). A meta-analysis of randomised trials concluded that 
zinc supplementation can be a useful adjunct to antidepressant medication for 
treating major depressive disorder, although it is not clear whether zinc deficiency 
may be a cause of major depression (Lai et al., 2012). In addition to the non-
specific symptoms, effects of mild or marginal zinc deficiency have been difficult 
to ascertain due to lack of a zinc biomarker that is both specific and sensitive to 
zinc status (King, 2011).
2.3 Assessing Iron and Zinc Status
The physiology of iron is such that there are numerous measures that can together 
provide a full picture of an individual’s iron status. Serum ferritin is positively 
correlated with the amount of stored iron in bone marrow, and thus reflects the 
level of iron stores in the body (Gibson, 2005). It reflects whether iron status is 
normal, deficient or in overload, although the severity of deficiency cannot be 
differentiated using serum ferritin alone (Gibson, 2005). As serum ferritin is a 
positive acute phase protein, in states of inflammation or infection serum ferritin 
concentrations are elevated and no longer correlate with iron stores, and the World 
Health Organization has recommended that serum ferritin is interpreted in 
conjunction with at least one inflammatory marker (e.g. C-reactive protein) (World 
Health Organization/Centers for Disease Control and Prevention, 2007). There is 
conjecture surrounding reference values used to interpret serum ferritin (with or 
without inflammation), and the World Health Organization and the US Centers for 
Disease Control and Prevention are together conducting a series of systematic 
reviews with the goal of internationally harmonising reference values (Garcia-
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Casal, Peña-Rosas, & Pasricha). Presently, < 15 μg/L (World Health 
Organization/Centers for Disease Control and Prevention, 2007) or < 20 μg/L 
(Gibson, 2005) are thought to indicate depleted iron stores that characterise stage 1 
of deficiency. In stage 2 of deficiency, serum ferritin concentration further 
declines. During this stage, the reduced supply of iron to the bone marrow is 
reflected in decreased transferrin saturation. Transferrin saturation is an index of 
serum iron to total iron binding capacity, and when iron decreases, transferrin 
molecules transport less iron. Simultaneously, serum transferrin receptor 
concentration increases as cells produce more receptors to receive transferrin at the 
membrane (Gibson, 2005). In stage 3, the haemoglobin concentration of whole 
blood decreases. However, decreased haemoglobin concentration alone cannot be 
used to identify iron-deficiency anaemia as anaemia has other aetiologies in 
addition to iron deficiency, necessitating the use of other iron biomarkers (Gibson, 
2005). The World Health Organisation has suggested that in addition to 
haemoglobin, serum ferritin or transferrin receptor is also measured to assess iron 
status (World Health Organization/Centers for Disease Control and Prevention, 
2007).
Biomarkers of zinc status are less established than markers of iron, and there are 
no zinc biomarkers appropriate to evaluate an individual’s zinc status (King, 
2011). Difficulties of measuring zinc status can be attributed to zinc being used 
across an array of processes, in contrast to the physiology of iron (King, 2011).
Indicators of zinc status have included: zinc concentrations of serum or plasma, 
hair, and cells such as erythrocytes and platelets; activity of zinc-dependent 
enzymes and proteins such as alkaline phosphatase; and measures of zinc kinetics 
(i.e. zinc turnover) (Brown et al., 2004; Gibson, Hess, Hotz, & Brown, 2008). Hair 
zinc concentrations represent the amount of zinc available to the hair follicle 4-8
weeks prior to sampling, and hence are stable and reflect chronic zinc status 
(Gibson, 2005). There are strong indications that hair zinc is a valid zinc 
biomarker in young children, but its suitability in adults is unknown as are the 
effects of age, beauty treatments and rate of hair growth (Brown et al., 2004). The 
zinc concentrations of erythrocytes and platelets are also thought to represent zinc 
status over a longer period of time, for instance erythrocyte zinc reflects the 120-
day lifecycle of the erythrocyte (Gibson, 2005), although its usefulness is limited 
as it does not reflect dietary changes (Lowe, Fekete, & Decsi, 2009). The activity 
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of alkaline phosphatase in serum (as the most commonly studied zinc-dependent 
enzyme) is reduced in severe zinc deficiency but specificity to zinc status is poor 
(Gibson et al., 2008), and activity is also reduced in response to conditions 
including magnesium deficiency and cardiac surgery (Lum, 1995). Kinetic studies 
estimate the size of an individual’s exchangeable zinc pool (EZP; the zinc that is 
redistributed) or the rate of its turnover; in severe deficiency, the EZP size is 
reduced and turnover speed increases (Gibson et al., 2008). As kinetic studies 
involve administration of stable isotopes and follow-up measurements, they are 
costly and time-consuming (Gibson et al., 2008). The most commonly used marker 
of zinc status, and the only zinc biomarker with population reference data, is serum 
or plasma zinc concentration (Brown et al., 2004; Hotz, Peerson, & Brown, 2003).
As opposed to other biomarkers, serum zinc responds to zinc intake, and in a
recent meta-analysis of randomised controlled trials and observational studies, 
Lowe et al. (2012) quantified a dose-response: each doubling of zinc intake (mg/d) 
increased serum zinc concentration by 6% (Lowe et al., 2012). However, there are 
important limitations that affect interpretation of serum zinc. Serum zinc 
concentrations are not considered a specific marker of zinc nutrition as low 
concentrations may reflect the rapid redistribution of the zinc pool to meet tissue 
requirements, including in inflammatory states when circulating zinc is shifted to 
the liver; low concentrations may also be observed in states of haemodilution,
including use of oral contraception or pregnancy; circulating zinc undergoes 
diurnal variation (concentrations being highest in the morning) and concentrations 
are slightly higher in a fasting state; the low quantities of zinc in serum leave 
samples vulnerable to contamination (e.g. zinc in dust); and importantly, 
circulating zinc may not reflect marginal zinc deficiency as when intakes are 
moderately low, serum zinc is likely to remain in the normal range (i.e. 12-15
μmol/L) – substantial declines in serum zinc concentration generally only manifest 
with intakes of 2-3 mg/d (Brown et al., 2004; Gibson et al., 2008). Provided these 
limitations are acknowledged (e.g. recording fasting status and time of sampling, 
recording oral contraceptive use, taking measures to prevent contamination), 
circulating zinc concentrations are a useful indicator of the zinc status of a 
population (Brown et al., 2004).
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2.4 Iron and Zinc Status of Populations
Serum ferritin and serum zinc concentrations have been used to assess the iron and 
zinc status in population surveys of economically-developed nations, including 
Australia. Table 2.2 displays the mean serum ferritin concentrations of such 
surveys and the prevalence of adequacy or inadequacy. Variation in age groupings 
and cut-off values for adequacy prevent direct comparisons between countries, 
although it is evident that compared to men, women have lower serum ferritin and 
are more likely to have suboptimal serum ferritin concentrations. In women, serum 
ferritin concentrations seem to increase with age, in line with menopausal status 
(Table 2.2).
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Table 2.2 Serum and plasma ferritin concentrations and prevalence of low 
ferritin in national surveys
Country Survey Sample
Ferritin 
(mean (95% 
CI) μg/L)
% low 
ferritin
Australia
Australian Health 
Survey 2011-2013
(Australian Bureau of 
Statistics, 2014a)
Males 18+ y (n =
2258) 205
a (SE 1.7) 2b
Females 18+ y (n
= 2815) 87
a (SE 1.9) 8b
Canada
2009-2011 Canadian 
Health
Measures Survey 
(Cooper, Greene-
Finestone, Lowell, 
Levesque, & Robinson, 
2012)
Males 20-49 yc 164
d
(152-177) 1
b
Males 50-64 yc 166
d
(148-187) 1
b
Males 65-79 yc 155
d
(138-175) 0
b
Females 20-49 ye 4
d
(38-44) 9
b
Females 50-64 ye 85
d
(73-98) 6
b
Females 65-79 ye 89
d
(74-107) 6
b
New 
Zealand
2008/09 New Zealand 
Adult Nutrition Survey 
(University of Otago and 
Ministry of Health,
2011)
Males 15+ y (n =
1470)
177a
(165-189) 2
f
Females 15+ y (n
= 1878)
79a
(75-84) 8
f
UK
2008/09-2010/11 UK 
National Diet and 
Nutrition Survey (UK
Department of Health, 
2011b)
Males 19-64 y (n
= 160) 155
a,g
N/AFemales 19-64 y 
(n = 231) 53
a,g
US
NHANES 2003-2006
(US Centers for Disease 
Control and Prevention, 
2012)
Females 20-39 yh
(n = 1780)
37
(34-40)d
Females 
20-49 y 
(n = 2539)
3b
Females 40-49 yh
(n = 759)
40.0
(35-46)d
Note. NHANES = National Health and Nutrition Examination Survey (mean 
ferritin was assessed in the 2005-2006 cycle; prevalence of low ferritin was 
assessed in the 2003-2006 cycle); CI = confidence interval; SE = standard error.
a Arithmetic mean.
b /RZIHUULWLQGHILQHGDVȝJ/
c Total n = 1684 Canadian males aged 20-79 y.
d Geometric mean.
e Total n = 1975 Canadian females aged 20-79 y.
f /RZIHUULWLQGHILQHGDVȝJ/
g No CI or SE available.
h Ferritin not measured in adult males.
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The International Zinc Nutrition Consultative Group (IZiNCG) has suggested 
serum zinc reference ranges for use in population studies based on the 2.5th 
percentile of NHANES II (1976-1980) participants (Brown et al., 2004), however 
given the difficulties with measuring a marker present in such minute quantities 
and the logistics of enforcing fasting status for blood sampling in national surveys, 
few countries have measured zinc concentrations. Presented in Table 2.3 are the 
US’ serum zinc concentrations from NHANES II (1976-1980) (Hotz & Brown, 
2004) and the UK’s measurements of plasma zinc from the 2008/09-2010/11 
National Diet and Nutrition Survey (UK Department of Health, 2011b). Similar to 
serum ferritin, it appears males have higher zinc concentrations than females.
Table 2.3 Serum and plasma zinc concentrations in national surveys
Country Survey Sample Mean zinc ȝPRO/
2.5th
percentile 
ȝPRO/
US
NHANES II 
1976-1980
(Hotz &
Brown, 2004;
Hotz et al., 
2003)
Males 10-64 y
AM fasting (n = 1767) 15.0
a 11.3
Males 10-64 y
AM non-fasting (n =
1750)
14.4a 10.7
Males 10-64 y
PM (n = 2765) 12.5
a 9.3
Females 10-70+ y
AM fasting (n = 1576) 14.1
a 10.7
Females 10-70+ y
AM non-fasting (n =
1658)
12.5a 10.1
Females 10-70+ y
PM (n = 2343) 11.6
a 9.0
UK
2008/09-
2010/11 UK 
National Diet 
and Nutrition 
Survey (UK
Department of 
Health, 
2011b)
Males 19-64 y
AM fasting (n = 160) 15.8
b 10.3
Females 19-64 y
AM fasting (n = 231) 15.5
b 10.0
Note. NHANES – National Health and Nutrition Examination Survey.
a Serum zinc; geometric mean.
b Plasma zinc; arithmetic mean.
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2.5 Recommended Intakes of Iron and Zinc
Many countries have quantified the dietary requirements of humans. These 
reference values are generally determined by a panel based on scientific evidence 
and are used to assess whether the intakes of individuals or groups are adequate 
(Lawrence & Robertson, 2007). For each nutrient, recommendations are derived 
from the frequency distribution of requirements of a group of individuals. The 
resulting values are an Estimated Average Requirement (EAR), which is generally
the quantity meeting the needs of half the healthy individuals in a given life stage 
and sex group (i.e. the 50th percentile) (Institute of Medicine, 2001). Another key 
reference value can be derived from the EAR, known as the Recommended 
Dietary Intake (RDI) in Australia and New Zealand, the Recommended Dietary 
Allowance (RDA) in the US and Canada, and the Reference Nutrient Intake (RNI)
in the UK (Lawrence & Robertson, 2007). This value meets the requirements of 
nearly all individuals in a given life stage and sex group. Across the US, Canada, 
the UK, New Zealand and Australia, the EAR for iron ranges from 5-11.4 mg/day 
and the EAR for zinc ranges from 5.5-12 mg/day (Table 2.4). While 
recommendations vary across these economically-developed nations, there is 
consistency in that greater amounts of iron are recommended for women, and 
greater amounts of zinc are recommended for men. These sex-specific differences 
reflect the recognised routes of bodily iron and zinc losses displayed in Table 2.1.
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Table 2.4 Recommended intakes of iron and zinc in Australia and New 
Zealand, UK, and US and Canada
Australia and New 
Zealand (National 
Health and Medical 
Research Council, 
2006)
UK (Department 
of Health, 1991)
US and Canada 
(Institute of 
Medicine, 2001)
EAR 
(mg/d)
RDI 
(mg/d)
EAR 
(mg/d)
RNI 
(mg/d)
EAR 
(mg/d)
RDA 
(mg/d)
Iron
Males 
19-50 y 6 8 6.7 8.7 6 8
Males 
51+ y 6 8 6.7 8.7 6 8
Females 
19-50 ya 8 18 11.4 14.8 8.1 18
Females 
51+ y 5 8 6.7 8.7 5 8
Zinc
Males 
19-50 y 12 14 7.3 9.5 9.4 11
Males 
51+ y 12 14 7.3 9.5 9.4 11
Females 
19-50 ya 6.5 8 5.5 7.0 6.8 8
Females 
51+ y 6.5 8 5.5 7.0 6.8 8
Note. EAR = Estimated Average Requirement (meets the needs of 50% of 
individuals in the life stage group); RDI/RNI/RDA = Recommended Dietary 
Intake/Reference Nutrient Intake/Recommended Dietary Allowance (meets the 
needs of nearly all individuals in the life stage group).
a Non-pregnant and non-lactating women.
2.6 Iron and Zinc Intakes of Populations
Government agencies in the US, Canada, the UK, New Zealand and Australia have 
assessed population dietary iron and zinc intakes, and the US, the UK, New 
Zealand and Australia have also assessed the main dietary sources contributing to 
these intakes (Table 2.5 and Table 2.6). It is noteworthy that in these regions, 
inadequate iron and zinc intakes have been linked to low energy intakes attributed 
to weight loss diets and poor dietary habits (Gibson et al., 2008; Houston, 
Summers, & Soltesz, 1997). As foods have been categorised differently in these 
national surveys (e.g. whether pasta or rice have been grouped with breakfast 
cereals and bread), foods have been grouped into broader categories in Table 2.5
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and Table 2.6 for consistency. Across the surveys and among males and females, 
the bulk of dietary iron and zinc was sourced from cereal and meat products. 
Vegetables contributed to iron but not zinc intakes, and dairy contributed to zinc 
but not iron intakes. Males had higher intakes of both iron and zinc than females. 
Females were more likely to have inadequate iron intakes than males in all 
countries. In contrast, due to the higher recommendations for males, males were 
more likely than females to have inadequate zinc intakes in all countries but the 
US (Table 2.5 and Table 2.6).
The contribution of cereal foods to iron and zinc intakes (Table 2.5 and Table 2.6)
is noteworthy as these foods are often targets for fortification. In economically-
developed countries, such fortification tends to be market-driven (e.g. voluntary 
fortification of breakfast cereals) or targeted-fortification (e.g. infant formula), as 
opposed to mass-fortification (e.g. mandatory fortification of staple foods such as 
wheat flour) (Allen, de Benoist, Dary, & Hurrell, 2006). The balance of these three 
forms of iron and zinc fortification varies across countries. Mass-fortification of 
iron in wheat flour is mandatory in the US, Canada (each 44 ppm; began in the 
1940s (Institute of Medicine, 2003)) and the UK (16.5 ppm, began in 1953 
(Scientific Advisory Committee on Nutrition, 2010)) but is not mandatory in 
Australia or New Zealand (Flour Fortification Initiative, 2012). Mass zinc 
fortification is not mandatory in any English-speaking, economically-developed 
country, and is only mandatory in countries which are not a focus of this review: 
Indonesia (30 ppm in wheat flour), Jordan (20 ppm in wheat flour), Mexico (16 
ppm in wheat and maize flours) and South Africa (15 ppm in wheat and maize 
flours) (Brown, Hambidge, & Ranum, 2010; Flour Fortification Initiative, 2012).
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2.7 Inhibitors and Enhancers of Absorption
Iron and zinc are noted to interact with other meal components resulting in 
enhancement or inhibition of absorption through the intestine wall and into the 
bloodstream (Hurrell & Egli, 2010; Lönnerdal, 2000). The absorption studies that 
have explored these interactions have generally tested absorption or fractional 
absorption from single meals using the widely-accepted stable isotopic or 
radioisotopic labelling techniques (Cook et al., 1972; Layrisse & Martínez-Torres, 
1972; Sandström, 1997). In these methods, stable isotopes or radioisotopes of iron 
or zinc are placed in a ‘carrier’ meal (e.g. a bread roll or more complex food 
matrices including hamburger meals) that is consumed with or without a meal 
component suspected to influence absorption. To estimate iron absorption, 
incorporation of these stable isotopes or radioisotopes into erythrocytes or whole 
body counting of radioactivity is measured, while stable isotopes or radioisotopes 
in faeces, urine, or the whole body are measured to estimate zinc absorption 
(Fairweather-Tait & Dainty, 2002). The amount of iron or zinc absorbed in the 
presence of the meal component in question is then compared to the amount 
absorbed without that meal component. Typically, participants act as their own 
control, consuming the isotopes with and without the meal component of interest. 
The majority of absorption research has investigated iron, in particular non-haem 
iron, and the meal components investigated include phytate, animal tissue, 
polyphenols, soy protein, calcium, and ascorbic acid.
2.7.1 Phytate.
Phytic acid (myo-inositol hexakisphosphate; IP6) and its salts (phytates) are the 
main storage form of phosphate in seeds and grains (Cosgrove, 1966; Reddy & 
Sathe, 2001; Shears & Turner, 2007). Chemically, phytic acid and phytate are 
known to be powerful chelators, binding to metals and forming insoluble 
compounds (Reddy & Sathe, 2001), and for this reason, it is thought phytate may 
impede absorption of nutrients such as iron and zinc. Single-meal studies of 
phytate in bran or as IP6 sodium phytate have demonstrated that as little as 2 mg 
phytate can reduce iron absorption by 18% (Hallberg et al., 1989). These studies 
have also shown that the inhibitory effect increases with the phytate content, such 
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that 250 mg phytate in a meal can reduce absorption by 82% (Hallberg et al., 1989;
Hallberg et al., 1987). Furthermore, hydrolysing phytate by dehulling grains, 
adding phytase or hydrochloric acid, or catalysing the action of endogenous 
phytase (e.g. soaking bran for 24 hours at 55°C) minimises the inhibition of iron 
absorption (Hallberg et al., 1987; Hurrell, Reddy, Juillerat, & Cook, 2003;
Larsson, Rossander-Hulthen, Sandstrom, & Sandberg, 1996), with catalysis of 
endogenous phytase increasing absorption by 119% (Hallberg et al., 1987). There 
is also some evidence that other myo-inositol phosphates that contain fewer 
phosphate groups than IP6 (e.g. IP3, IP4, IP5) may also impede iron absorption 
(Sandberg et al., 1999). The influence of phytate on zinc absorption has been 
similarly demonstrated. Reducing the phytate content of foods by fermentation and 
catalysing phytase in water, or comparing crop cultivars with varied phytate 
content have shown that phytate inhibits absorption of zinc with a dose-dependent 
effect (Adams et al., 2002; Larsson et al., 1996; Navert, Sandström, & Cederblad, 
1985).
2.7.2 Animal tissue.
Findings from absorption studies suggest that different animal tissues can impact 
iron absorption with varied outcomes (Bjorn-Rasmussen & Hallberg, 1979; Cook 
& Monsen, 1976). Consuming animal tissue such as pork, lamb, beef, chicken or 
fish with meals seem to enhance iron absorption (Bjorn-Rasmussen & Hallberg, 
1979; Cook & Monsen, 1976), while egg, casein and dairy foods have no such 
effect (Cook & Monsen, 1976; Hurrell, Lynch, Trinidad, Dassenko, & Cook, 
1989). Furthermore, it appears that incorporating animal tissue in meals can 
counteract the inhibitory effect of phytate (Bæch et al., 2003; Navas-Carretero et 
al., 2008). Consuming 196 g red kidney beans (227 mg phytate) with 100 g salmon 
was shown to improve iron absorption by 48% (Navas-Carretero et al., 2008). The 
quantity of animal protein seems to be critical: 50 g of pork increased iron 
absorption from a rice meal (220 mg phytate) by 44%, but no effect was observed 
when just 25 g of pork was incorporated into the meal (Bæch et al., 2003). It is 
unknown whether the amount of protein required differs depending on the source 
animal. The inclusion of animal tissue, likely at least 50 g, to a meal is expected to 
improve iron absorption. However, a longer-term study comparing a self-selected 
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five-day diet containing 222 g/day of meat, fish and poultry found no difference in 
iron absorption (Reddy, Hurrell, & Cook, 2006). Therefore, the exact quantity and 
type of animal protein required remains unknown.
The influence of animal tissue on zinc absorption has been assessed by Sandström 
et al. (Sandström, Almgren, Kivisto, & Cederblad, 1989), who observed increased 
zinc absorption when chicken was combined with a meal, while fish, milk, cheese 
and beef had no effect. However, this study was limited as it was not a cross-over 
study where participants acted as their own control. Rather, the results for all 
participants were pooled, thus the true effect on zinc absorption is not known
2.7.3 Soy protein.
Up to 30 g of soy protein has been demonstrated to inhibit both iron and zinc 
absorption in single-meal studies (Cook, Morck, & Lynch, 1981; Davidsson, 
Almgren, Sandstrom, Juillerat, & Hurrell, 1996; Hurrell et al., 1992; Lönnerdal, 
Cederblad, Davidsson, & Sandstrom, 1984). While the phytate present in soy 
products contributes to the inhibition of iron absorption, some interference with 
absorption remains when phytate is removed, suggesting other compounds in soy 
are likely to be implicated (Hurrell et al., 1992). The interactions between phytate, 
soy and zinc absorption are not yet understood (Lönnerdal, 2000).
2.7.4 Calcium.
Results from studies investigating the influence of calcium from food and 
supplements on iron absorption have been conflicting. Studies assessing the effect 
of calcium naturally present in dairy foods have produced mixed results. In single-
meal studies, consuming 150 mL milk (165 mg calcium) with bread rolls inhibited 
iron absorption by 57% (Hallberg, Brune, Erlandsson, Sandberg, & Rossander-
Hulten, 1991), while 250 mL milk (Hallberg & Rossander, 1982), 150 g milk and 
125 g yoghurt (Galan, Cherouvrier, Preziosi, & Hercberg, 1991) with more 
complex meals (e.g. steak meal, hamburger meal) had no effect. In relatively 
longer absorption studies measuring iron absorption over five days, consumption 
of dairy products inhibited absorption when all meals were provided (Gleerup, 
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Rossander-Hulthen, Gramatkovski, & Hallberg, 1995) but no effect was observed 
when diets were self-selected by participants (Reddy & Cook, 1997). Single-meal 
and single-day studies indicate that supplemental or fortificant calcium has an 
inhibitory effect on haem and non-haem iron absorption (Cook, Dassenko, & 
Whittaker, 1991; Hallberg et al., 1991; Hallberg, Rossander-Hulthen, Brune, & 
Gleerup, 1993; Minihane & Fairweather-Tait, 1998), with as little as 40 mg 
fortificant calcium reducing absorption by 49% (Hallberg et al., 1991). The 
inhibitory effect of supplemental calcium demonstrated in these short-term 
absorption studies has not translated to impaired iron status, with consumption of 
supplemental calcium (1000-1200 mg/day calcium) for 12 weeks to six months 
having no impact on iron status (Minihane & Fairweather-Tait, 1998; Sokoll & 
Dawson-Hughes, 1992).
Studies assessing the effect of calcium on zinc absorption or zinc balance seem to 
indicate that fortificant and supplemental calcium have no effect (Dawson-Hughes, 
Seligson, & Hughes, 1986; Lönnerdal et al., 1984; McKenna, Ilich, Andon, Wang, 
& Matkovic, 1997; Spencer, Kramer, Norris, & Osis, 1984).
2.7.5 Ascorbic acid.
Ascorbic acid has consistently been shown to enhance iron absorption when 
provided in single-meal studies as food sources (Diaz et al., 2003; Hallberg et al., 
1986; Hallberg & Rossander, 1982; Nair et al., 2013) or in fortificant form 
(Hallberg et al., 1986; Thankachan, Walczyk, Muthayya, Kurpad, & Hurrell, 
2008). Importantly, the improvement in iron absorption seems to vary depending 
on the composition of the meal, with 50 mg ascorbic acid (equivalent to 
approximately 100 g of fresh orange) increasing absorption by 61% from a 
hamburger meal and 164% from a pizza meal (Hallberg et al., 1986). Similarly, 
iron absorption from bread rolls containing as much as 250 mg phytate was 
improved with the addition of 50 mg ascorbic acid (Hallberg et al., 1986, 1989),
indicating ascorbic acid can counteract the effect of phytate when consumed 
simultaneously.
While evidence for the impact of ascorbic acid on iron absorption is strong, no 
studies have demonstrated any such effect on zinc absorption. Single-meal studies 
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measuring zinc absorption with ascorbic acid naturally present in a food source 
(Nair et al., 2013) or added as a fortificant (Sandström & Cederblad, 1987) found 
no enhancing or inhibiting effects.
2.7.6 Polyphenols in beverages.
Polyphenols are a class of antioxidants, and complex combinations of polyphenols 
are found in foods and beverages sourced from plants including tea and coffee 
(Manach, Scalbert, Morand, Remesy, & Jimenez, 2004). Single-meal studies using 
tea and coffee as sources of polyphenols have shown that polyphenols decrease 
iron absorption (Disler et al., 1975; Hallberg & Rossander, 1982; Hurrell, Reddy, 
& Cook, 1999; Morck, Lynch, & Cook, 1983; Thankachan et al., 2008). Although 
few studies have measured the polyphenol content of test beverages, it appears 
polyphenols have a dose-dependent effect on iron absorption, with increasingly 
concentrated tea having more potency (Hurrell et al., 1999). Tea made from 3 g tea 
leaves concentrated at 396 mg/275 mL serve polyphenols reduced absorption by 
91%, while the same tea diluted to 99 mg/275 mL serve polyphenols reduced iron 
absorption by 82% (Hurrell et al., 1999). The timing of beverage consumption may 
also be influential. This notion was demonstrated by Morck et al. (1983) who 
found that consuming coffee one hour following a meal or simultaneously with a 
meal both inhibited iron absorption by 44%, while coffee consumption one hour 
prior to food had no effect (Morck et al., 1983). The specific polyphenolic 
compounds responsible for the decreased iron absorption have not all been 
identified, although the influence of catechin polyphenols present in these 
beverages (e.g. epigallocatechin-3-gallate) has been demonstrated in Caco-2 cell 
models of human iron absorption (Kim, Ham, Shigenaga, & Han, 2008). While the 
inhibitory properties of polyphenols on iron absorption have consistently been 
demonstrated in absorption studies, complications arise when translating these 
findings into dietary recommendations. The quantity and composition of 
polyphenols varies widely, for example the total amount of catechins in tea made 
from 100 g of dry black tea may range from 1019 mg to 12480 mg, and the 
processing of tea leaves, form (e.g. tea bag versus loose leaf) and brewing method 
(including amount and temperature of water and brew time) further affect the 
resulting content of polyphenols (Peterson et al., 2005). Adding milk to beverages 
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does not appear to meaningfully alter the inhibitory effect of polyphenols (Hurrell 
et al., 1999).
No isotopic zinc absorption studies have been conducted for beverage 
polyphenols. Ganji and Kies (1994) have used zinc balance methodology to 
measure the effect of tea (Ganji & Kies, 1994). Participants resided in a metabolic 
ward and all input and output of zinc was measured with or without the co-
consumption of tea (Ganji & Kies, 1994). Tea consumption did not affect zinc 
balance (Ganji & Kies, 1994), however as the body uses endogenous intestinal 
secretions to regulate zinc metabolism, balance techniques do not provide an 
estimate of zinc absorption (Fairweather-Tait & Dainty, 2002; Sandström, 1997).
2.7.7 Alcoholic beverages.
Studies on the effect of alcoholic beverage consumption on iron absorption have 
indicated potential inhibitory or enhancing effects based on the beverage and its 
alcohol content. Whisky appears to reduce iron absorption, independent of alcohol 
content (Celada, Rudolf, & Donath, 1978). White wine reduces absorption to a 
lesser extent than red wine, however low-alcohol white wine seems to enhance 
absorption while low-alcohol red wine has no effect on absorption (Cook, Reddy, 
& Hurrell, 1995).
Animal models have not found any association between alcohol consumption and 
zinc absorption (Dinsmore, McMaster, Callender, & Love, 1985).
2.7.8 Absorption inhibition and enhancement in whole diets.
Collings et al. conducted meta-analysis of 19 studies that altered participants’ 
intake of one or multiple enhancers and/or inhibitors, choosing to focus on studies 
that measured iron absorption from whole diets rather than single meals (Collings 
et al., 2013). Their analyses found that individually, ascorbic acid increased 
absorption by 2.4% (95% CI 0.4 to 4.4%; p = .02), and meat protein tentatively 
increased absorption by 1.6% (95% CI 0 to 3.2%, p = .05), however intakes of the 
proposed inhibitors calcium, milk, and phytate had no effect on absorption 
(Collings et al., 2013). Among the studies that altered intakes of more than one 
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component, diets that increased consumption of enhancers while decreasing 
consumption of inhibitors to maximise bioavailability increased iron absorption by 
3.6% (95% CI 1.9 to 4.3%, p < .001) compared to the diets that minimised 
bioavailability (Collings et al., 2013). This work provides convincing evidence that 
ascorbic acid and meat protein enhance iron absorption from whole diets, raising 
the question of whether their consumption subsequently impact iron status.
There is comparatively less research studying the effect of absorption inhibitors 
and enhancers on zinc absorption in whole diets. Based on a review of whole-diet 
absorption studies, IZiNCG did not find any influence of calcium or animal tissue 
on zinc absorption, but tentatively suggested that zinc absorption is impaired in 
diets with a phytate:zinc molar ratio > 18 (Brown et al., 2004).
2.8 Iron and Zinc Status and Consumption of Absorption Inhibitors and 
Enhancers 
The inhibitory and enhancing effects of compounds demonstrated in single meal 
absorption studies and to a lesser extent in whole diet absorption studies have not 
consistently translated to influencing iron or zinc status. The effect of iron 
absorption enhancers and inhibitors on iron status has largely been investigated in 
cross-sectional work. Such studies in premenopausal women in developed 
countries have tended to find positive associations between meat consumption and 
iron status but no association with ascorbic acid (Galan et al., 1998; Heath, Skeaff, 
Williams, & Gibson, 2001; Leonard, Chalmers, Collins, & Patterson, 2014a),
although a 16-week intervention in which ascorbic acid was paired with 
consumption of a heavily fortified breakfast cereal (16 mg/serve iron) improved 
serum ferritin by 47% (Beck, Conlon, Kruger, Coad, & Stonehouse, 2011). Cross-
sectional studies assessing intakes of calcium or dairy products (Galan et al., 1998;
Heath, Skeaff, Williams, et al., 2001; Leonard et al., 2014a; Pynaert et al., 2009),
intakes of beverage tannins (Galan et al., 1998; Heath, Skeaff, Williams, et al., 
2001; Pynaert et al., 2009; Rigas et al., 2014), and intakes of phytate or fibre as a 
proxy for phytate (Galan et al., 1998; Heath, Skeaff, Williams, et al., 2001;
Leonard et al., 2014a) have observed mixed results, finding either weak inverse 
associations between these inhibitors and iron status or no association. Two whole 
diet interventions in women with low iron stores that aimed to maximise iron 
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bioavailability by advising participants to increase consumption of absorption 
enhancers while decreasing consumption of inhibitors have been published (Heath, 
Skeaff, O'Brien, Williams, & Gibson, 2001; Patterson, Brown, Roberts, & Seldon, 
2001). One intervention yielded a nonsignificant 26% increase in serum ferritin (p
= .068) (Heath, Skeaff, O'Brien, et al., 2001), and the second study saw a within-
group increase of 24% but lacked an iron-impaired control group, thus the effect of 
the intervention is unknown (Patterson et al., 2001).
In their paper, Collings et al. (2013) noted that participants on high bioavailability 
diets tended to adapt to the diet and gradually absorb less iron over time, and 
acknowledged that inter-individual variation in iron absorption remained 
substantial despite the controlled studies (Collings et al., 2013). The inter-
individual variation in iron absorption may be due to variation in hepcidin, as 
circulating hepcidin levels are inversely related to the amount of iron absorbed 
from supplements and fortified and non-fortified foods (Roe, Collings, Dainty, 
Swinkels, & Fairweather-Tait, 2009; Young et al., 2009; Zimmermann et al., 
2009). Given hepcidin is inversely associated with iron absorption, if the intake-
induced upregulation of hepcidin production is only temporary, long term control 
of iron absorption and therefore iron status may be largely driven by genetic, 
individual variation in hepcidin expression and not by bioavailability (Demeyer et 
al., 2014).
The positive influence of iron intake on iron status has been comprehensively 
reviewed by meta-analyses (Casgrain, Collings, Harvey, Hooper, & Fairweather-
Tait, 2012; Gera, Sachdev, & Boy, 2012), and a dose effect identified: in adults, 
each 1 g/d increase of elemental iron is associated with a 0.1 μg/L increase in 
serum ferritin (95% CI 0.01 to 0.20 μg/L; p = .036) (Casgrain et al., 2012).
However, there has been no published work assessing whether hepcidin moderates 
this association between intake and status. If the association between intake and 
status is largely accounted for by hepcidin, dietary advice to improve iron status 
that is based around consumption of inhibitors and enhancers of absorption is 
unlikely to be beneficial and other interventions are necessary. Conversely, if 
bioavailability remains an important factor despite the role of hepcidin, this 
finding would confirm the current use of dietary advice to improve intake and 
status.
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The lack of a specific and sensitive biomarker of marginal zinc status has impeded 
investigations of the effect of absorption inhibitors and enhancers on zinc status. A
recent meta-analysis of observational studies found individuals following a 
vegetarian diet had lower zinc intakes and lower serum zinc concentrations 
compared to individuals following non-vegetarian diets (Foster, Chu, Petocz, & 
Samman, 2013), but whether the difference in zinc status is due to the meat or 
phytate contents of the diets remains unknown as this study did not account for 
phytate intake. Cross-sectional studies have demonstrated weak negative 
correlations of -.163 and -.21 between the phytate:zinc molar ratio and serum zinc 
concentration in premenopausal women and adolescents (Donovan & Gibson, 
1995; Gibson, Heath, Limbaga, Prosser, & Skeaff, 2001). However, only one of 
these studies accounted for the effects of oral contraceptive use and inflammation
on serum zinc, and did so by omitting from analyses women who used oral
contraceptives or presented with inflammation (Gibson et al., 2001).
To integrate the influence of inhibitors and enhancers on absorption of iron and 
zinc, researchers have proposed a number of algorithms to estimate iron and zinc 
bioavailability (Brown et al., 2004; Hallberg & Hulthen, 2000; Monsen et al., 
1978; Reddy, Hurrell, & Cook, 2000). Models related to iron bioavailability are 
based on results from single meal absorption studies, whereas the IZiNCG’s 
algorithm to estimate zinc bioavailability is based on findings from total diet 
studies. It is suggested the algorithms for iron may not be as accurate as those for 
zinc (Hunt, 2010).
2.9 Research Investigating both Iron and Zinc Nutrition
Due to the diet-based similarities of iron and zinc, deficiency of both minerals is 
thought to occur simultaneously (Brown et al., 2004), and a handful of studies 
have assessed associations between iron and zinc status. The three studies that 
investigated associations in premenopausal women have reported positive 
correlations between serum ferritin and serum zinc concentrations ranging from 
0.10 to 0.45 (Gibson et al., 1999; Prosser, Heath, Williams, & Gibson, 2010;
Yokoi et al., 2007), and one has found significantly lower serum ferritin 
concentration in women with low zinc status (mean serum ferritin 10.8 (SD 7.2) 
μg/L vs. 26.0 (SD 15.3) μg/L) (Yokoi, Alcock, & Sandstead, 1994). These 
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findings support an association between iron and zinc status, however only one 
study (Prosser et al., 2010) accounted for infection and inflammation, which are 
known to elevate serum ferritin and suppress serum zinc concentrations (Brown et 
al., 2004; World Health Organization, 2011). In other population groups, Sri 
Lankan adolescents with iron deficiency had increased risk of also having zinc 
deficiency (OR 1.8 (95% CI 1.2 to 2.6) (Hettiarachchi, Liyanage, 
Wickremasinghe, Hilmers, & Abrahams, 2006), and low-income minority children 
in the US who had anaemia presented with lower serum zinc concentrations than 
those without anaemia (mean serum zinc 12.0 (SD 1.8) μmol/L vs. 13.1 (SD 2.2) 
μmol/L) (Cole et al., 2010), although such groups may experience issues that 
confound associations between iron and zinc status. In economically-developed 
populations, although evidence is limited, there appears to be a positive association 
between iron and zinc status (Gibson et al., 1999; Prosser et al., 2010; Yokoi et al., 
2007), and as iron and zinc losses have different routes, this association may 
indicate a link between iron and zinc nutriture.
2.10 Summary
Iron and zinc deficiencies are thought to occur simultaneously in populations due 
to the distribution of iron and zinc within similar foods and the absorption of both 
nutrients is negatively affected by dietary compounds such as phytate.
Accordingly, prevalence of iron-deficiency anaemia has been used as ‘suggestive 
evidence’ of risk of zinc deficiency. As premenopausal women are at increased 
risk of iron deficiency, zinc deficiency may also be a concern, however knowledge 
of the associations between these nutrients is limited due to difficulties in 
assessing biochemical zinc status. In addition, there is a lack of recent data 
detailing iron status in Australian women and no data detailing zinc status. Serum 
zinc is the most commonly used biomarker to measure zinc status but more work 
is needed to understand factors influencing zinc status. In contrast to zinc, 
numerous biomarkers are available to assess iron status but effects of diet on iron 
status have not been consistently demonstrated. Variation in hepcidin production 
may account for a lack of strong associations between diet and iron status but this 
research question has not been investigated to date.
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2.11 Overall Thesis Aims
The overall aims of this research were to assess dietary intakes of iron and zinc; to 
investigate dietary determinants of iron and zinc status; and to identify possible 
associations between iron and zinc intakes and biochemical status in a sample of 
premenopausal women in Australia.
Specific aims in this sample of premenopausal Australian women were:
1. Describe total intakes of iron and zinc (diet and supplements), and assess 
adequacy of dietary intakes of iron and zinc;
2. Identify the main sources of dietary iron and dietary zinc;
3. Investigate associations between dietary iron and zinc intakes;
4. Investigate associations between biochemical iron and zinc status;
5. Identify dietary determinants of iron stores after accounting for blood loss;
6. Determine whether iron intake predicts iron stores independently of 
circulating hepcidin levels;
7. Identify nutritional determinants of serum zinc concentration after 
accounting for confounders of serum zinc concentration;
8. Investigate whether sources of blood loss are determinants of serum zinc 
concentration.
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3.1 Introduction
Cross-sectional data from a sample of premenopausal women in Melbourne and 
Sydney, Australia, were used to investigate iron and zinc nutrition and achieve the 
aims described in Chapter 2. The purpose of this chapter is to describe the non-
dietary data collection procedures common to these chapters: recruitment; 
collection of demographic and anthropometric information; and biochemical 
analyses. Dietary assessment methodology is described in Chapter 4. Additional 
methods that are specific to each study (e.g. statistical analysis for each chapter, 
hepcidin concentration for Chapter 7) are described in the corresponding chapter.
3.2 Research Ethics
Ethics approval for data collection between 2010 and 2011 was granted by the 
Deakin University Human Research Ethics Committee (reference 2009-191) and 
by the Australian Red Cross Blood Service Ethics Committee (reference 2010#01).
Ethics approval for data collection between 2012 and 2014 was granted by the 
Deakin University Human Research Ethics Committee (reference 2012-046). All 
women provided written informed consent prior to participating.
3.3 Sampling and Timing
Women 18 to 50 years of age were recruited in three phases: a) from the student 
and staff population at Deakin University (Burwood, Melbourne, Australia) 
between July – November 2010; b) from blood donors registered with the 
Australian Red Cross Blood Service (Blood Service; Sydney, Australia) between 
November 2010 – May 2011; and c) from non-blood donating members of the 
student and staff population at Deakin University (Burwood, Melbourne, 
Australia) and non-blood donating residents of metropolitan Melbourne between 
July 2012 – January 2014.
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No formal sample size calculation was performed but following the common 
recommendation for at least 10 participants per independent variable in linear 
regression analyses (Vittinghoff, Glidden, Shiboski, & McCulloch, 2012), it was 
possible to investigate multivariate associations with iron stores and serum zinc 
concentrations in the study sample used in this thesis.
3.3.1 Recruitment.
Both phases of recruitment at the Deakin University Burwood campus were
conducted via flyers, announcements in lectures, and on the university’s online 
teaching and learning portal. Recruitment of Melbourne residents was conducted 
via Facebook (‘sharing’ of a Facebook page about the study and paid 
advertisements of this page within Facebook) and printed advertisements in local 
newspapers. All flyers and advertisements requested interested women to contact 
the candidate via phone or email to receive further information and for the 
candidate to assess the women’s eligibility to participate (section 3.3.2 Criteria for 
participation.). An appointment at the Deakin University Burwood campus with 
the candidate was scheduled for eligible women, and a participation packet 
including the plain language statement outlining information about the study,
consent form, and questionnaires were mailed. Women were asked to read the 
plain language statement and, if interested in participating, complete the consent 
form and questionnaires for return at their appointment. During the appointment, 
the questionnaires were reviewed and anthropometric measurements were taken. 
Participants were given a set of blood collection tubes to take to a commercial 
pathology clinic at a convenient time and a second appointment was scheduled to 
review their pathology results (serum ferritin and haemoglobin). 
Recruitment at the Blood Service was conducted as part of routine phone calls 
reminding registered blood donors when they are eligible to make their next blood 
donation. During the calls to women identified in the Blood Service’s records as 
being in the target age range and living in Sydney, the Blood Service’s staff 
explained the study and assessed their eligibility to participate (section 3.3.2 
Criteria for participation.). Interested women were mailed the plain language 
statement, consent form and questionnaires, and returned the consent form and 
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completed questionnaires to staff at their next blood donation appointment. 
Appointments were held within one month following the phone call at one of three
specified blood collection centres. New and regular donors making a drop-in visit 
at these three collection centres were also informed of the study, and could read 
the plain language statement and complete the consent form and questionnaires 
while waiting to make their donation. Blood samples were collected immediately 
prior to the blood donation.
Women were not paid for their participation in this study.
3.3.2 Criteria for participation.
Across all recruitment phases, women who were currently pregnant or lactating 
and women who had been through menopause were ineligible to participate. 
Women recruited in the Melbourne recruitment phases were eligible to participate 
if they were 18 to 50 years of age and had not been pregnant or lactating in the last 
12 months. For the cohort recruited in 2012 to 2014, a criterion was introduced to 
exclude women who had donated blood in the last two years as a number of blood 
donors had been recruited by the Blood Service. Fifty-five women who expressed 
interest in 2012 to 2014 were ineligible to participate due to recent blood donation.
Women recruited by the Blood Service were eligible to participate if they were 20
to 40 years of age and had not been pregnant or lactating in the last six months. 
Women who were ineligible to donate blood on the date of their appointment 
according to the Blood Service’s criteria (e.g. low haemoglobin, current cold or 
flu) were still eligible to participate in the study.
The age range was extended in Melbourne recruitment phases to allow more 
women to participate and to facilitate recruitment.
3.4 Data Collection
3.4.1 Anthropometry.
For women recruited at Deakin University, height and weight were measured 
wearing light clothing with shoes removed. Weight was measured to 0.1 kg using 
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Seca 708 electronic scales (Hamburg, Germany) or the scale facility of a Tanita 
BC-418 Body Composition Analyzer (Tokyo, Japan). Height was measured to 0.1 
cm using a Holtain wall-mounted stadiometer (Crymych, Pembrokeshire, UK). 
Measurements were taken in duplicate and an average was used in data analysis.
For women recruited at the Blood Service, weight was measured with shoes 
removed as part of pre-donation protocols and height was self-reported.
Body mass index (BMI) was calculated as weight in kilograms divided by height 
in metres squared (kg/m2) and assessed following the World Health Organization’s 
categorisation where BMI < 18.50 kg/m2 is underweight; BMI 18.50 to 24.99 
kg/m2 is in the normal range; BMI 25.00 to 29.99 kg/m2 is overweight; and BMI >
30.00 kg/m2 is obese (World Health Organization, 2000a).
3.4.2 Demographic, medical background and blood loss information.
All participants answered the same demographic, medical background and blood
loss questionnaire (Appendix A).
Demographic and medical background.
Age and country of birth were recorded as open-ended questions. Age was used as 
a continuous variable and country of birth was collapsed into a dichotomous 
variable of ‘Not born in Australia / Born in Australia’. 
Level of education and employment status were recorded using categorical 
questions (e.g. ‘What is your current employment status?’ [Full-time 
employment/Part-time employment/Home duties]). These data were collapsed into 
dichotomous variables: ‘No tertiary education / Tertiary educated’ and ‘Not 
currently employed / Currently employed’. 
General health information included details of cigarette smoking (e.g. ‘Are you a 
current smoker/ex-smoker/non-smoker’). Smoking status was collapsed into a 
dichotomous variable of ‘Not currently smoking / Current smoker’. Women’s use 
of contraception (e.g. ‘Do you use an oral contraceptive pill, an intra-uterine 
device, or Depo-Provera and how long have you been using this contraceptive 
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method?’) was also recorded. This data was collapsed into a dichotomous variable 
of ‘Not using oral contraception / Currently using oral contraception’. Women 
who reported using an intra-uterine device or Depo-Provera (n = 5) were 
categorised as ‘Not using oral contraception’. 
Consumption of a special diet was self-reported in a categorical question (i.e. ‘Do 
you follow a special diet?’). If a respondent answered yes, they were asked to 
indicate whether their diet was one of four options (i.e. ‘Vegetarian (no meat of 
any kind) / Mostly vegetarian but eat some meats / Vegan / Other (please 
specify)’). This data was collapsed into a dichotomous variable of ‘Not following a 
special diet / Following a special diet’, and the types of special diets were 
presented for descriptive purposes only.
Blood donation.
The blood donation history of women recruited at the Blood Service was sourced 
from Blood Service records. The information consisted of the number of donations 
made over the past 12 months and the donation type at each visit (whole blood or 
apheresis). The volume of blood donated over the past year was quantified using 
conversion factors provided by the Blood Service. Each whole blood donation was 
considered to be 470 mL and each apheresis (plasmapheresis and plateletpheresis) 
donation was considered to be 60 mL of whole blood. 
Women recruited at Deakin University in 2010 self-reported their blood donor 
status and frequency of donation via questionnaire. This information was 
converted to mL of blood donated over the past year using the factors noted above. 
Women recruited at Deakin University in 2012 to 2014 had not donated blood in 
the past two years as an eligibility criterion.
Nosebleeds.
Experience of nose bleeds was recorded using a categorical question (i.e. ‘Do you 
get nose bleeds?’ [Yes/No].
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Menstrual blood losses.
A previously published questionnaire was used to record self-reported menstrual 
blood loss (Heath, Skeaff, & Gibson, 1998). Women were asked to record the 
month and year of their last menses, and frequency of menses (e.g. ‘What is the 
frequency of your menstrual periods?’ [1 to 4 cycles per year/4 to 8 cycles per 
year/8 to 12 cycles per year]). Open-ended questions were used to assess the 
number of heavy and light days during menses, the number of pads and tampons 
used, and the brand name of tampons (e.g. ‘On a ‘heavy’ day, how many pads 
and/or tampons do you use? What absorbency level are they?’) This questionnaire 
assessing menstrual blood loss has been validated among women aged 18-29 years 
in New Zealand where it was shown to be positively and moderately correlated 
with weights of menstrual products (r = .61, p = 0.001) (Heath et al., 1998).
In line with the method used by Heath, Skeaff and Gibson (1999), pads and 
tampons were assigned a relative absorption number (1, 2 or 3) based on the 
absorption level stated on packaging or manufacturer websites. For example, U By 
Kotex ‘mini’ tampons with absorbency of 8 g, their ‘regular’ tampons with 
absorbency of 11 g, and their ‘super’ tampons with absorbency of 14 g were 
assigned absorption numbers of 1, 2 and 3, respectively. Equation 3.1 was used to 
indicate the magnitude of menstrual blood loss as blood loss units per menses.
Blood loss units were also estimated per year to account for women who did not 
menstruate monthly; blood loss units per menses were multiplied by a factor of 1, 
2 or 3 depending on the reported frequency of menses (1 = 1-4 cycles per year, 2 = 
4-8 cycles per year, 3 = 8-12 cycles per year). 
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Equation 3.1 Equation to estimate menstrual blood loss units per menses
Menstrual Recall = (nHD × Heavy Amount) + (nLD × Light Amount) Blood 
Loss Units
Where:
HD = number of heavy days during a menses
Heavy Amount = (number of pads used on a heavy day × their relative absorbency 
number) + (number of tampons used on a heavy day × their relative absorbency 
number)
LD = number of light days during a menses
Light Amount = (number of pads used on a light day × their relative absorbency 
number) + (number of tampons used on a light day × their relative absorbency 
number)
(Heath et al., 1998)
3.4.3 Use of dietary supplements.
Use of dietary supplements containing iron was recorded as part of a diet checklist 
(Zhou, Schilling, & Makrides, 2005) (included as part of Appendix A Background 
questionnaire). No other data were used from this checklist as dietary zinc intakes 
were also being assessed. Participants were asked to write the name of any dietary 
supplements they were using that contained iron, the frequency of consumption, 
and the dose. Supplements were characterised as multivitamin/mineral 
supplements containing iron or as iron-specific supplements, and the dose of 
supplemental iron (elemental iron) was confirmed by checking supplement 
packaging or the manufacturers’ websites. To estimate supplemental iron intake 
per day, the total amount of iron from all supplements consumed per week was 
divided by seven days.
Supplemental zinc intakes were recorded as part of the background questionnaire 
discussed in section 3.4.2. Women were asked to report the dose and the frequency 
of consumption of supplements and medications in open-ended questions. As with 
iron supplements, the dose of zinc was confirmed (elemental zinc), supplements 
were categorised as zinc-specific or multivitamin/mineral supplements, and total 
supplemental zinc intake per day was calculated.
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Supplemental iron and zinc intakes were added to dietary intakes to determine
total intakes, however assessment of dietary adequacy by comparison of dietary 
intakes to dietary recommendations was conducted using dietary intakes only (see 
section 4.3.3 Total iron and zinc intakes).
3.4.4 Biochemical analyses.
Participants were asked to provide blood samples that were analysed for serum 
ferritin, haemoglobin, C-reactive protein (CRP), and serum zinc concentrations. 
Women recruited at the Blood Service provided non-fasting blood samples as 
sampling occurred just prior to a blood donation, and samples were collected in 
tubes transported from Deakin University. The Blood Service then analysed these 
samples for serum ferritin and CRP. As noted below, haemoglobin was determined 
separately at the Blood Service. For women recruited in Melbourne, Dorevitch 
Pathology (Heidelberg, Melbourne, Australia), a commercial pathology service, 
was responsible for the blood collection and analysis of serum ferritin, 
haemoglobin and CRP. At their appointment at Deakin University, participants 
were provided with blood collection tubes and asked to present fasting at any 
Dorevitch Pathology collection centre at a convenient time. Fasting samples were 
provided by 43% (n = 152) women and non-fasting samples were provided by 
57% (n = 203) women. The time of blood sampling was recorded by staff at the 
Blood Service and Dorevitch Pathology. Blood sampling took place between 08:00 
and 16:55 and between 07:40 and 18:30 for the Sydney and Melbourne cohorts 
respectively. Both Dorevitch Pathology and the Blood Service are accredited with 
the National Association of Testing Authorities (Australia) in conjunction with the 
Royal College of Pathologists of Australasia and comply with the requirements of 
ISO 15189:2012.
Serum ferritin.
For all participants, serum ferritin was analysed in venous samples collected in BD 
Vacutainer SST II Plus plastic serum tubes (all supplied by Dorevitch Pathology). 
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The Blood Service analysed serum ferritin using the AxSYM Ferritin assay on the 
AxSYM (Abbott Diagnostics, Abbott Park, IL, US) (Table 3.1). Dorevitch 
Pathology used the ADVIA Centaur Ferritin Assay on the Siemens ADVIA 
Centaur (Siemens Healthcare Diagnostics, Deerfield, Illinois, US) (Table 3.1). 
Precision of the Dorevitch Pathology assay was 4.6% at 32 μg/L, 4.6% at 165
μg/L, and 4.4% at 372 μg/L.
Haemoglobin.
The Blood Service determined haemoglobin concentration by fingerprick capillary 
testing prior to blood donation as per Blood Service protocol using a Hemocue B-
Haemoglobin Photometer (Hemocue, Angelholm, Sweden) (Table 3.1).
For women recruited in Melbourne, venous samples were collected in tubes 
containing ethylenediaminetetraacetic acid (EDTA) anticoagulant (K2E
Vacutainer, supplied by Dorevitch Pathology), and analysed for haemoglobin 
using a Sysmex Automated Hematology Analyzer (Sysmex, Kobe, Japan) (Table 
3.1). Precision at Dorevitch Pathology was < 1%.
As fingerprick capillary haemoglobin and venous haemoglobin values are known 
to differ (Gibson, 2005), haemoglobin concentrations reported in this thesis should 
be interpreted with caution.
C-reactive protein.
As with serum ferritin, for all participants CRP was analysed in venous samples 
collected in BD Vacutainer SST II Plus plastic serum tubes (all supplied by 
Dorevitch Pathology). 
The Blood Service used the Quantikine Human CRP Immunoassay (R&D
Systems, Minneapolis, MN, US), and Dorevitch Pathology used a latex-enhanced 
immunoturbidimetric assay on a Siemens ADVIA 2400 (Bayer Diagnostics, 
Tarrytown, NY, US) (Table 3.1) to measure CRP. Assay performance at Dorevitch 
Pathology was 1.7% at 6.8 mg/L and 1.4% at 48 mg/L.
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Serum zinc.
For all participants, serum zinc was analysed in venous blood samples collected in 
BD Trace Element tubes (cat. no. 368380, BD Australia, North Ryde, Sydney, 
Australia). Serum was separated by staff at the Blood Service or at Dorevitch 
Pathology and stored at -70°C at Deakin University in trace element-free 
microcentrifuge tubes (cat. no. 3013-870-000, Labcon, Ballarat, Australia) prior to 
transport and analysis for serum zinc in the Trace Element Laboratory at the 
Department of Human Nutrition, University of Otago, Dunedin, New Zealand. 
Serum zinc was measured using a ContrAA 700 continuum source flame atomic 
absorption spectrometer (Analytik Jena AG, Jena, Germany) following a modified 
method of Smith et al. (1979). Serial replicates of an in-house pooled serum and 
quality control sera (UTAK, UTAK Laboratories, Valencia, California, US) were 
used to check the precision and accuracy of the assay. Samples were analysed in 
two batches – those collected from 2010 to 2011 were analysed in 2011, and those 
collected from 2012 to 2014 were analysed in 2014. For the first batch, the 
interassay CV (as %) for serum zinc was 3.5% (n = 17), and the analysed mean 
value for the zinc serum quality control was 10.4 μmol/L (CV 5.4%, n = 12) 
compared with the manufacturer’s certified mean (SD) value of 10.4 (2.6) μmol/L. 
The interassay CV in the second batch was 2.2% (n = 6), and the analysed mean 
value for the quality control was 10.2 μmol/L (2.4%, n = 3) compared with the 
manufacturer’s certified mean (SD) value of 10.1 (2.4) μmol/L. 
Samples with serum zinc concentrations exceeding 18.97 μmol/L were excluded
due to potential contamination (Engle-Stone, Ndjebayi, Nankap, Killilea, & 
Brown, 2014).
A summary of data collection and biochemical analysis are provided in Table 3.1.
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Table 3.1 Summary of data collection and biochemical analysis
Melbourne: July 2010 –
November 2010 and July 
2012 – January 2014
Sydney: November 2010 –
May 2011
Data collection Deakin University Australian Red Cross Blood Service
Height Direct measurement Self-report
Weight Direct measurement Direct measurement
Demographic 
information Background questionnaire Background questionnaire
Dietary 
assessment DQES v3.1 DQES v3.1
Blood sample Fasting Non-fasting
Serum ferritin
Two-site sandwich 
immunoassay using Siemens 
ADVIA Centaur
Microparticle enzyme 
immunoassay using Abbott 
Diagnostics AxSYM
Haemoglobin
Venepuncture sample
Sodium lauryl sulphate method 
using Sysmex XE-2100
Fingerprick capillary sample
Hemocue B-Haemoglobin 
Photometer
C-reactive 
protein
Latex-enhanced 
immunoturbidimetric assay
using Siemens ADVIA 2400
Quantikine Human CRP 
immunoassay
Serum zinc Flame atomic absorption spectrophotometry
Flame atomic absorption 
spectrophotometry
Note. DQES v3.1 = Dietary Questionnaire for Epidemiological Studies v3.1
3.5 Data used in this thesis
Data from the three recruitment phases were combined for the studies presented in 
this thesis. The sample sizes and relative contributions to measures are displayed 
in Figure 3.1. Prior to descriptive and inferential analyses, some data were 
excluded: participants were excluded from analyses of dietary information (see 
Chapter 4) if energy intakes fell three standard deviations away from the mean (n
= 3) (Lioret, McNaughton, Spence, Crawford, & Campbell, 2013; Spence et al., 
2013); serum zinc data were excluded if participants’ values exceeded 18.97 
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μmol/L, indicative of potential contamination (Engle-Stone et al., 2014) (n = 6); 
and one participant was excluded from analyses of serum ferritin as she later 
reported receiving a recent intravenous iron infusion and had serum ferritin 461 
μg/L. As shown in Table 3.2, the number of participants in each study varied 
depending on the measures used in the studies. As the participants used in each 
study differ modestly to the total cohort, the demographic and anthropometric 
characteristics of women who returned the background questionnaire are provided 
in Appendix B.
Figure 3.1 Data collected from the three recruitment phases
Note. SF = serum ferritin; Hb = haemoglobin; CRP = C-reactive protein; DQES 
v3.1 = Dietary Questionnaire for Epidemiological Studies version 3.1; Background 
qn. = background questionnaire.
July 2010 – November 2010 in 
Melbourne
N = 51
November 2010 – May 2011 in 
Sydney
N = 203
July 2012 – January 2014 in 
Melbourne
N = 142
Total
N = 396
Measure n
SF, Hb, CRP 41
Serum zinc 37
DQES v3.1 50
Background qn. 51
Measure n
SF, Hb, CRP 111
Serum zinc 109
DQES v3.1 140
Background qn. 142
Measure n
SF, Hb, CRP 355
Serum zinc 348
DQES v3.1 382
Background qn. 386
Measure n
SF, Hb, CRP 203
Serum zinc 202
DQES v3.1 192
Background qn. 193
46
Chapter 3: General Methodology
Table 3.2 Inclusion criteria and sample size for chapters in this thesis
Criteria for inclusion in analyses Sample size
Chapter 5 
Sources of iron and zinc Meeting energy intake criteria
a N = 379
Chapter 6
Associations between 
dietary and biochemical 
iron and zinc
Dietary associations: Meeting 
energy intake criteriona
Biochemical associations: Serum 
ferritinb, haemoglobin, serum 
zincc and CRP data
Dietary 
associations: N =
379
Biochemical 
associations: N =
321
Chapter 7 
Determinants of iron 
stores
Meeting energy intake criteriaa
+
Serum ferritinb, haemoglobin and 
CRP data
N = 338
Chapter 8
Determinants of serum 
zinc concentration
Meeting energy intake criterion 
+
Serum zincc and CRP data
N = 321
a Excludes three participants with energy intakes greater than 3 SD from the mean 
(Lioret et al., 2013; Spence et al., 2013).
b Excludes one participant with serum ferritin 461 μg/L due to recent intravenous 
iron infusion. 
c Excludes six participants with serum zinc concentration > 18.97 μmol/L, 
indicative of potential contamination (Engle-Stone et al., 2014).
3.6 Funding and ownership of information
This project was funded by a Deakin University Partnership Grant with the 
Australian Red Cross Blood Service; a competitive, peer-reviewed grant from 
Meat and Livestock Australia Ltd (MLA); and internal support from the Centre for
Physical Activity and Nutrition Research, Deakin University. Deakin University 
owns all intellectual property. The provision of funding by MLA is declared in all 
current and future publications arising from this thesis, however MLA was not
involved in the collection, analyses, or interpretation of data, and there are no 
contractual obligations to MLA to promote the findings of this project.
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4.1 Introduction
For all studies in this thesis, dietary information including dietary iron and zinc 
intakes was collected using Cancer Council Victoria (Australia)’s Dietary 
Questionnaire for Epidemiological Studies v3.1 (DQES v3.1; Appendix C). DQES 
v3.1 is a semi-quantitative food frequency questionnaire (FFQ) that asks 
respondents to report their food and beverage intake over the past 12 months. The 
original version of DQES was developed to estimate food and nutrient intakes for 
a prospective cohort study conducted in Melbourne, Australia from 1990-1993
(Ireland et al., 1994), and was based on the FFQ used in the US Nurses’ Health 
Study (Willett, 2013). DQES has been modified twice: once in the late 1990s 
(DQES v2) (Hodge, Patterson, Brown, Ireland, & Giles, 2000; Nutritional 
Assessment Office - Cancer Epidemiology Centre - Cancer Council Victoria, 
2014) and once in 2009 (DQES v3.1, used in the current studies). DQES captures a 
picture of overall dietary intake, in contrast to nutrient-specific FFQs that capture 
intakes of foods related to a single nutrient. This broader scope makes it an ideal 
tool to measure dietary intakes of both iron and zinc.
Cancer Council Victoria was responsible for the design of DQES v3.1, and 
selected the food and beverage items and formulated the questions. Computation 
of food and nutrient intakes was conducted by the candidate, independently of 
Cancer Council Victoria, as Cancer Council Victoria’s nutritional analysis service 
was not available at the time. The methods used by the candidate to extract this 
dietary information from DQES v3.1 are presented in this chapter. After 
completing these computations, Cancer Council Victoria made their analysis 
service available, but upon receiving and reviewing these data, it was found the 
methods described in this chapter were more appropriate for the sample of 
premenopausal women. For example, Cancer Council Victoria analysis considered 
a standard portion of ‘Dried beans, dried peas, chick peas or lentils’ to be 329 g 
compared to 93 g (equivalent of ½ cup (Food Standards Australia New Zealand, 
2015)) used by the candidate in the analysis presented in this thesis. Cancer 
Council Victoria’s analysis also did not account for breakfast cereal preference as 
48
Chapter 4: Dietary Methodology
recorded in DQES v3.1: for example, when participants reported consuming two 
types of cereal in a 25:75 ratio, Cancer Council Victoria’s analysis considered the 
cereals to be consumed in equal proportions. This change is potentially important 
as manufacturers are permitted to fortify breakfast cereals with iron and zinc in 
Australia (Food Standards Australia New Zealand, 2014a), and an accurate 
reflection of breakfast cereal consumption was considered important for estimating 
intakes of these two nutrients. In the analysis presented in this thesis, if a 
participant reported consuming two types of cereals in a 25:75 ratio, this ratio was 
used to estimate the quantities consumed. 
Cancer Council Victoria are yet to publish the validation of this version of DQES 
(v3.1).
4.2 Dietary Analysis: Cancer Council Victoria Dietary Questionnaire for 
Epidemiological Studies version 3.1 (DQES v3.1)
DQES v3.1 is a paper-based questionnaire that consists of 154 multiple choice 
questions and was used to estimate intakes of 140 foods and beverages (Appendix 
C). It was designed by Cancer Council Victoria to minimise respondent burden 
related to dietary assessment and thus contains no open-ended questions. 
The first section of DQES v3.1 (questions 1 to 5) asks about household 
characteristics (e.g. ‘How many people live in your household?’) and use of oils at 
the household level (e.g. ‘How much olive oil is used per month in your 
household?’). All other sections only consider intakes at the respondent level.
The second section (questions 6 to 14) asks about the types of various foods 
(including milk, spreads, breads) normally consumed by the respondent, and the 
frequency that these foods are consumed (e.g. ‘In the last 12 months, how much 
milk did you usually use per day? Please include milk drunk on its own, flavoured 
milk, soy milk and milk or soy milk added to cereal or to beverages such as tea, 
coffee, caffe latte and drinking chocolate’ [None/Less than ½ a cup per day (less 
than 125 mL)/About ½ a cup per day (125 mL)/About 1 cup per day (250 
mL)/About 2 cups per day (500 mL)/3 or more cups per day (750 mL)], ‘What 
types of milk did you usually use? Please mark all types used. [Full 
cream/Reduced fat milk 1-3% (Anything with “low fat” in title e.g. REV, Light 
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Start, Devondale Smart milk)/Skim milk less than 1% fat (Anything with “skim” 
or “no fat” in title e.g. Weight Watchers, Skinny milk)/Soy milk/Flavoured milk 
(milkshakes, rice milk, coconut milk)]). 
Questions in the third section (questions 15 to 22) asked respondents to select how 
many serves of fruit and serves of vegetables they consume per day, and portion 
sizes of certain foods. Responses to the questions on fruit and vegetable serves 
were used to adjust intakes of individual fruits and vegetables reported in later 
sections of DQES v3.1 (see section 4.2.2 Estimating the amount of food and 
beverage consumed per day, Scaling fruit and vegetable intakes.). This approach 
was also used in DQES v2 (Nutritional Assessment Office - Cancer Epidemiology 
Centre - Cancer Council Victoria, 2014).
This section also includes five picture-based questions that were used to establish 
the respondents’ usual portion sizes of certain foods (including rice, fish, steak, 
vegetables) using photographic examples of three different serving sizes (e.g. 
‘When you ate salad in the last 12 months, how much did you usually eat?’ [I did 
not eat salad/Less than A/A/Between A & B/B/Between B & C/C/More than C]). 
These questions were used to scale the standard serve of certain foods according to 
the respondents’ preference, and were also used in DQES v2 (Nutritional 
Assessment Office - Cancer Epidemiology Centre - Cancer Council Victoria, 
2014).
The fourth section of DQES v3.1 (questions 23 and 24-1 to 24-19) asks about 
breakfast cereal consumption, presenting a list of 19 breakfast cereal brands and 
varieties available in Australia, and frequencies of consumption (e.g. ‘In the last 12 
months, which two breakfast cereals (other than porridge) did you eat most often? 
In column A, please mark the two types you ate most often, then mark the amount 
of the time you ate that cereal in column B’; Amount of the time per year you ate 
that cereal: 1/4 / 2/4 / 3/4 / All or almost all). 
The bulk of food items are presented in the fifth section of DQES v3.1 (questions 
25-A to 25-G). This section lists a range of foods grouped into categories (10 
cereal-based foods, 11 dairy foods and fats, 7 meat items, 3 fish items, 23 fruits, 32 
vegetables, and 12 miscellaneous foods such as olives, pizza, pastries, tomato 
sauce) and respondents report how frequently the foods have been consumed over 
the past 12 months (e.g. ‘Over the last 12 months, how often did you usually eat 
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each of the following foods?’ [Never/Less than once per month/1-3 times per 
month/1 time per week/2 times per week/3-4 times per week/5-6 times per week/1 
time per day/2 times per day/3 or more times per day]). Frequency of using 
multivitamins and other dietary supplements are also recorded using the same 
categorisation (questions 26 and 27-1 to 27-14), although these data were not used 
for the studies presented in this thesis (see section 3.4.3 Use of dietary 
supplements.), as supplement doses are not recorded in DQES v3.1.
The sixth section (questions 28 to 36) records consumption of alcohol, asking 
about the frequency of consuming any type of alcohol, beer, wine, and spirits (e.g. 
‘In the last 12 months, how often did you drink wine?’ [1 day per month or less 
often/2-3 days per month/1 day per week/2 days per week/3-4 days per week/5-6
days per week/Every day/Never]) and the amount consumed (e.g. ‘On the days 
when you drank wine during the last 12 months, how much did you usually drink 
in a single day?’ [Nil/Up to or 1/2/3/4/5/6 or more glasses (150 mL) / Bottles (750
mL) / Litre]). 
The final section (questions 37 to 40) records consumption of tea, herbal tea, 
coffee, and coffee substitutes (e.g. ‘In the last 12 months, how often did you drink 
coffee?’ [Never or less than once per month/1-3 cups per month/1 cup per week/2-
4 cups per week/5-6 cups per week/1 cup per day/2-3 cups per day/4-5 cups per 
day/6+ cups per day]).
Women participating in the studies presented in this thesis self-completed the 
paper-based version of DQES v3.1. Once data entry was completed, conversion of 
the women’s questionnaire responses to nutrient intakes was conducted by the 
candidate and involved the following steps:
1) Establishing representative foods and standard serves for the items listed in 
DQES v3.1 (section 4.2.1);
2) Estimating the amount of representative foods consumed as ‘daily 
equivalents’ based on the conversion factors used in DQES v2 (Nutritional 
Assessment Office - Cancer Epidemiology Centre - Cancer Council 
Victoria, 2014) (section 4.2.2);
a. Scaling intakes of certain foods based on reported portion sizes 
b. Adjusting intakes of individual fruit and vegetables to total reported 
serves per day
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3) Using food composition databases to estimate usual nutrient intake (section 
4.2.3Estimation of usual nutrient intakes.).
4.2.1 Representative foods and standard serves.
Representative foods.
To estimate nutrient intakes using DQES v3.1, the food and beverage items listed 
in the questionnaire needed to be linked to food composition databases. For each 
food and beverage listed in DQES v3.1, one or more listings in the Australian food 
composition databases NUTTAB 2010 (Food Standards Australia New Zealand, 
2014b) and AUSNUT 2007 (Food Standards Australia New Zealand, 2013a) were 
selected as representative foods/beverages. For example, the NUTTAB 2010 
listing Milk,cow,fluid,reduced fat (1%) was chosen to represent the DQES v3.1 
item ‘Q08-2 Reduced fat milk 1-3% fat (anything with “low fat” in title e.g. REV, 
Light Start, Devondale Smart milk)’. When a DQES v3.1 item incorporated more 
than one food or beverage, each food or beverage was selected from the food 
composition databases and a quantity of that item was selected to make up the 
total. For example, item ‘Q05 Vegetable oil (include blended vegetable oil, sesame 
oil, peanut oil, sunflower oil etc.)’ was represented by five NUTTAB 2010 
listings: 30% Oil,blend of polyunsaturated vegetable oils; 30% Oil,blend of 
monounsaturated vegetable oils; 30% Oil,sunflower; 5% Oil,sesame; and 5% 
Oil,peanut.
Standard serves for premenopausal women.
For the majority of food and beverage items listed in DQES v3.1, serving sizes 
were not specified in the questionnaire, so standard serves were also determined 
with the sample of premenopausal women in mind. Standard serves and their 
weight in grams were informed by the AUSNUT 2007 measures database (Food 
Standards Australia New Zealand, 2015), the Australian Dietary Guidelines 
(National Health and Medical Research Council, 2013), and the packaging of 
example products. The representative foods and beverages and their standard 
serves were established in consultation with dietitians and nutrition scientists 
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(supervisors of this thesis and Associate Professor Sarah McNaughton at Deakin 
University Centre for Physical Activity & Nutrition Sciences). When the Cancer 
Council Victoria’s nutritional analysis of DQES v3.1 became available, Cancer 
Council Victoria’s standard serves were deduced by identifying the gram per day 
quantity Cancer Council Victoria had allocated a participant who reported 
consuming one serve of the food per day. Some differences in standard serve sizes 
were noted and examples are displayed in Table 4.1.
The full list of representative foods/beverages and standard serves used in analysis 
by the candidate are included in Appendix D, in columns A, B, and C.
Table 4.1 Examples of differences between standard serves used by the 
candidate and by Cancer Council Victoria in analysis of DQES v3.1
DQES v3.1 item Standard serve used in this thesis
Standard serve used by 
Cancer Council Victoria
Dried beans, dried peas, 
chick peas or lentils 93 g (1/2 cup)
a 329 g
Yogurt 200 gb 105 g
Beef or veal 100 gb 213 g
Tinned fish 80 g (1 tin tuna, drained)a 113 g
Note. DQES = Dietary Questionnaire for Epidemiological Studies.
a AUSNUT 2007 measures database (Food Standards Australia New Zealand, 
2015)
b Australian Dietary Guidelines (National Health and Medical Research Council, 
2013)
4.2.2 Estimating the amount of food and beverage consumed per day.
Estimating the amount of food and drink consumed per day involved two steps: 1) 
converting serving sizes included in DQES v3.1 and the population-tailored 
standard serves to grams consumed per day; and 2) adjusting the grams per day of 
certain foods (i.e. meat, fish, pasta/noodles, fruit, vegetables) depending on 
responses to additional questions in DQES v3.1 that accounted for preferred 
portion size and the number of fruits and vegetables listed. All conversions and 
adjustments to compute food and beverage intakes as grams per day were 
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performed in Microsoft Excel 2013 (Microsoft Corporation, Redmond, 
Washington, US).
Converting serves to grams per day.
DQES v3.1 records the frequency that participants consume the food and 
beverages listed using different sets of response options depending on the food or 
beverage. For example, milk consumption is recorded as number of cups per day, 
egg consumption is recorded as number of eggs per week, while the bulk of items 
are recorded using a 10-item scale: Never/Less than once per month/1-3 times per 
month/1 time per week/2 times per week/3-4 times per week/5-6 times per week/1 
time per day/2 times per day/3 or more times per day. Presenting different sets of 
response options allows DQES v3.1 to capture variation in intakes that may be 
missed if the same set of response options was used throughout the questionnaire 
(Willett, 2013). Where DQES v3.1 did not directly record consumption of 
food/beverages per day, women’s responses were converted to the equivalent of 
grams per day. For example, number of eggs consumed per week (with standard 
serve of 1 egg = 44 g edible portion (Food Standards Australia New Zealand, 
2015)) was divided by 7. To convert the 10-item scale used for the majority of 
foods, the standard serves were multiplied by the conversion factors also used in 
DQES v2 (Table 4.2). For example, if a woman reported she consumed tinned fish 
twice per week, the daily equivalent consumption was calculated as 80 g tinned 
fish (i.e. standard serve of a drained single-serve tin) × 0.28 (i.e. factor for 2 times 
per week) = 22.4 g/day. Once these conversions were completed, the gram per day 
quantities of meat, fish, pasta/noodles, fruit and vegetables were scaled.
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Table 4.2 Factors used to convert frequency responses in DQES v3.1 to daily 
equivalents
Frequency response option Conversion factor
Never 0
Less than once per month 0.02
1-3 times per month 0.07
1 time per week 0.14
2 times per week 0.28
3-4 times per week 0.5
5-6 times per week 0.78
1 time per day 1
2 times per day 2
3 or more times per day 3
(Nutritional Assessment Office - Cancer Epidemiology Centre - Cancer Council 
Victoria, 2014)
Scaling intakes according to preferred portion size.
For meat, seafood, rice, and pasta/noodles, the converted grams per day was 
multiplied by a ‘portion factor’, calculated as shown in Figure 4.1. These portion 
factors were based on those used in DQES v2 (Nutritional Assessment Office -
Cancer Epidemiology Centre - Cancer Council Victoria, 2014).
Figure 4.1 Photographs used to determine preferred portion size. 
Individual portion factors were calculated from six questions (questions 17 
to 22) with the displayed format and used to scale participants’ consumption 
of meat, seafood, rice, and pasta/noodles. Factors were calculated as the 
mean of the six questions, where ‘Less than A’ = 0.25; ‘A’ = 0.5; ‘Between A 
& B’ = 0.75; ‘B’ = 1.0; ‘Between B & C’ = 1.25; ‘C’ = 1.5; ‘More than C’ = 
1.75. Responses of ‘I did not eat [food item]’ were not included in the mean.
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Scaling fruit and vegetable intakes.
The converted grams per day consumption of each of the 23 fruits and 30 
vegetables listed in DQES v3.1 were scaled in relation to the number of fruit and 
vegetable servings participants consumed daily (questions 15 and 16) following 
the approach taken in DQES v2 (Nutritional Assessment Office - Cancer 
Epidemiology Centre - Cancer Council Victoria, 2014). The total converted grams 
per day of all 23 fruits was divided by the reported daily fruit consumption, 
assuming one serve weighed 150 g (National Health and Medical Research 
Council, 2013). For example, if the sum of a woman’s converted consumption of 
the 23 fruits totalled 360 g/d and the woman reported consuming two serves of 
fruit daily (i.e. 300 g/d), the converted consumption of each fruit was then 
multiplied by a factor of 0.83 (i.e. 360 ÷ 300) to bring the total converted fruit 
consumption to 300 g. The same factoring was conducted for vegetables, assuming 
each serve weighed 75 g (National Health and Medical Research Council, 2013).
4.2.3 Estimation of usual nutrient intakes.
Once the estimated quantities of food and beverages in DQES v3.1 were finalised 
(section 4.2.2 Estimating the amount of food and beverage consumed per day.), the 
participants’ daily nutrient intakes were computed. The representative food and 
beverages (Australian food composition databases NUTTAB 2010 (Food 
Standards Australia New Zealand, 2014b) and AUSNUT 2007 (Food Standards 
Australia New Zealand, 2013a)) and the quantities consumed by each participant 
were transferred from Microsoft Excel 2013 (Microsoft Corporation, Redmond, 
Washington, US) into FoodWorks 7 (Xyris Software, Brisbane, Queensland, 
Australia). This dietary analysis software provided each participants’ usual daily 
intake of nutrients including energy, iron and zinc using NUTTAB 2010 (Food 
Standards Australia New Zealand, 2014b) and AUSNUT 2007 (Food Standards 
Australia New Zealand, 2013a).
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Phytate intake.
As phytate values are not included in any Australian food composition database, 
participants’ phytate intakes were estimated separately to all other nutrients. Usual 
daily phytate intake was estimated using the University of Otago’s (Dunedin, New 
Zealand) database of the phytate content of 5775 food and beverages. This 
database was based on published literature of phytate concentration in foods, 
which were adjusted to reflect food processing methods in New Zealand (Hartley, 
2014), and was considered the most appropriate for an Australian population. The 
database provides phytate values as mg per 100 g. Phytate values that 
corresponded to the representative foods consumed by each participant per day 
was computed using Microsoft Excel 2013 (Microsoft Corporation, Redmond, 
Washington, US).
4.2.4 Quality control of DQES v3.1 nutrient analysis.
To assess whether the nutrient intakes estimated using the above methods were 
reasonable, participant intakes of macronutrients were compared to data from the 
Australian Health Survey (AHS) 2011-2013, the most recent nationally-
representative health survey of the Australian population (Australian Bureau of 
Statistics, 2014d). As part of this survey, 24-hour diet recalls were conducted using 
five-pass methodology with 12153 residents at least two years of age, including 
2596 women 20-49 years of age (Australian Bureau of Statistics, 2014d).
Resulting daily intakes are provided in Table 4.3. The main differences between 
women in this research program and women in AHS 2011-2013 were a greater 
proportion of energy coming from fat and less from carbohydrate in the present 
sample of women compared to women in AHS 2011-2013. As the nutrient analysis 
of DQES v3.1 produced macronutrient intakes similar to AHS 2011-2013,
estimates were considered reasonable. 
As noted in section 3.5 Data used in this thesis, three women reported intakes three 
standard deviations greater than the mean and were excluded from dietary analyses 
(Lioret et al., 2013; Spence et al., 2013).
57
Chapter 4: Dietary Methodology
Table 4.3 Macronutrient intake estimated in the study group (n = 379) using 
DQES v3.1 and in the Australian Health Survey 2011-2013 using 24-hour 
recalls
Women in 
study 
groupa
18-50 y
Range for 
study group
AHS 
2011-2013
women 
19-30 yc
AHS 
2011-2013
women 31-
50 yc
Energy (kJ/d) 7699 (2207) 1452, 14451 7863 7540
Protein (g/d) 75.4 (29.2) 13.6, 255.8 78.1 79.7
Total fat (g/d) 74.2 (25.2) 14.9, 192 69.9 65.3
Saturated fat (g/d) 25.2 (10.2) 4.2, 63.2 26.7 24.4
Carbohydrate (g/d) 190.8 (63.7) 34.6, 405.6 213.7 196.5
Sugars (g/d) 93.1 (35.8) 18.6, 242.9 99.0 91.1
Dietary fibre (g/d) 23.7 (8.6) 4.7, 62.8 20.3 20.7
% kJ from protein 17 (4) 5, 35 18 19
% kJ from fat 36 (6) 17, 52 32 31
% kJ from saturated fat 12 (3) 4, 21 12 12
% kJ from carbohydrate 40 (7) 14, 66 46 44
Note. AHS = Australian Health Survey.
a Intakes reported as mean (SD).
b Intakes reported as minimum, maximum.
c Intakes reported as mean.
4.3 Assessment of Dietary Iron and Zinc Adequacy
The adequacy of participants’ dietary iron intake was assessed using the 
probability approach and the adequacy of dietary zinc intake was assessed using 
the Estimated Average Requirement (EAR) cutpoint method (Institute of 
Medicine, 2001; National Health and Medical Research Council, 2006). Iron and 
zinc from supplements were not included in these assessments.
4.3.1 Using the probability approach to assess dietary iron intakes.
Due to the wide inter-individual variation in menstrual losses, iron requirements in 
premenopausal women are distributed asymmetrically around the median, thus 
unlike most nutrients, the cutpoint method of assessing intakes against the EAR for 
iron (i.e. the amount estimated to meet the requirements of half the healthy 
individuals in the group) cannot be used to estimate the prevalence of inadequate 
iron intakes (National Research Council, 1986). Instead, dietary assessment must 
use the probability approach, which compares the distribution of iron intakes to a 
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proposed distribution of iron requirements for a life-stage group (Beaton, 1994;
National Research Council, 1986). The US Institute of Medicine (IOM) has 
published 14 levels of usual iron intake associated with probabilities of inadequacy 
for cohorts of women based on oral contraceptive use (cohort not using oral 
contraception, cohort using oral contraception, and mixed cohort of users and non-
users) (Institute of Medicine, 2001). As the sample of women studied in this thesis 
included a portion using oral contraceptives, the probability values for mixed oral 
contraceptive groups was chosen to assess intakes (Table 4.4; Columns A and B). 
To apply the probability approach, the number of women with dietary iron intakes 
(mg/d) falling in each of the 14 usual iron intake ranges were tallied and calculated 
as percentages of the sample (Table 4.4; Column C). These percentages were then 
multiplied by the IOM’s probability values corresponding to the iron intake ranges 
and then the resulting 14 values were summed to obtain the prevalence of women 
at risk of inadequate intakes in the sample (Table 4.4; Column D). 
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Table 4.4 Probability of inadequate dietary iron intake at different ranges of 
usual iron intakes (mg/d)a and application of the probability approach to 
assess iron intakes among participants in this thesis (N = 379)
Column A Column B Column C Column D
Probability 
that usual 
intakes are 
inadequatea
Levels of usual
iron intakes 
(mg/d)a
Women in study group
with usual intakes
(n (%))
Prevalence of 
inadequacy 
(probability ×
proportion)
1.0 < 4.18 3 (0.79) 0.79
.96 4.18-4.63 4 (1.06) 1.01
.93 4.64-5.19 3 (0.79) 0.74
.85 5.20-5.94 11 (2.9) 2.47
.75 5.95-6.55 18 (4.75) 3.56
.65 6.56-7.13 21 (5.54) 3.60
.55 7.14-7.73 26 (6.86) 3.77
.45 7.74-8.39 27 (7.12) 3.21
.35 8.40-9.21 33 (8.71) 3.05
.25 9.22-10.36 57 (15.04) 3.76
.15 10.37-12.49 80 (21.11) 3.17
.08 12.50-14.85 56 (14.78) 1.18
.04 14.86-17.51 28 (7.39) 0.30
0 > 17.51 12 (3.17) 0.00
Total = 31%
a From US Institute of Medicine (2001). Probability values and corresponding 
levels of usual iron intake are for menstruating women (mixed group of 17% oral 
contraceptive users, 83% non-users).
4.3.2 Using the Estimated Average Requirement cutpoint method to assess 
dietary zinc intakes.
As zinc requirements are assumed to be normally distributed, risk of inadequate 
zinc intakes in this sample was estimated using the EAR cutpoint method as 
outlined by the IOM (2000). The proportion of participants with usual dietary zinc 
intakes (mg/d) below the Australian EAR for zinc for women aged 19-50 y (< 6.5 
mg/d (National Health and Medical Research Council, 2006)) was determined.
4.3.3 Total iron and zinc intakes.
In addition to dietary intakes of iron and zinc, the total intakes of iron and zinc 
were determined by combining dietary intakes computed from DQES v3.1 (mg/d) 
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and adding daily supplemental iron and zinc intakes (mg/d) (see section 3.4.3 Use 
of dietary supplements.).
61
Chapter 5: Dietary Iron and Zinc Intakes
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Components of this chapter have been published in Lim, K., Booth, A., Szymlek-
Gay, E. A., Gibson, R. S., Bailey, K. B., Irving, D., Nowson, C., & Riddell, L. 
(2015). Associations between dietary iron and zinc intakes, and between 
biochemical iron and zinc status in women. Nutrients, 7(4), 2983-2999. doi: 
10.3390/nu7042983
5.1 Introduction
Iron and zinc are essential nutrients required by the body to support oxygen use, 
immune function and general cellular metabolism (section 2.2 Implications of 
Impaired Iron and Zinc Status), therefore maintaining sufficient intakes of iron and 
zinc are required to promote optimal health (Institute of Medicine, 2001).
Identifying Australian women’s current intake levels of these nutrients and the 
main food sources contributing to intakes can help further our understanding of 
dietary strategies required to maintain women’s health. It is particularly important 
to identify the main food sources of dietary iron as the chemical form of iron 
determines its bioavailability. As haem iron, found only in the haemoglobin and 
myoglobin in meat, is more efficiently absorbed than non-haem iron, which is 
present as bound salts (Gibson, 2005), women sourcing iron largely from plant-
based sources may not absorb sufficient iron. Similarly, plant-based sources of 
zinc are less available for absorption than animal sources as they often contain 
absorption inhibitors (Brown et al., 2004), and identifying the main sources of zinc 
in the diet can help direct campaigns to increase intake. Therefore, the aims of this 
study are to assess the adequacy of women’s iron and zinc intakes, and determine 
the major food sources.
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5.1.1 Aims.
Aims:
x Describe total intakes of iron and zinc (diet and supplements), and assess 
adequacy of dietary intakes of iron and zinc in a sample of premenopausal 
women;
x Identify the main sources of dietary iron and dietary zinc in a sample of 
premenopausal women.
5.2 Methods
See Chapter 3 General Methodology for detail.
5.2.1 Participants.
See section 3.3 Sampling and timing for detail
5.2.2 Demographic and anthropometric information.
See section 3.4.1 Anthropometry and section 3.4.2 Demographic and medical 
background and blood loss information.
5.2.3 Assessment of dietary iron and zinc intakes. 
See Chapter 4 Dietary Methodology.
5.2.4 Assessment of dietary supplement use.
See section 3.4.3 Use of dietary supplements. 
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5.2.5 Estimating contributions of food groups to dietary iron and zinc 
intakes.
The following steps were used to estimate contributions of food groups to dietary 
iron intake and dietary zinc intake:
1) As outlined in Chapter 4, the iron and zinc content of each 
food/beverage item in DQES v3.1 was estimated.
2) Each DQES v3.1 item was allocated to a food group, following the 
same grouping used in the Australian Health Survey (AHS) 2011-2013
(Australian Bureau of Statistics, 2014c).
a. Each DQES v3.1 item was matched to an individual AHS 2011-
2013 food/beverage (Appendix D, column D).
b. In the AHS 2011-2013 food grouping system, each individual 
food/beverage is allocated to a minor category (Appendix D, 
column E), which is allocated to a sub-major group (Appendix 
D, column F), which in turn belongs to a major group 
(Appendix D, column G). An example of the categorisation is 
presented in Table 5.1.
Table 5.1 Multigrain bread as an example of food categorisation following the 
Australian Health Survey 2011-2013 system
Level of categorisation Example
DQES v3.1 food/beverage item Q12-4 Multigrain bread
AHS 2011-2013 individual 
food/beverage match Bread, mixed grain, commercial
AHS 2011-2013 minor category Breads, and bread rolls, mixed grain, mandatorily fortified
AHS 2011-2013 sub-major 
group
Regular breads, and bread rolls 
(plain/unfilled/untopped varieties)
AHS 2011-2013 major group Cereals and cereal products
Note. AHS = Australian Health Survey
3) The iron content and zinc content of all food and beverage items in 
each of the sub-major and major food groups were summed to estimate 
the amount of dietary iron and zinc contributed by each food group in
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mg. In total, DQES v3.1 covered 62 sub-major food groups and 19 
major food groups.
4) To convert the mg of iron and zinc to proportions of iron and zinc 
intake, the mg contributed by each AHS 2011-2013 food group was 
divided by the mean dietary iron intake and the mean dietary zinc 
intake of the cohort, and multiplied by 100 to present as a percentage. 
This percentage represents proportions of intakes at the group level, 
and is consistent with the method for determining the proportion of 
nutrients from food groups in AHS 2011-2013 (Australian Bureau of 
Statistics, 2014d).
Participants’ food sources of iron and zinc were compared to data from the sample 
of women aged 19-50 y gathered as part of the National Nutrition and Physical 
Activity component of AHS 2011-2013, which had been weighted to represent the 
Australian population of women (Australian Bureau of Statistics, 2014b).
Where sub-major groups have contributed more than 10% to total dietary iron or 
zinc intakes, the proportion of iron or zinc from the individual DQES v3.1 
food/beverage items has been presented if the individual food contribution is 
greater than 1% (e.g. to follow the example in Table 5.1, the proportion of iron 
from multigrain bread is also listed). The proportion of iron and zinc from the 
AHS 2011-2013 minor categories has not been published.
5.2.6 Statistical analysis.
The distributions of continuous variables were established by inspecting 
histograms, with normally distributed data presented as mean (SD) and skewed 
data presented as median (interquartile range (IQR; 25th to 75th centiles). 
Categorical data are presented as n (%).
Analyses were performed using Stata/SE 13.1 (StataCorp, Texas, US). A two 
sample t-test was used to assess whether dietary iron intakes differed according to 
use of iron supplements, and as dietary zinc intakes were not normally distributed, 
a Wilcoxon rank-sum test was used to assess whether dietary zinc intakes differed 
according to use of zinc supplements.
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5.3 Results
5.3.1 Description of participants.
Descriptive characteristics of women whose dietary data are included in this study 
are provided in Table 5.2. 
Table 5.2 Characteristics of the study group of premenopausal women aged 
18-50 y (N = 379)
Mean (SD) n (%) or median (IQR)
Age (y) 28.7 (7.3)
Height (m) 1.66 (0.06)
Weight (kg) 66.2 (11.7)
Body mass index (kg/m2) 24 (3.9)
Underweight 12 (3%)
Normal weight 255 (68%)
Overweight 73 (20%)
Obese 34 (9%)
Born in Australia 289 (76%)
Tertiary education 307 (81%)
Currently employed 332 (88%)
Current smoker 27 (7%)
Has children 59 (16%)
Energy intake (MJ/d) 7.7 (2.2)
On ‘special diet’ 87 (23%)
Vegetarian 16 (4%)
Mostly vegetarian but eats some 
meats 33 (9%)
Other dietsa 38 (10%)
a ‘Other diets’ include gluten-free and/or wheat-free (n = 20), vegan (n = 5), 
weight management (including high protein, reduced calories, Lite n Easy, low fat; 
n = 5), Palaeolithic/primal (n = 2).
5.3.2 Food intake.
Participants’ consumption of meats and major food groups are provided in Table 
5.3.
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Table 5.3 Usual consumption of meats and major food groups in study group:
women aged 18-50 y
Including non-consumers Excluding non-consumers
n Median (IQR)consumption (g/d) n
Median (IQR)
consumption (g/d)
Lamb and beef 379 26 (9 to 40) 332 28 (15 to 45)
Chicken 379 23 (12 to 39) 337 25 (14 to 40)
Pork 379 2 (0 to 8) 253 6 (2 to 11)
Fish 379 18 (8 to 34) 340 20 (12 to 36)
Total meat, fish 
and poultry 379 79 (52 to 118) 358 81 (58 to 120)
Nuts 379 6 (3 to 17) 360 8 (3 to 17)
Vegetables 379 219 (146 to 295) 379 219 (146 to 295)
Fruit 379 310 (186 to 450) 377 310 (186 to 450)
Dairy 379 294 (149 to 526) 373 296 (153 to 530)
5.3.3 Iron and zinc intake.
Participants’ usual iron and zinc intakes are provided in Table 5.4. Usual dietary 
iron and zinc intakes ranged from 1.8 to 25 mg/d and 1.6 to 40.9 mg/d 
respectively. Excluding contributions from supplements, 31% of the cohort were at 
risk of inadequate dietary iron intakes and 19% at risk of inadequate zinc dietary 
intakes. Twenty percent (73/373 women) were taking some form of supplemental 
iron (three women were taking both an iron-specific supplement and a 
multivitamin/mineral containing iron). The dose of elemental iron in iron-specific 
supplements ranged from 0.4 to 105 mg/d, and the dose of iron in 
multivitamin/mineral supplements ranged from 0.4 to 60 mg/d; the most potent 
multivitamin/mineral supplement was a prenatal daily supplement. Fourteen 
percent (52/370 women) were taking some form of zinc supplementation (one 
woman was taking both a zinc-specific supplement and a multivitamin/mineral 
containing zinc). Only 2/8 participants taking zinc-specific supplements provided 
dose or manufacturer information and these supplements contributed 25 to 50 
67
Chapter 5: Intakes and Food Sources
mg/d of elemental zinc. The dose of zinc from multivitamin/mineral supplements 
ranged from 0.4 to 30 mg/d. 
Consumers and non-consumers of iron from supplements did not differ in dietary 
iron intakes (t(330) = 0.45, p = .652), and there was also no difference in dietary 
zinc intakes among consumers and non-consumers of supplemental zinc (Z = 0.33, 
p = .741). 
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Table 5.4 Characteristics of dietary and supplemental iron and zinc intakes in 
study group: women aged 18-50 y (N = 379)
Mean (SD) Median (IQR) n (%)
Dietary iron intake (mg/d) 10.5 (3.5)
At risk of inadequate iron 
intakea 117 (31%)
Taking iron-specific supplements 32 (8%)
Elemental iron from iron-
specific supplements (mg/d)b
13.3 (5.0 to 
30.0)
Taking multivitamin/mineral 
supplements containing iron 44 (12%)
Elemental iron from 
multivitamin/mineral 
supplements (mg/d)c
5.0 (4.9 to 5.0)
Total iron intake (mg/d) 11.0 (8.3 to 14.1)
Dietary zinc intake (mg/d) 8.7 (7.0 to 11.1)
At risk of inadequate zinc 
intaked 72 (19%)
Taking zinc-specific supplementse 8 (2%)
Taking multivitamin/mineral 
supplements containing zinc 45 (12%)
Elemental zinc from 
multivitamin/mineral 
supplements (mg/d)f
6.3 (4.0 to 10.0)
Total zinc intake (mg/d) 9.2 (7.2 to 11.9)
Note. IQR = interquartile range (25th to 75th centiles).
a Assessed using probability approach (Beaton, 1994; National Research Council, 
1986).
b Supplemental iron dose data unavailable for 5/32 women taking iron-specific 
supplements. 
c Supplemental iron dose data unavailable for 1/44 women taking 
multivitamin/mineral supplements.
d Assessed using EAR cutpoint method (National Health and Medical Research 
Council, 2006).
e Supplement zinc dose data only available for 2/8 women taking zinc-specific 
supplements (25 mg/d and 50 mg/d).
f Supplement zinc dose data unavailable for 1/45 women taking 
multivitamin/mineral supplements.
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5.3.4 Sources of dietary iron. 
The food sources of dietary iron reported by women in the present study are 
displayed in Table 5.5 alongside data collected in AHS 2011-2013 for ease of 
comparison. The main major groups contributing to dietary iron intake were 1) 
cereals and cereal products; 2) vegetable products and dishes; and 3) meat, poultry 
and game products and dishes. The sub-major groups contributing most to cereals 
and cereal products were ready to eat breakfast cereals (particularly Weet-Bix) and 
bread. The highest-contributing sub-major group in vegetable products and dishes 
was leaf and stalk vegetables (e.g. spinach and silverbeet), and in meat, poultry 
and game the highest-contributing sub-group was unprocessed beef, lamb and
pork. 
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Table 5.5 Contribution of foods to dietary iron intake among the study group
of women aged 18-50 y and in the Australian Health Survey 2011-2013
Food group
Contribution to dietary iron intake 
(%)
Study group
18-50 y
(N = 379)
AHS 
2011-
2013
women 
19-30 ya
AHS
2011-
2013
women 
31-50 ya
Cereals and cereal products 30.7 25.1 26.8
Breakfast cereals, ready to eat 13.0 13.0 12.9
Weet-Bix (regular) 4.2 - -
Non-toasted muesli 2.0 - -
Fibre Plus, Just Right, Sports 
Plus, Special K 1.1 - -
Regular breads, and bread rolls 
(plain/unfilled/untopped varieties) 10.5 8.5 9.6
Multigrain bread 3.0 - -
Wholemeal bread 2.8 - -
White bread 1.6 - -
Rye bread 1.6 - -
Soy and linseed bread 1.1
Flours and other cereal grains and 
starches 3.6 0.7 0.7
Breakfast cereals, hot porridge style 2.1 0.5 1.1
Pasta and pasta products (without 
sauce) 1.5 0.7 0.6
Cereal based products and dishes 6.1 19.3 15.4
Savoury biscuits 2.1 0.6 0.8
Cakes, muffins, scones, cake-type
desserts 1.4 1.9 2.1
Pastries 1.1 2.6 1.9
Sweet biscuits 0.8 1.0 0.9
Mixed dishes where cereal is the 
major ingredient 0.7 13.0 9.5
Vegetable products and dishes 16.4 11.9 11.7
Leaf and stalk vegetables 6.5 0.9 1.2
Other fruiting vegetables 2.4 1.5 1.1
Cabbage, cauliflower and similar 
brassica vegetables 2.3 0.9 0.8
Peas and beans 1.8 0.5 0.8
Tomato and tomato products 1.4 0.4 0.6
Carrot and similar root vegetables 1.0 0.5 0.5
Potatoes 0.8 2.8 2.4
Other vegetables and vegetable 
combinations 0.3 1.1 1.2
Dishes where vegetable is the major 
component 0.05 3.4 3.1
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Food group
Contribution to dietary iron intake 
(%)
Study group
18-50 y
(N = 379)
AHS 
2011-
2013
women 
19-30 ya
AHS
2011-
2013
women 
31-50 ya
Meat, poultry and game products and 
dishes 14.0 14.7 15.9
Beef, sheep and pork, unprocessed 8.9 5.1 5.5
Poultry and feathered game 2.7 1.5 1.7
Processed meat 1.7 1.0 1.0
Sausages, frankfurts and saveloys 0.6 1.0 1.2
Mixed dishes where beef, sheep, 
pork or mammalian game is the 
major component
- 3.5 3.7
Mixed dishes where poultry or 
feathered game is the major 
component
- 2.5 2.6
Fruit products and dishes 8.1 3.4 4.3
Tropical and subtropical fruit 1.9 0.7 0.9
Other fruit 1.7 0.5 0.6
Berry fruit 1.4 0.2 0.2
Stone fruit 1.1 0.2 0.4
Pome fruit 0.8 0.6 0.7
Citrus fruit 0.8 0.7 0.8
Dried fruit, preserved fruit 0.5 0.4 0.5
Mixtures of two or more groups of 
fruit 0.0 0.2 0.2
Legume and pulse products and dishes 3.8 1.2 1.1
Seed and nut products and dishes 3.6 1.7 2.0
Non-alcoholic beverages 3.1 7.2 5.3
Confectionery and cereal/nut/fruit/seed 
bars 2.6 2.1 2.0
Milk products and dishes 2.1 1.4 1.5
Miscellaneous 2.0 0.8 0.7
Egg products and dishes 1.8 2.3 2.5
Fish and seafood products and dishes 1.7 1.5 3.1
Dairy & meat substitutes 1.7 1.3 0.8
Alcoholic beverages 1.2 0.8 1.4
Savoury sauces and condiments 1.0 1.1 1.3
Snack foods 0.5 1.0 0.7
Sugar products and dishes 0.2 0.3 0.3
Fats and oils 0.0 0.0 0.0
Note. AHS = Australian Health Survey
a Data in AHS 2011-2013 were weighted to represent the Australian population.
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5.3.5 Sources of dietary zinc. 
The percentage contribution to dietary zinc intakes are displayed in Table 5.6. The 
major food groups with the largest contributions to zinc intakes were 1) meat, 
poultry and game; 2) milk products and dishes; and 3) cereals and cereal products. 
Beef as a single item was a key contributor to zinc intakes, representing 48% of all 
dietary zinc coming from the major group of meat, poultry and game. 
Table 5.6 Contribution of foods to dietary zinc intake among the study group 
of women aged 18-50 y and in the Australian Health Survey 2011-2013
Food group
Contribution to dietary zinc intake 
(%)
Study group
18-50 y
(N = 379)
AHS 
2011-
2013
women 
19-30 ya
AHS 
2011-
2013
women 
31-50 ya
Meat, poultry and game products and 
dishes 30.3 27.8 30.2
Beef, sheep and pork, unprocessed 20.3 11.7 13.2
Beef or veal 14.4 - -
Lamb 3.8 - -
Pork 2.1 - -
Poultry and feathered game 5.7 3.0 3.5
Processed meat 3.2 1.8 1.8
Sausages, frankfurts and saveloys 1.1 1.8 2.0
Mixed dishes where beef, sheep,
pork or mammalian game is the 
major component
- 6.3 6.5
Mixed dishes where poultry or 
feathered game is the major 
component
- 3.1 3.1
Milk products and dishes 18.8 11 11.2
Dairy milk (cow, sheep and goat) 8.7 4.6 4.7
Cheese 5.1 3.1 3.7
Yoghurt 0.3 1.6 1.6
Frozen milk products 0.1 0.4 0.4
Flavoured milks and milkshakes 0.1 1.0 0.6
Cream 0 0 0
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Food group
Contribution to dietary zinc intake 
(%)
Study group
18-50 y
(N = 379)
AHS 
2011-
2013
women 
19-30 ya
AHS 
2011-
2013
women 
31-50 ya
Cereals and cereal products 17.2 15.3 15.6
Regular breads, and bread rolls 
(plain/unfilled/untopped varieties) 6.9 5.3 5.7
Breakfast cereals, ready to eat 5.4 5.9 5.5
Flours and other cereal grains and 
starches 2.4 2.1 1.9
Breakfast cereals, hot porridge style 1.2 0.6 1.1
Pasta and pasta products (without 
sauce) 1.2 0.4 0.4
Cereal based products and dishes 4.6 19.1 14.5
Savoury biscuits 1.3 0.5 0.6
Mixed dishes where cereal is the 
major ingredient 1.2 14.9 10.6
Pastries 1.0 2.0 1.6
Cakes, muffins, scones, cake-type 
desserts 0.7 1.1 1.1
Sweet biscuits 0.4 0.5 0.4
Vegetable products and dishes 9.6 8.7 8.3
Other fruiting vegetables 2.6 1.0 0.7
Peas and beans 1.9 0.6 0.8
Leaf and stalk vegetables 1.7 0.2 0.3
Carrot and similar root vegetables 1.0 0.5 0.4
Tomato and tomato products 0.9 0.4 0.7
Cabbage, cauliflower and similar 
brassica vegetables 0.9 0.3 0.3
Potatoes 0.5 1.9 1.6
Other vegetables and vegetable 
combinations 0.2 0.8 0.8
Dishes where vegetable is the major 
component 0.0 2.9 2.6
Seed and nut products and dishes 4.5 0.5 0.3
Fruit products and dishes 4.4 1.8 2.2
Tropical and subtropical fruit 1.2 0.4 0.5
Other fruit 0.9 0.2 0.3
Berry fruit 0.7 0.1 0.1
Stone fruit 0.6 0.1 0.2
Pome fruit 0.4 0.3 0.4
Citrus fruit 0.4 0.3 0.3
Dried fruit, preserved fruit 0.1 0.2 0.2
Mixtures of two or more groups of 
fruit 0.0 0.1 0.1
Legume and pulse products and dishes 2.2 0.6 0.6
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Food group
Contribution to dietary zinc intake 
(%)
Study group
18-50 y
(N = 379)
AHS 
2011-
2013
women 
19-30 ya
AHS 
2011-
2013
women 
31-50 ya
Confectionery and cereal/nut/fruit/seed 
bars 2.0 1.4 1.1
Fish and seafood products and dishes 1.8 3.2 3.8
Non-alcoholic beverages 1.7 2.0 2.1
Egg products and dishes 1.5 1.7 1.7
Dairy & meat substitutes 0.6 0.7 0.5
Snack foods 0.6 0.9 0.7
Alcoholic beverages 0.5 0.3 0.6
Miscellaneous 0.3 0.5 0.3
Sugar products and dishes 0.3 0.6 0.5
Fats and oils 0.1 0 0
Savoury sauces and condiments 0.1 0.5 0.5
Note. AHS = Australian Health Survey
a Data in AHS 2011-2013 were weighted to represent the Australian population.
5.4 Discussion
In this sample of premenopausal women, 31% were at risk of inadequate intakes of 
dietary iron and 19% were at risk of inadequate intakes of dietary zinc. There were 
slight differences in dietary sources of iron and zinc. Women sourced most of their 
dietary iron from cereals and cereal products (31%), vegetables (16%), and meat 
and poultry (14%), whereas most dietary zinc was acquired from meat and poultry 
(30%), milk products (19%), and cereals and cereal products (17%). Together, 
these data indicate that approximately one third of women in our sample were 
consuming intakes of iron and zinc that put them at risk of nutrient insufficiency. 
In the case of iron, women’s reliance on plant-based sources of iron rather than 
haem iron in meat may place them at further risk of inadequate iron due to reduced 
bioavailability of non-haem iron (see Chapter 7 Determinants of Iron Stores). 
The dominance of the cereals, vegetables and meat major food groups as sources 
of iron and zinc in the present study are similar to that reported in AHS 2011-2013
(Australian Bureau of Statistics, 2014b), although there are some notable 
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differences related to differences in how foods were classified. In AHS 2011-2013,
foods classed under the major food group ‘Cereal based products and dishes’ (as 
distinct from ‘Cereals and cereal products’) were the second largest contributors to 
women’s dietary iron and zinc intakes, in particular foods in the sub-major group 
‘Mixed dishes where cereal is the major ingredient’ (Australian Bureau of 
Statistics, 2014b). In contrast, in the current sample of women, cereal-based foods 
and cereal-based mixed dishes were ranked fifth in terms of contributions to 
dietary intakes of iron or zinc. This difference is likely due to the foods included in 
the AHS 2011-2013 ‘Mixed dishes where cereal is the major ingredient’ sub-major 
group. These mixed dishes include pizza; sandwiches and filled rolls; burgers, taco 
and tortilla dishes; pasta and noodle dishes; rice dishes; dumplings; and sushi 
(Food Standards Australia New Zealand, 2013b). Of these items, only pizza is 
listed as an item in DQES v3.1, and the other cereal-based mixed dishes are 
considered in terms of their components. For example, AHS 2011-2013 considers 
spaghetti bolognese a single mixed dish, but depending on the recipe, its 
components fall under the DQES v3.1 items of ‘beef’, ‘pasta or noodles’, ‘fresh 
tomatoes (raw or cooked)’ or ‘canned tomatoes and tomato juice’, ‘tomato 
products including puree, paste or pasta sauce’, and ‘onion or leeks’. Contributions 
to nutrient intakes from these items therefore count towards different food groups 
in the two surveys. The two surveys also used different food composition 
databases: the database used in the current study was developed at least four years 
prior to the database used in AHS 2011-2013, and food manufacturers may have 
reformulated products in the meantime (e.g. adjusted iron fortification). 
Another notable difference between the two surveys was the contribution of dairy 
products to dietary zinc intakes as women in the present study sourced 19% of 
dietary zinc from dairy compared to 11% in AHS 2011-2013 (Australian Bureau 
of Statistics, 2014b). This difference may be linked to the different methods used 
to measure women’s food and drink intake. While DQES v3.1 recorded milk 
intake as: none; < 125 mL/d; about 125 mL/d; about 250 mL/d; about 500 mL/d; 
or at least 750 mL/d, AHS 2011-2013 used 24-hour diet recalls with food model 
booklets that perhaps allowed for a more precise estimate, which may explain why
women in the present study consumed on average 232 mL/d dairy milk compared 
to the 120 mL/d consumed by women in AHS 2011-2013. Although there are 
undoubtedly differences due to the intake measurement methods, there may also 
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be differences in the dietary habits of the women who chose to participate in the 
current study. In AHS 2011-2013, 54% of women aged 19-30 years and 72% of 
women aged 31-50 years reported consuming dairy milk in their diet recall, 
whereas 84% of women in the present study reported using milk in DQES v3.1. 
Similarly, 95% of current participants reported consuming nuts and seeds 
compared to 15% of AHS 2011-2013 women aged 19-30 years and 19% of those 
aged 31-50 years. The different dietary assessment methods, different food 
categorisation, and potentially different dietary habits of this cohort and the AHS 
2011-2013 women suggest the dietary data from this cohort is not typical of the 
general population of premenopausal women. Indeed, compared to national data, 
the current sample was less likely to be overweight or obese, more likely to have a 
tertiary degree, more likely to be currently employed, and less likely to currently 
smoke (data in Appendix B). These differences may also explain why in terms of 
adequacy of usual intakes, the proportion of women at risk of inadequate dietary 
iron intakes was slightly lower in the present sample than the proportion in AHS 
2011-2013, while the proportion of women at risk of inadequate dietary zinc 
intakes was slightly higher in this study than in AHS 2011-2013 (Table 5.7). 
Table 5.7 Usual dietary iron and zinc intakes of women in the study group 
and in the 2011-2013 Australian Health Survey a
Women in 
study group
18-50 y
AHS 2011-
2013 women 
19-30 y
AHS 2011-
2013 women 
31-50 y
Dietary iron intake (mg/d) 10.5 (3.5)c 9.0 9.0
At risk of inadequate iron 
intake (%) 117 (31%) 38 38
Total iron intake (mg/d)b 11.0 (8.3 to 14.1)d 11.1 10.7
Dietary zinc intake (mg/d) 8.7 (7.0 to 11.1) 8.9 9.3
At risk of inadequate zinc 
intake (%) 72 (19%) 14 10
Note. AHS = Australian Health Survey
a Usual nutrient intakes in the current study assessed by food frequency 
questionnaire and in the Australian Health Survey assessed using two 24-hour 
recalls (Australian Bureau of Statistics, 2015).
b Total zinc intake including supplements not available.
c Mean (SD).
d Median (IQR).
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It is concerning that women in the study group seem to consume only 15% of iron 
from meat sources (i.e. 1.5 mg/d) as the human body absorbs the haem iron found 
exclusively in meat more efficiently than non-haem iron (Institute of Medicine, 
2001), and meat is known to enhance iron absorption (Collings et al., 2013).
Relying on iron from plant-based sources such as cereals and vegetables may 
reduce the iron bioavailability of women’s diets, potentially leading to impaired 
iron status (Institute of Medicine, 2001). In setting dietary iron intake 
recommendations, it is assumed that 10% of dietary iron consumed is in haem 
form (Institute of Medicine, 2001). Applying the long-held assumption that 40% of 
iron in meat, fish and poultry is in haem form (Monsen et al., 1978), it seems that 
the women in the present study consume approximately only 6% of their dietary 
iron in haem form and thus their haem iron intakes fall below the conservative 
assumption used to set iron intake recommendations. As would be expected from 
low intakes of haem iron, meat consumption was low in the study group. Women 
who consumed meat reported eating median 81 g/d total meat and 28 g/d red meat,
less than the amounts suggested by the Australian government (2.5 serves of either 
65 g/d cooked lean meat (beef, veal, lamb, pork), 80 g/d cooked poultry, 100 g/d 
fish) (National Health and Medical Research Council, 2013). Previous research
from the US has indicated that adults who consume beef and pork are more likely 
to believe their diets contain too much fat and saturated fat than adults who do not 
consume these meats (Guenther, Jensen, Batres-Marquez, & Chen, 2005), and 
work in Ireland found individuals who associated pork and poultry with positive 
perceptions of health, eating enjoyment and food safety reported stronger 
intentions to consume these meats (McCarthy, O'Reilly, Cotter, & de Boer, 2004).
It is possible women in the present study hold negative perceptions towards meat 
and accordingly restrict their intake, rather than look for lean meats. Therefore, 
research investigating why Australian women may limit their meat intake could 
help inform health-oriented approaches to increase intakes.
A second concern in the findings of the present study is the relatively high 
contribution of processed cereals and cereal products to dietary intakes of iron and 
zinc. Ready to eat breakfast cereals and breads that fall in this category are 
permitted to be fortified with iron and zinc (Food Standards Australia New 
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Zealand, 2014a), which may account for their contributions to iron and zinc 
intakes. However, these products also frequently contain added sodium and sugar 
(Grimes, Nowson, & Lawrence, 2008; Obesity Policy Coalition, 2015), therefore 
broadly encouraging consumption of breads and cereals to increase iron and zinc 
intakes may increase consumption of these nutrients. Specifically encouraging 
consumption of bread and cereal varieties that contain low amounts of sodium and 
sugar would align with guidelines and would help achieve higher intakes of iron 
and zinc, although bioavailability would need to be considered.
Although recommending women increase intakes of meat and certain cereal 
products may assist women to increase their iron and zinc intakes, these 
recommendations are problematic for women following special diets, for instance 
those following a wheat-free or gluten-free diet (5% of this cohort), and those 
following a vegetarian or vegan diet (18% and 1% of this cohort, respectively). A 
well-planned diet is necessary in these women to ensure they are not at risk of 
inadequacy (Reid, Marsh, Zeuschner, Saunders, & Baines, 2013; Shepherd & 
Gibson, 2013).
5.5 Conclusion
In summary, 31% of Australian premenopausal women may be at risk of dietary 
iron inadequacy and 19% may be at risk of dietary zinc inadequacy. Cereals and 
cereal products, vegetables, and meat and poultry were the main sources of dietary 
iron, while meat and poultry, dairy products, and cereals and cereal products were 
the main sources of dietary zinc. As meat was a relatively small contributor to 
dietary iron intakes, promoting consumption of meat, specifically lean red meat, 
may help reduce the number of women at risk of iron inadequacy while improving 
bioavailability of the diet, however the reasons for low meat intake in this group 
first needs to be explored. Consumption of cereal products and meats may 
contribute to higher iron and zinc intakes, but women who follow special gluten-
free or vegan diets will need more tailored recommendations.
79
Chapter 6: Associations Between Dietary 
Iron and Zinc Intakes, and Between 
Biochemical Iron and Zinc Status in 
Women
Components of this chapter have been published in Lim, K., Booth, A., Szymlek-
Gay, E. A., Gibson, R. S., Bailey, K. B., Irving, D., Nowson, C., & Riddell, L. 
(2015). Associations between dietary iron and zinc intakes, and between 
biochemical iron and zinc status in women. Nutrients, 7(4), 2983-2999. doi: 
10.3390/nu7042983 
6.1 Introduction
Iron and zinc are frequently found in similar food sources, therefore it is thought 
that inadequate dietary iron and zinc intakes may occur simultaneously (Gibson, 
Heath, & Ferguson, 2002). There is also evidence that the form of iron and zinc in 
plant-based foods is less readily available for absorption than from diets containing 
meat, perhaps more so than other trace minerals (Hunt, 2003), and that compounds 
such as phytate may further impede absorption of both iron and zinc from foods 
(Hunt, 2003). Due to these diet-based similarities, there is potential for iron and 
zinc status to be positively correlated (Brown et al., 2004; Gibson et al., 1999;
Prosser et al., 2010; Yokoi et al., 1994; Yokoi et al., 2007). Prevalence of iron 
deficiency anaemia is proposed as a proxy for zinc deficiency (Brown et al., 2004), 
and as premenopausal women are at increased risk of iron deficiency, their zinc 
status may similarly be impaired. There are no data on zinc status to explore this 
relationship in Australian women. Three studies in premenopausal women 
conducted in industrialised countries have reported positive correlations between 
serum ferritin and serum zinc concentrations ranging from 0.10 to 0.45 (Gibson et 
al., 1999; Prosser et al., 2010; Yokoi et al., 2007), and one found significantly 
lower serum ferritin concentration in women with low zinc status (mean serum 
ferritin 10.8 (SD 7.2) μg/L vs. 26.0 (SD 15.3) μg/L) (Yokoi et al., 1994). These 
findings support an association between iron and zinc status, however only one 
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study (Prosser et al., 2010) accounted for infection and inflammation, which are 
known to elevate serum ferritin and suppress serum zinc concentrations (Brown et 
al., 2004; World Health Organization, 2011). Investigating the association between 
iron and zinc status whilst accounting for inflammation may further understanding 
of the relationship between these two nutrients and provide some insight into 
whether depleted iron stores may predict risk of impaired zinc status among 
Australian women. Therefore, this study aimed to investigate associations between 
dietary iron and zinc intakes and iron and zinc status. 
6.1.1 Aims and Hypotheses.
Aims:
x Investigate associations between dietary iron and zinc intakes in a sample 
of premenopausal women; 
x Investigate associations between biochemical iron and zinc status in a 
sample of premenopausal women. 
Hypotheses: 
x A positive association between dietary iron and zinc intakes will be 
observed. 
x A positive association between biochemical iron and zinc status will be 
observed. 
6.2 Methods
See Chapter 3 General Methodology for detail.
6.2.1 Participants.
See section 3.3 Sampling and timing. 
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6.2.2 Demographic and anthropometric information. 
See section 3.4.1 Anthropometry and section 3.4.2 Demographic and medical 
background and blood loss information. 
6.2.3 Assessment of dietary iron and zinc intake and supplement use.
See Chapter 4 Dietary Methodology and section 3.4.3 Use of dietary supplements..  
Adequacy of dietary iron and zinc intakes. 
See section 4.3 Assessment of dietary iron and zinc adequacy. 
6.2.4 Biochemistry.
Blood samples were analysed for serum ferritin, haemoglobin, C-reactive protein 
(CRP), and serum zinc concentrations by the methods outlined in Section 3.4.4 
Biochemical analyses.  
For all participants, serum zinc concentrations were standardised to 08:00 blood 
sampling using the method of Arsenault et al. (2011): 
1) A linear regression model was run with serum zinc concentration as the 
dependent variable and blood sampling time in hours as a covariate. The 
result of interest was the ȕ-coefficient for sampling time. In the present
study, ȕ = -0.115). 
2) Each participant’s sampling time was centred around 08:00. For example, a 
participant who had blood sampled at 10:00 would have a centred value of 
2 (i.e. 10:00 – 08:00). 
3) Each participant’s centred value was multiplied by the ȕ-coefficient for 
sampling time obtained in step 1. For example, 2 × -0.115 = -0.230. 
4) The value obtained in step 3 was subtracted from the participant’s raw 
serum zinc concentration. The resulting value was considered the zinc 
concentration standardised to 08:00. These values were interpreted 
according to fasting status.
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Standardised serum zinc concentrations were used for all descriptive and 
inferential analyses.
For descriptive purposes only, serum ferritin concentrations were corrected for 
inflammation if CRP concentration exceeded 5 mg/L. In these women, serum 
ferritin concentrations were multiplied by a factor of 0.65 (Thurnham et al., 2010). 
Biomarker reference values.
Internationally-recognised reference values were used to categorise biomarker data 
(Table 6.1).
Table 6.1 Reference values used to interpret biomarkers of iron and zinc 
status
Biomarker 
Classification Serum ferritin Haemoglobin CRP Serum zinc 
Depleted iron storesa < 15 μg/L J/ < 5 mg/L - 
Iron overloadb > 150 μg/L - < 5 mg/L - 
Anaemiaa - < 120 g/L - - 
Iron-deficiency 
anaemiaa < 15 μg/L < 120 g/L - - 
Non-iron deficiency 
anaemia J/ < 120 g/L < 5 mg/L - 
Low serum zinc 
concentrationc - - - 
AM fasting: 
< 10.7 μmol/L
AM nonfasting:  
< 10.1 μmol/L 
Inflammation/
infectiond - - PJ/ - 
Note. CRP = C-reactive protein. 
a World Health Organization/Centers for Disease Control and Prevention (2007).
b World Health Organization (2011).
c Brown et al. (2004). 
d Thurnham and McCabe (2012). 
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6.2.5 Statistical analysis. 
The distributions of continuous variables were established by inspecting 
histograms, with normally distributed data presented as mean (SD) and skewed 
data presented as median (interquartile range (IQR; 25th to 75th centiles)). 
Categorical data are presented as n (%). To compare groups, independent samples 
t-tests were used for normally distributed data, Wilcoxon rank-sum tests were used 
for skewed data, Pearson chi-square tests were as used for categorical data with 
H[SHFWHGFRXQWVDQG)LVKHUVH[DFWWHVWVZHUHXVHGIRUFDWHJRULFDOGDWDZLWK
expected counts < 5.  
Nested linear regression analyses were used to investigate associations between 
dietary iron intake (mg/d; dependent variable) and dietary zinc intake (mg/d; 
independent variable), with and without energy intake (MJ/d) as a potential 
confounding variable. Inspection of residual-versus-fitted and component-plus-
residual plots was conducted to confirm adherence to linear regression 
assumptions, and the fit of the nested models was compared using a likelihood 
ratio test. DfBeta statistics were produced and the regression analysis was repeated 
omitting any participants whose DfBeta statistic indicated disproportionate 
LQIOXHQFHRQWKHGLHWDU\]LQFLQWDNHUHJUHVVLRQFRHIILFLHQWFXWRII'I%HWD!¥Q
(Belsley, Kuh, & Welsch, 1980)).
To investigate associations between inadequate dietary iron and zinc intakes, 
women were dichotomised to those meeting the zinc EAR and those not meeting 
the zinc EAR, and the percentage of participants at risk of inadequate iron intakes 
in each group was compared using a two-proportion z-test (an immediate two-
sample proportion test).  
Nested linear regression analyses were also used to investigate continuous 
associations between uncorrected serum ferritin (μg/L) as the dependent variable 
and serum zinc (μmol/L, standardised to blood sampling at 08:00) as the 
independent variable, with and without potential confounding variables (fasting 
status, CRP (mg/L), age, BMI, use of oral contraception, mL of donated blood 
over the past 12 months, use of dietary supplements containing iron and/or zinc). 
Plotting the residuals against the fitted values showed heteroscedasticity, so serum 
ferritin was natural-log transformed for these analyses. The fit of these nested 
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models were also compared using the likelihood ratio test and analysis was 
repeated omitting women whose DfBeta value indicated undue influence on the 
serum zinc regression coefficient. 
Analyses were performed using Stata/SE 12.0 (StataCorp, Texas, US). 
6.3 Results
6.3.1 Dietary and supplemental iron and zinc intakes.
See section 5.3.2 Iron and zinc intake for a description of the participants’ usual 
dietary intakes of iron and zinc and supplement use (n = 379). 
6.3.2 Associations between usual dietary iron and zinc intakes.
There was a positive association between dietary iron intake and dietary zinc 
intake. Multiple linear regression indicated that for every 1 mg/d increase of 
dietary iron intake, mean dietary zinc intake increased by 0.7 mg/d, and 65% of 
variation in dietary iron and zinc intakes could be accounted for by each other 
(Table 6.2). When adjusting for energy intake, each 1 mg/d increase of dietary iron 
intake was associated with a 0.4 mg/d increase in dietary zinc intake (Table 6.2), 
and a likelihood ratio test indicated that energy adjustment improved the fit of the 
model (likelihood ratio Ȥ2 = 60.18, p < .001). Omitting nine women identified 
using DfBetas as being overly influential observations from the adjusted model did 
not markedly change results, as a 1 mg/d increase in dietary iron intake still 
increased mean dietary zinc intake by 0.4 mg/d (Table 6.2).
Using a two-proportion z-test, the proportion of women at risk of inadequate 
dietary iron intakes was 63% (95% CI 52 to 74%) among those with dietary zinc 
intakes below the EAR versus 23% (95% CI 18 to 28%) among those meeting the 
zinc EAR (p < 0.001). 
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Table 6.2 Association between mg/d dietary iron intake (dependent variable) 
and mg/d dietary zinc intake in women aged 18-50 y (n = 379) 
Independent variable: dietary zinc intake (mg/d) ȕ&, p-value
Unadjusted model
Adj. R2 = .648, p < .001
0.739
(0.684 to 0.794) < .001 
Adjusted modela
Adj. R2 = .730, p < .001
0.433
(0.359 to 0.507) < .001 
Adjusted model excluding 9 influential 
participantsa,b
Adj. R2 = .743, p < .001
0.374
(0.301 to 0.447) < .001 
a Adjusted for energy intake (MJ/d). 
b Influence assessed using DfBetas.
6.3.3 Biochemical iron and zinc status.
Details of participants’ iron and zinc biomarkers are provided in Table 6.3. After 
correcting serum ferritin levels in women with inflammation, 37% of this cohort 
had depleted iron stores (30% with normal haemoglobin, 7% with low 
haemoglobin). Seventeen percent (57/326) of women had low serum zinc 
concentrations. 
Table 6.3 Biochemical measures associated with iron and zinc status in 
women aged 18-50 y (N = 326) 
n (%) Median (IQR) Mean (SD)
Serum ferritin (μg/L)a 21 (11 to 38)
CRP (mg/L) 0.63 (0.17 to 2.11)
Haemoglobin (g/L) 132 (10)
Depleted iron storesa,b 97 (30%)
Iron-deficiency anaemiaa,c 22 (7%)
Non-iron deficiency anaemiad 7 (2%)
Iron overloade 2 (0.6%)
Elevated CRPf 32 (10%)
Fasting serum zinc, μmol/L (n =
143)g 12.6 (1.7) 
Low fasting serum zinc (n (%))h 17 (12%) 
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Nonfasting serum zinc, μmol/L (n =
183)g 11.8 (2.0) 
Low nonfasting serum zinc (n
(%))h 40 (22%) 
Note. IQR = interquartile range (25th centile to 50th centile). CRP = C-reactive 
protein.
a 6HUXPIHUULWLQFRUUHFWHGIRUDFXWHLQIHFWLRQ,QZRPHQZLWK&53PJ/VHUXP
ferritin was multiplied by a factor of 0.65 as suggested by Thurnham et al. (2010).
b Depleted iron stores defined as corrected serum ferritin < 15 μg/L, haemoglobin 
J/(World Health Organization/Centers for Disease Control and 
Prevention, 2007). 
c Iron-deficiency anaemia defined as corrected serum ferritin < 15 μg/L, 
haemoglobin < 120 g/L (World Health Organization/Centers for Disease Control 
and Prevention, 2007). 
d Non-iron deficiency anaemia defined as haemoglobin < 120 g/L and corrected 
VHUXPIHUULWLQJ/(World Health Organization/Centers for Disease Control 
and Prevention, 2007). 
e Iron overload defined as serum ferritin > 150 μg/L and CRP < 5 mg/L (World 
Health Organization, 2011).  
f(OHYDWHG&53GHILQHGDVPJ/(Thurnham & McCabe, 2012). 
g Serum zinc standardised to 08:00 sampling time. 
h Low serum zinc defined according to fasting status – fasting: < 10.7 μmol/L; 
nonfasting: < 10.1 μmol/L (Brown et al., 2004). 
Associations between iron and zinc status.  
There was a small positive association between women’s serum ferritin and serum 
zinc concentrations. Simple linear regression of natural log-transformed serum 
ferritin (not corrected for acute infection) on serum zinc indicated that an increase 
of 1 μmol/L in serum zinc was associated with a 10% increase in mean serum 
ferritin (Table 6.4). This association decreased slightly after adjusting for fasting 
status, CRP, age, BMI, use of oral contraception, blood donation, and use of iron 
and/or zinc supplements, so that an increase of 1 μmol/L in serum zinc was 
associated with a 6% increase in mean serum ferritin (Table 6.4). A greater 
proportion of the variance was explained by the adjusted model compared to the 
unadjusted model, and a likelihood ratio test indicated that the fit of the adjusted 
model was better than that of the unadjusteGPRGHOOLNHOLKRRGUDWLRȤ2 = 60.47, p
< 0.001).  
A more conservative model (Appendix E) omitting 16 women identified as having 
disproportionate influence on the serum zinc regression coefficient did not change 
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the findings, with 1 μmol/L in serum zinc associated with a 5.9% increase in mean 
serum ferritLQDQWLORJDULWKPȕ&, to 1.121).  
Table 6.4 Multiple regression analysis of associations between serum ferritin 
and serum zinc concentrations in women aged 18-50 y (N = 326)a
Logarithmic scale 
ȕ&,
$QWLORJDULWKPRIȕ
(95% CI) p-value 
Unadjusted model 
Adj. R2 = 0.035, p < 0.001
0.096
(0.043 to 0.148)
1.100
(1.043 to 1.160) < 0.001
Adjusted modelb
Adj. R2 = 0.181, p < 0.001
0.061
(0.010 to 0.112)
1.063
(1.010 to 1.118) 0.019
a In all models, natural log-transformed μg/L serum ferritin was the dependent 
variable and untransformed serum zinc (μmol/L, standardised to 08:00 sampling) 
was the independent variable.
b Adjusted for fasting status, log-transformed C-reactive protein (mg/L), age 
(years), BMI (kg/m2), oral contraceptive use, blood donation (mL/year), use of 
dietary supplements containing iron and/or zinc. 
There was no association between low serum ferritin and low zinc levels in this 
cohort. Fifteen percent (32/213) of women with adequate iron stores presented 
with low serum zinc concentration, compared to 22% (25/113) of women with 
GHSOHWHGLURQVWRUHVKRZHYHUWKHVHSURSRUWLRQVZHUHQRWVWDWLVWLFDOO\GLIIHUHQWȤ2(1, 
N = 326) = 2.58, p = 0.108. Furthermore, using logistic regression to account for 
fasting status, CRP, oral contraceptive use, and supplement use found women with 
low serum zinc concentrations were not at increased risk of depleted iron stores 
compared to women with normal serum zinc concentrations (odds ratio for having 
depleted iron stores if serum zinc concentration is low = 1.37, p = 0.340 (95% CI 
0.72 to 2.64)). 
6.4 Discussion
A significant positive relationship between dietary iron intakes and dietary zinc 
intakes was observed in the current sample of women. Accounting for energy 
intake, each 1 mg/d increase in dietary iron intake corresponded with a 0.4 mg/d 
increase in dietary zinc intake. Furthermore, women with dietary zinc intakes 
below Australian recommendations (EAR of 6.5 mg/d (National Health and 
Medical Research Council, 2006)) were at greater risk of inadequate dietary iron 
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intakes as determined using the probability approach (63% at risk vs. 23% at risk). 
These findings support observations in other populations that food sources of zinc 
are also important food sources of iron (Cole et al., 2010), and the theory that low 
intakes of either nutrient increase the likelihood of low intakes of the other 
(Gibson et al., 2002).  
In the current sample of women with complete biomarker data, a small positive 
association between biochemical iron and zinc status was observed, with a 1 
μmol/L increase in serum zinc corresponding to a six percent increase in serum 
ferritin. This finding is in line with previous research that also reported a positive 
association (Gibson et al., 1999; Prosser et al., 2010; Yokoi et al., 2007), however 
in the present investigation, women with biomarkers below internationally-
recognised cut-offs for low levels of one mineral were not more likely to present 
with low levels of the other mineral. Together, these findings suggest that while 
there may be a positive relationship between iron and zinc status at a population 
level, it may be too small to translate to a clinically meaningful association among 
women in Australia. Serum ferritin was not a useful proxy for serum zinc 
concentrations in the context of the current study, and women with depleted iron 
stores are not at increased risk of impaired zinc status.  
In the present cohort of women, the strong association observed between usual 
iron and zinc intakes was not accompanied by a similarly strong association 
between iron and zinc status, possibly reflecting the nutrients’ different responses 
to potential inhibitors and enhancers of absorption. Prosser et al. investigated the 
effect of a four-month dietary iron intervention on serum zinc of premenopausal 
women (Prosser et al., 2010). Women with low iron stores were randomised to a 
group receiving 50 mg/d supplemental iron, a placebo group, or a whole-diet 
intervention designed to increase iron bioavailability (Heath, Skeaff, O'Brien, et 
al., 2001). Women in the dietary intervention did not change their dietary iron or 
dietary zinc intakes, but their intakes of meat/fish/poultry, haem iron, and vitamin 
C increased and phytate intakes decreased (Heath, Skeaff, O'Brien, et al., 2001;
Prosser et al., 2010). This diet improved serum ferritin by 26% (Heath, Skeaff, 
O'Brien, et al., 2001), however it had no effect on serum zinc concentrations 
compared to the placebo group (Prosser et al., 2010). An increase in serum ferritin 
concentration via dietary means is not necessarily partnered with an increase in 
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serum zinc concentration, perhaps as factors influencing the proportion of iron 
available for absorption are not as influential on the bioavailability of zinc, and an 
increase in absolute zinc intake might also be needed to increase serum zinc in 
women. Although there was a strong association between dietary iron and zinc 
intakes in the current study, it seems targeted advice specific for each nutrient is 
required, and bioavailability of both cannot be improved through the same dietary 
means.
In contrast to previous research investigating both iron status and zinc status of 
women in Western countries (Gibson et al., 1999; Yokoi et al., 1994; Yokoi et al., 
2007), an inflammatory marker was incorporated in the present study. Using a 
regression model that included CRP only slightly attenuated the association 
between iron and zinc status, perhaps due to the small proportion of women with 
elevated CRP in the present sample (10%). In other groups, measuring and 
correcting for CRP may be prudent if investigating a relationship between iron and 
zinc status. The distribution of CRP concentrations in the present sample falls 
below the distribution observed among women from the National Health and 
Nutrition Examination Survey (NHANES) 1999-2000 aged 20-49 years (median 
CRP approximately 2 mg/L (IQR 0.8 to 6 mg/L)) (Ford, Giles, Mokdad, & Myers, 
2004). In this NHANES cohort, at least 25% of women had CRP > 5 mg/L, and in 
such groups who are more prone to inflammation and infection, correcting for 
CRP may be more important. Where risk of inflammation is unknown, measuring 
CRP is recommended.
The present investigation supports findings from previous research suggesting a 
small statistical association between iron and zinc status in premenopausal women 
(Gibson et al., 1999; Prosser et al., 2010; Yokoi et al., 1994; Yokoi et al., 2007). 
The strengths of this present study was use of internationally recognised 
biomarkers for iron status and zinc status, and use of conservative statistical 
analyses that accounted for disproportionately influential data. Limitations include 
the sample of participants perhaps not being representative of premenopausal 
women in Australia (e.g. high proportion of women with tertiary education,
majority with BMI values within the normal range and a lower proportion of 
current smokers (Appendix B)). It is also acknowledged that the IOM values used 
to conduct the probability method of assessing usual dietary iron intake may not 
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represent the iron requirements of this cohort of women as there was a greater 
prevalence of oral contraceptive use among these participants than proposed by the 
IOM, and the IOM values do not account for blood donation. The use of oral 
contraception may also inflate the prevalence of low serum zinc concentrations, as 
oral contraceptives are known to suppress serum zinc concentration (Brown et al., 
2004). It has been suggested this suppressive effect is due to oral contraceptives 
reducing albumin synthesis, which affects serum zinc concentrations as 75% of 
circulating zinc is bound to albumin(Gleichmann, Bachmann, Dengler, & Dudeck, 
1973; King, 1987). Therefore, to confirm the findings of this study, population-
based studies assessing biochemical iron and zinc status are required, as is 
information on how current rates of oral contraceptive use and blood donation 
might affect women’s iron requirements.
6.5 Conclusion 
In conclusion, this study observed positive associations between usual dietary iron 
and zinc intakes in premenopausal women, with those meeting dietary zinc 
recommendations being less likely to have inadequate iron intakes compared to 
those not meeting zinc recommendations. There was also a small positive 
association between iron status and zinc status in the same cohort, although this 
association may not be clinically meaningful. These data therefore do not support 
the ability to identify women at risk of impaired zinc status through exploration of 
iron status, and further work understanding the zinc status of women within the 
Australian population is required. 
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7.1 Introduction
Iron deficiency is the most prevalent nutritional disorder worldwide (World Health 
Organization, 2000b). It has been estimated that in Australia, 12% of women aged 
between 16 to 44 years present with depleted iron stores (serum ferritin < 15 μg/L 
(World Health Organization, 2011)) compared to 1 to 2% of men (Australian 
Bureau of Statistics, 2014a). Further, one-third of the women in the current 
research program presented with depleted iron stores (Chapter 6), indicating low 
iron is a concern. Premenopausal women with depleted stores are more likely to 
experience impaired physical performance (Pasricha et al., 2014) and potentially 
impaired cognitive ability (Leonard et al., 2014b; Murray-Kolb & Beard, 2007;
Steinbicker & Muckenthaler, 2013), therefore maintaining adequate iron status is 
important for wellbeing. In adults, iron losses consist of basal losses in faeces, 
epithelial cells, sweat and urine, and any sources of blood (Beard et al., 1996;
Gibson, 2005). Iron homeostasis is maintained via intestinal absorption rather than 
active secretion of excesses, with iron absorption increasing when iron status is 
impaired (Hallberg, 1981; Zimmermann & Hurrell, 2007). Control of intestinal 
absorption is held by hepcidin, which reduces export of iron from the enterocyte 
into circulation (Nemeth, Tuttle, et al., 2004). When iron concentration of the body 
is low, hepcidin production is suppressed and iron absorption increases 
(Pietrangelo, 2004).  
Dietary influences of iron absorption include the form of iron and consumption of 
other components. Haem iron is more bioavailable than non-haem iron (Gibson, 
2005), and bioavailability of iron in a whole diet is increased by consumption of 
ascorbic acid and meat protein (Collings et al., 2013). In single meals, iron 
absorption has been shown to be reduced by consumption of phytate (Hallberg et 
al., 1989; Hallberg et al., 1987), and potentially calcium (Hallberg et al., 1991;
Hallberg et al., 1987) and polyphenols in tea and coffee (Disler et al., 1975; Morck 
et al., 1983). However, there exists inter-individual variation in iron absorption 
that may be caused by genetic variation in hepcidin expression (Roe et al., 2009;
Young et al., 2009; Zimmermann et al., 2009). It has been postulated that this 
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genetic variation may be a greater influence of iron absorption than any dietary 
factor (Demeyer et al., 2014), but no evidence has been published examining 
hepcidin and dietary intake. The contribution of hepcidin to iron absorption has 
been investigated in an acute setting in a single meal absorption study 
(Zimmermann et al., 2009). In this study, Zimmermann et al. (2009) found 
circulating hepcidin explained a ‘modest’ 28% of variance in absorption, leading 
the authors to suggest additional physiological and genetic factors are important in 
influencing absorption (Zimmermann et al., 2009). However, this study did not 
explore the interaction between hepcidin levels, dietary iron, and iron status. Thus, 
there is no research into whether the association between iron intake and iron 
status, as reviewed by Casgrain et al. (2012), is moderated by hepcidin.  
As hepcidin measurement is relatively novel, there are no published studies 
considering the combined effect of blood loss, iron intake, and hepcidin on iron 
status. Blood loss is known to impair iron status: the progressively deleterious 
effect of regular blood donation on iron stores has been recognised since the late 
1970s (Spencer, 2013), and menstrual iron losses must be factored in 
approximations of women’s physiological iron requirements (Institute of 
Medicine, 2001). Furthermore, a recent longitudinal study has demonstrated 
hepcidin concentrations decline with repeated blood donations, although there is a 
great deal of variance in this response (Mast et al., 2013). Compared to blood loss, 
the dietary factors understood to enhance or inhibit iron absorption have not 
consistently been found to predict iron status as expected (section 2.8 Iron and 
Zinc Status and Consumption of Absorption Inhibitors and Enhancers). As iron 
absorption is inversely associated with hepcidin, and hepcidin production is down-
regulated in erythropoiesis, investigations of dietary determinants of iron status 
should account for blood loss, and when possible, measure hepcidin concentration. 
Studies investigating predictors of iron stores in premenopausal women including 
blood donation, menstrual losses or oral contraceptive use, and intakes of iron or 
iron-rich foods have only predicted 9% of variance in serum ferritin (Pynaert et al., 
2009; Rigas et al., 2014, A. Rigas, personal communication, 18 May 2015),
indicating much more remains to be understood, including the role of hepcidin. 
Therefore, the present study aimed to identify dietary determinants of iron stores 
once accounting for sources of blood loss, and determine whether iron intake 
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might predict iron stores independent of hepcidin in a sample of premenopausal 
women. 
7.1.1 Aims and hypotheses.
Aims:
x Identify dietary determinants of iron stores after accounting for blood loss 
in a sample of premenopausal women; 
x Determine whether iron intake predicts iron stores independently of 
circulating hepcidin levels in a sample of premenopausal women.
Hypotheses: 
x Iron-rich foods, whether plants or animal muscle, will be significant 
determinants of iron stores. 
x Enhancers and inhibitors of iron absorption previously identified in 
literature will be significant determinants of iron stores.
x Iron intake will not predict iron stores independently of hepcidin. 
7.2 Methods
See Chapter 3 General Methodology for detail.
7.2.1 Participants.
See section 3.2 Sampling and timing. 
7.2.2 Demographic and anthropometric information. 
See section 3.4.1 Anthropometry and section 3.4.2 Demographic and medical 
background and blood loss information. 
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7.2.3 Assessment of dietary iron intake and supplement use.
See Chapter 4 Dietary Methodology and section 3.4.3 Use of dietary supplements..  
7.2.4 Assessment of blood loss. 
The sources of blood loss included in this study were menstrual losses, nosebleeds, 
and blood donation status. Methods of assessment are described in section 3.4.2 
Demographic and medical background and blood loss information. 
7.2.5 Biochemistry.
Blood samples were analysed for serum ferritin, haemoglobin, C-reactive protein 
(CRP), and hepcidin. Serum ferritin, haemoglobin, and CRP analyses are outlined 
in Section 3.4.4 Biochemical analysis. For descriptive statistics, serum ferritin 
concentrations were multiplied by a factor of 0.65 if CRP concentration exceeded 
5 mg/L (n = 34) to correct serum ferritin concentrations for inflammation 
(Thurnham et al., 2010). Inferential statistics used uncorrected serum ferritin 
values with CRP included as a covariate in models. As hepcidin concentrations are 
also elevated in an inflammatory state (Ganz & Nemeth, 2011), inclusion of CRP 
in inferential analyses was required.
Serum hepcidin.
At the time of blood sampling, aliquots of serum were stored at -70°C at Deakin 
University, Burwood until analysed for hepcidin concentration. Serum hepcidin 
was analysed at Deakin University, Burwood, using a commercially-available 
competitive enzyme immunoassay kit for hepcidin-25 (cat. no. S-1337, 
Bachem/Peninsula Laboratories, San Carlos, CA, US). This kit is extraction-free 
and measures hepcidin in human serum in the range of 0-25 ng/mL, with average 
IC50 of 1.5 ng/mL. The manufacturer’s protocol and suggested preparation of 
standards were followed, and only kit chemicals were used in analysis. Rabbit 
hepcidin-25 antiserum (25 μL) was incubated at room temperature for one hour 
then incubated along with the serum samples (50 μL) for a further two hours at 
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room temperature. Biotinylated hepcidin tracer (25 μL) was applied and incubated 
overnight at 4°C. The next day, when assays had been brought back to room 
temperature, plates were manually washed five times with the provided buffer 
(containing Trizma base and Trizma hydrochloride (pH 7.4), NaCl, Tween 20, 
0.2% Thimerosal and 1% BSA), then streptavidin HRP (100 μL) was incubated at 
room temperature for one hour. Plates were washed five times and TMB substrate 
solution (100 μL) was applied. The reaction was terminated using hydrochloric 
acid (100 μL) and absorbance measured at 450 nm on a Synergy2 Microplate 
Reader (BioTek, Winooski, VT, US). The raw absorbance data were fit using 
GraphPad Prism 6 (GraphPad Software, La Jolla, CA, US) and hepcidin values 
imported into Stata/SE 13.1 (StataCorp, Texas, US) for analyses.
Serum samples of 265 women were available for hepcidin analysis. Seventy-nine 
women (30%) were randomly selected using Stata’s random number generator 
function and assayed in duplicate. The mean coefficient of variance (CV) of the 
duplicate samples was 6.6 (SD 8.2)%. For samples analysed in duplicate, a single 
hepcidin value was randomly selected for data analysis. Pooled samples were 
assayed in triplicate across the five plates. Mean intra-assay CV for these pooled 
samples was 13% (range 11 to 15%) and the inter-assay CV was 17%. 
7.2.6 Statistical analysis. 
The distributions of continuous variables were established by inspecting 
histograms, with normally distributed data presented as mean (SD) and skewed 
data presented as median (interquartile range (IQR; 27th to 75th centiles).
Categorical data are presented as n (%). Differences between groups were assessed 
using independent samples t-tests for normally distributed data, and for skewed 
data using Wilcoxon rank-sum tests. Correlations were assessed in normally 
distributed data using Pearson correlation, and in skewed data using Spearman’s 
rank correlation.  
Multiple regression was used to investigate the determinants of iron status. First, a 
base model of non-nutritional determinants of iron stores was constructed using 
automated backwards selection, to which nutritional determinants could be added. 
Backwards selection of the base model was used to facilitate the exploratory 
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nature of the analysis, and non-nutritional predictors were identified using a 
relatively liberal selection criterion of p  .2 (Vittinghoff et al., 2012). The 
dependent variable was serum ferritin (μg/L) and based on literature (see Chapter 
2), the potential non-nutritional predictors were body mass index (BMI; kg/m2), 
whole blood donated (as 100 mL/year), tertiary education (yes/no), have had 
children (yes/no), current oral contraceptive use (yes/no), and menstrual blood loss 
over the year (blood loss units × frequency of menses). In all analyses, CRP 
(mg/L) was forced into the base model to account for the influence of acute 
infection and inflammation on serum ferritin concentration (Thurnham & McCabe, 
2012). Presence of collinearity among independent variables was determined using 
criterion of r (Vittinghoff et al., 2012). Plotting the residuals against the fitted 
values showed heteroscedasticity, so serum ferritin and CRP were natural log-
transformed for these analyses.  
Once the base model was established, nutritional determinants were individually 
and then simultaneously added as independent variables to explore possible 
univariate and multivariate associations. These determinants were natural log-
transformed if residuals did not meet the linearity or homoscedasticity assumptions 
of linear regression; for variables where individuals had values of 0, 1 was added 
to all participants’ values prior to log transformation.  
To investigate whether usual iron intakes might influence iron stores 
independently of circulating hepcidin concentration, natural log transformed 
hepcidin level was also included as an independent variable. As diurnal variation 
in serum hepcidin concentration has been reported (Ganz, Olbina, Girelli, Nemeth, 
& Westerman, 2008), time of sampling was also included as a continuous 
covariate. To further investigate the impact of hepcidin on the association between 
iron intake and iron stores, an interaction term of hepcidin (ng/mL) × iron intake 
was added to the model. Dietary iron intake (mg/d) and total iron intake (diet + 
supplements, mg/d natural log-transformed) were used as indicators of iron intake. 
To visualise this interaction, the postestimation ‘margins’ command in Stata/SE 
13.1 (StataCorp, Texas, US) was used to predict the change in the slope of serum 
ferritin on iron intake at different levels of hepcidin concentration.  
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7.3 Results
7.3.1 Description of participants.
A description of participants included in this study is provided in Table 7.1.
Table 7.1 Characteristics of premenopausal women aged 18-50 y (N = 338)
n (%) Mean (SD) Median (IQR)
Age (y) 29.1 (7.4)
Height (m) 1.66 (0.06)
Weight (kg) 66.3 (11.8)
Body mass index (kg/m2) 24.0 (3.9)
Underweight 11 (3%)
Normal weight 224 (67%)
Overweight 69 (21%)
Obese 29 (9%)
Born in Australia 261 (77%)
Tertiary education 274 (81%)
Currently employed 297 (89%)
Current smoker 26 (7%)
Has children 55 (16%)
Donated blood in previous 12 
months 159 (47%) 
Amount donated (mL/y, n
= 159) 844 (478) 
Using oral contraception 125 (37%) 
Menstrual blood loss units 
per menses 31 (21 to 48) 
Frequency of menses
1-4 cycles/y 20 (6%)
4-8 cycles/y 26 (8%)
8-12 cycles/y 283 (86%)
Serum ferritin (μg/L)a 21 (11 to 37)
Depleted iron storesb 100 (30%)
Iron overloadc 22 (7%)
Haemoglobin (g/L) 132 (10)
Iron-deficiency anaemiad 20 (6%)
Non-iron deficiency 
anaemiae 9 (3%)
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C-reactive protein (mg/L) 0.66 (0.17 to 2.11)
Elevated CRPf 34 (10%)
Hepcidin (ng/mL) 8.76 (4.08 to 12.83)
Energy intake (MJ/d) 7.7 (2.2)
Dietary iron intake (mg/d) 10.4 (3.4)
Taking supplements 
containing iron 71 (21%) 
Supplemental iron intake 
(mg/d, n = 71) 5.0 (4.9 to 15.0) 
Total iron intake (diet + 
supplements) 10.8 (8.3 to 14.1) 
Dietary ascorbic acid intake 
(mg/d) 121 (57) 
Phytate intake (mg/d) 716 (493 to 1026)
On ‘special diet’ 77 (23%)
Vegetarian 15 (4%)
Mostly vegetarian but 
eats some meats 32 (9%) 
Other dietsg 30 (9%)
a 6HUXPIHUULWLQFRUUHFWHGIRUDFXWHLQIHFWLRQ,QZRPHQZLWK&53PJ/
serum ferritin was multiplied by a factor of 0.65 as suggested by Thurnham et al. 
(2010).
b Depleted iron stores defined as corrected serum ferritin < 15 μg/L, haemoglobin 
J/(World Health Organization/Centers for Disease Control and 
Prevention, 2007). 
c Iron overload defined as serum ferritin > 150 μg/L and CRP < 5 mg/L (World 
Health Organization, 2011).  
d Iron-deficiency anaemia defined as corrected serum ferritin < 15 μg/L, 
haemoglobin < 120 g/L. 
e Non-iron deficiency anaemia defined as haemoglobin < 120 g/L and corrected 
VHUXPIHUULWLQJ/(World Health Organization/Centers for Disease Control 
and Prevention, 2007). 
f Elevated CRP defined as CRP  5 mg/L.
g ‘Other diets’ include gluten-free or wheat-free (n = 16), vegan (n = 4), weight 
management (including high protein, reduced calories, Lite n Easy, low fat; n = 5).
7.3.2 Non-nutrition determinants of iron status.
Automated backwards selection retained blood donor status, 100 mL of blood 
donated per year, oral contraceptive use, and magnitude of menstrual blood loss 
over a year as predictors of natural log-transformed serum ferritin. Demographic 
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and anthropometric characteristics (age, BMI, tertiary education) and nosebleeds 
did not meet the statistical inclusion criterion. In the present cohort, 77% (n = 95) 
of oral contraceptive users had 8-12 menstrual cycles per year compared to 92% (n
= 188) of non-users Ȥ2(2, N = 329) = 15.61, p < .001. Although reported menstrual 
blood loss units per month did not significantly differ (median (IQR) blood loss 
units in oral contraceptive users: 28 (18 to 43) vs. nonusers: 32 (21 to 53) units, Z
= 1.816, p = .07), oral contraceptive users reported a lower magnitude of menstrual 
losses over the year (oral contraceptive users: 72 (50 to 117) vs. nonusers: 93 (62 
to 150) units, Z = 2.932, p = .003). To avoid collinearity, it was assumed oral 
contraceptive use was reflected in the yearly menstrual blood loss variable, and 
oral contraceptive use was omitted from the model but menstural blood loss units 
per year was retained. Similarly, the dichotomous variable of blood donor status 
was omitted from the model as this information is reflected in 100 mL of blood 
donated per year.  
The model of non-nutritional determinants of iron stores, adjusting for CRP, 
explained 19% of variance in serum ferritin. For each 100 mL of whole blood 
donated, serum ferritin decreased by 7.4%, and for each arbitrary unit increase in 
menstrual loss, serum ferritin decreased by 0.2% (Table 7.2). This model formed 
the base model used to investigate nutritional determinants.
Table 7.2 Non-nutritional determinants of natural log-transformed serum 
ferritin (N = 313)a
Adj. R2 = .188, p < .001 ȕ&, p-value
Blood donation (100 mL/year) -0.074 (-0.092 to -0.056) < .001
Menstrual blood loss units per year -0.002 (-0.004 to -0.001) < .001
a Adjusted for log-transformed C-reactive protein
7.3.3 Nutritional determinants of iron stores.
Individual determinants.
To investigate the role of individual nutritional aspects on serum ferritin, 
potentially influential nutrients and food groups were separately entered into the 
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base non-nutritional regression model of blood donation and menstrual loss units 
(Table 7.3). Usual dietary iron intake was associated with iron stores, such that a 1 
mg/d increase in dietary iron intake was associated with a 3% increase in serum 
ferritin (e.g. geometric mean of serum ferritin would increase from 19.9 to 20.5 
μg/L). This positive association remained when adjusting for energy intakes using 
the residual method. Total iron intake, comprising of both usual dietary iron intake 
and iron from supplements, was similarly associated with serum ferritin, with each 
10% increase in total iron intake related to a 2% increase in serum ferritin (e.g.
1.100.250 = 1.024; an increase in the geometric mean of total intakes from 11.4 to 
12.5 mg/d would shift the geometric mean of serum ferritin from 19.9 to 20.3 
μg/L). Supplemental iron intake alone was not associated with serum ferritin. 
Intakes of red and white meat, separately and combined, were associated with 
serum ferritin, with a 10% increase in intakes of combined red and white meat 
associated with a 1% increase in serum ferritin (e.g. increase in geometric mean of 
intakes from 92 to 101 g/d associated with increase in serum ferritin geometric 
mean from 29.3 to 29.6 μg/L). No associations were found between serum ferritin 
and consumption of any of dietary ascorbic acid, egg, calcium, phytate, cereals, 
vegetables, alcohol, red wine, or energy (Table 7.3).
Table 7.3 Univariate associations between nutritional determinants and 
natural log-transformed μg/L serum ferritin in women aged 18-50 y (N = 313) 
Nutritional determinant ȕ&, p-value for ȕ Adj. R
2
Non-
nutritional 
base 
model + 
Dietary iron intake (mg/d) 0.032(0.004 to 0.06) .027 .198
Energy-adj. dietary iron 
(mg/d)a
0.048
(0.002 to 0.095) .043 .196
Total iron intake (incl. 
supplements; mg/d)b
0.250
(0.068 to 0.432) .007 .208
Supplemental iron intake 
(mg/d)b
0.048
(-0.048 to 0.143) .325 .191
Red meat (beef + lamb; g/d)b 0.106(0.035 to 0.176) .003 .208
White meat (chicken + pork 
+ fish; g/d)b
0.120
(0.037 to 0.203) .005 .206
Red + white meat (g/d)b 0.113(0.033 to 0.193) .006 .205
Iron from red + white meat 
(mg/d)b
0.317
(0.103 to 0.531) .004 207
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Ascorbic acid (mg/d) -0.0004(-0.002 to 0.001) .615 .186
Egg (g/d) 0.008(-0.002 to 0.017) .107 .192
Calcium (mg/d)
0.00004
(-0.0002 to 
0.0003)
.786 .185
Phytate (mg/d)b 0.05(-0.116 to 0.216) .553 .186
Coffee, tea, herbal tea (g/d)b -0.025(-0.08 to 0.03) .366 .187
Cereals and cereal products 
(g/d)b,c,d
0.101
(-0.062 to 0.263) .263 .189
Iron-fortified breakfast 
cereals (g/d)d
0.0003
(-0.008 to 0.008) .932 .185
Vegetable products and 
dishes (g/d)c
0.001
(-0.003 to 0.002) .185 .190
Iron from cereals and cereal 
products + iron from 
vegetables (mg/d)d
0.039
(-0.006 to 0.085) .127 .191
Iron from cereals + 
vegetables + fruit + legumes 
(mg/d)d
0.029
(-0.011 to 0.068) .152 .191
Alcohol (g/d)b 0.002(-0.085 to 0.09) .956 .184
Red wine (g/d)b -0.001(-0.003 to 0.001) .487 .187
Energy intake (MJ/d) 0.027(-0.016 to 0.07) .215 .189
a Energy adjusted using the residual method. 
b Natural log-transformed independent variable. 
c Australian Health Survey major food group.
d Reported analysis was rerun omitting one participant with an outlier Cooks 
distance value who reported in FFQ consuming 0 g/d of any cereals but reported in 
24-hour recall (not used in analysis) consuming pita bread and oats. 
Combining determinants. 
More complex models of the base model plus more than one nutritional 
determinant were used to investigate their combined influence on the serum 
ferritin concentration of premenopausal women (Table 7.4). The independent 
variables represented diets combining usual iron intake with the potential 
inhibitors and enhancers of iron absorption. As displayed in Table 7.4, Model A 
examined the three main food groups contributing to dietary iron intakes as 
identified in Chapter 5, as well as ascorbic acid and phytate. In place of the dietary 
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sources of iron, Model B explored the effect of dietary iron intakes, and Model C 
assessed the effect of total iron intakes including supplemental iron. Iron intake 
(both dietary and total iron) and meat intake were consistently positively 
associated with iron stores. However, there were no significant associations with 
cereal consumption or with intakes of iron from cereals and vegetables. In each of 
the models, ascorbic acid and phytate intakes were not associated with serum 
ferritin. Additionally, including a three-way interaction in Model B between 
dietary iron intake, ascorbic acid and phytate to explore whether an inhibitory 
effect of phytate on the association between iron intake and iron stores is 
dependent on ascorbic acid intake was not significant (interaction p = .501; model 
not displayed).  
Table 7.4 Multivariate associations between non-nutritional determinants, 
nutritional determinants and natural log-transformed μg/L serum ferritin in 
women aged 18-50 y (N = 313)a
ȕ&, p-YDOXHIRUȕ
Model A: Adj. R2 = .200, p < .001
Blood donation (100 mL/y) -0.077
(-0.095 to -0.059) < .001 
Menstrual blood loss units per year -0.002
(-0.004 to -0.001) .001
Red + white meat (g/d)a 0.089
(0.006 to 0.171) .035
Cereals and cereal products (g/d)b,c 0.09
(-0.08 to 0.26) .300
Vegetable products and dishes (g/d)c 0.001
(0 to 0.002) .067
Ascorbic acid (mg/d) -0.001
(-0.003 to 0.001) .290
Phytate (mg/d)a -0.011
(-0.193 to 0.172) .910
Model B: Adj. R2 = .200, p < .001
Blood donation (100 mL/y) -0.075
(-0.093 to -0.057) < .001 
Menstrual blood loss units per year -0.003
(-0.004 to -0.001) < .001 
Dietary iron intake (mg/d) 0.047
(0.011 to 0.083) .011
Ascorbic acid (mg/d) -0.001
(-0.003 to 0.001) .233
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ȕ&, p-YDOXHIRUȕ
Phytate (mg/d)b -0.094
(-0.303 to 0.115) .378
Model C: Adj. R2 = .207, p < .001
Blood donation (100 mL/y) -0.076
(-0.095 to -0.058) < .001 
Menstrual blood loss units per year -0.002
(-0.004 to -0.001) .001
Total iron intake (incl. supplements; mg/d)b 0.299
(0.091 to 0.506) .005
Ascorbic acid (mg/d) -0.001
(-0.003 to 0.001) .301
Phytate (mg/d)b -0.046
(-0.232 to 0.14) .626
Model D: Adj. R2 = .207, p < .001
Blood donation (100 mL/y) -0.077
(-0.096 to -0.059) < .001 
Menstrual blood loss units per year -0.003
(-0.004 to -0.001) < .001 
Iron from red and white meat (mg/d)b 0.308
(0.091 to 0.525) .006
Iron from cereals and cereal products (mg/d)b 0.024
(-0.027 to 0.075) .349
Iron from vegetables (mg/d)c 0.003
(-0.083 to 0.09) .938
a All models adjusted for C-reactive protein
b Natural log-transformed independent variable. 
c Australian Health Survey major food group.
7.3.4 Association between iron intake and iron stores independent of 
hepcidin.
Hepcidin data was available for 265 women. When the regression analyses of the 
base model and the base model plus the individual nutritional determinants were 
repeated in these 265 women, no differences were observed in outcomes compared 
with the analyses that included 313 women (see Appendix F). To investigate 
whether the association between usual iron intake and serum ferritin occurs 
independently of circulating hepcidin levels, natural log transformed hepcidin 
concentration was added to the linear regression models of dietary iron and total 
iron intakes. Timing of blood sampling was also included to account for diurnal 
variation in serum hepcidin concentration (Ganz et al., 2008). The resulting 
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models accounting for circulating hepcidin levels are displayed in Table 7.5, with 
the influence of dietary iron intake represented by Model A and the influence of 
total iron intake (including supplements) represented by Model B. Including 
hepcidin as a covariate improved the model (likelihood ratio Ȥ2 = 60.18, p < .001): 
65% of the variance in iron stores was explained when hepcidin was included 
compared to 17% when hepcidin was excluded (model not shown). As 
demonstrated by Model A, there was no association between dietary iron intake 
and serum ferritin when adjusting for hepcidin ȕIRUGLHWDU\LURQLQWDNH p
= .265). In contrast, the positive association between total iron intake and serum 
IHUULWLQUHPDLQHGLQ0RGHO%ȕIRUWRWDOLURQLQWDNH p = .029) (Table 7.5). 
After including hepcidin in the model, a 10% increase in total iron intake 
corresponded with a 1.5% increase in serum ferritin (i.e. 1.100.155 = 1.015). 
Including hepcidin in the model attenuated the associations between serum ferritin 
and blood loss. For each 100 mL of donated blood, serum ferritin decreased by 3% 
when adjusting for hepcidin (Table 7.5), compared to 7% in the base model (Table 
7.2). Similarly, each unit of menstrual loss reduced serum ferritin by 0.1% when 
adjusting for hepcidin, compared to 0.2% in the base model. 
To explore how hepcidin influences the effect of iron intake on iron status, an 
interaction term between hepcidin and iron intake was added to Models A and B. 
These models are displayed as Models C and D in Table 7.5. Model C 
demonstrated an interaction between hepcidin and dietary iron intake, with higher 
hepcidin concentrations suppressing the association between iron intake and serum 
ferritin (p = .014), but there was no significant interaction present in Model D (p
= .092) (Table 7.5).  
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Table 7.5 Multivariate associations between dietary iron intake, total iron 
intake, hepcidin and natural log-transformed serum ferritin in women aged 
18-50 y (N = 265) 
ȕ&, p-YDOXHIRUȕ
Model A – dietary iron intake: 
Adj. R2 = .651, p < .001
C-reactive protein (mg/L)a -0.016
(-0.061 to 0.029) .483
Blood donation (100 mL/year) -0.029
(-0.043 to -0.015) < .001 
Arbitrary menstrual loss units per year -0.001
(-0.002 to 0) .036
Dietary iron intake (mg/d) 0.011
(-0.009 to 0.031) .265
Timing of sampling (hours) -0.08
(-0.113 to -0.047) < .001 
Hepcidin (ng/mL)a 0.788
(0.704 to 0.872) < .001 
Model Bb – total iron intake: 
Adj. R2 = .658, p < .001
C-reactive protein (mg/L)a -0.015
(-0.061 to 0.031) .532
Blood donation (100 mL/year) -0.03
(-0.045 to -0.016) < .001 
Arbitrary menstrual loss units per year -0.001
(-0.002 to 0) .050
Total iron intake (mg/d)a 0.155
(0.028 to 0.281) .017
Timing of sampling (hours) -0.075
(-0.109 to -0.042) < .001 
Hepcidin (ng/mL)a 0.784
(0.699 to 0.868) < .001 
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ȕ&, p-YDOXHIRUȕ
Model C – dietary iron intake × hepcidin: 
Adj. R2 = .658, p < .001
C-reactive protein (mg/L)a -0.014
(-0.058 to 0.031) .527
Blood donation (100 mL/year) -0.028
(-0.042 to -0.014) < .001 
Arbitrary menstrual loss units per year -0.001
(-0.002 to 0) .022
Timing of sampling (hours) -0.079
(-0.112 to -0.046) < .001 
Hepcidin (ng/mL)a 1.097
(0.842 to 1.351) < .001 
Dietary iron intake (mg/d) 0.074
(0.023 to 0.125) .006
Hepcidina × dietary iron intake -0.03
(-0.053 to -0.007) .013
Model Db – total iron intake × hepcidin: 
Adj. R2 = .661, p < .001
C-reactive protein (mg/L)a -0.015
(-0.06 to 0.031) 0.530
Blood donation (100 mL/year) -0.029
(-0.044 to -0.015) 0.000
Arbitrary menstrual loss units per year -0.001
(-0.002 to 0) 0.044
Timing of sampling (hours) -0.075
(-0.108 to -0.042) 0.000
Hepcidin (ng/mL)a 1.163
(0.704 to 1.622) 0.000
Total iron intake (mg/d)a 0.489
(0.073 to 0.905) 0.022
Hepcidina × total iron intakea -0.16
(-0.349 to 0.03) 0.099
a Natural log-transformed independent variable. 
b Model B excludes one woman with outlier Cooks distance value, whose BMI 
was 29.0 kg/m2, energy intake 1.4 MJ/d and total iron intake 1.8 mg/d. 
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To visualise the effect of hepcidin on the association between usual dietary iron 
intake and iron stores (i.e. the interaction in Table 7.5, Model C), the dietary iron--
iron stores relationship was plotted at different levels of hepcidin concentration 
(Figure 7.1, Table 7.6). The change in the slope of natural log-transformed serum 
ferritin on dietary iron intakes was predicted across the cohort’s range of natural 
log-transformed hepcidin values from 0 to 3.2 (1 to 24.54 ng/mL) at intervals of 
0.4, holding blood loss covariates at their mean (blood donation 400 mL/y; 
menstrual loss 104 arbitrary units, time of blood sample collection 11:15) (Figure 
7.1, Table 7.6). The positive association between dietary iron intake and log 
transformed serum ferritin was strongest at 1 ng/mL hepcidin (i.e. greatest changes 
in slope), progressively weakening as the intervals of hepcidin concentrations 
increased. At 7.39, 11.02, 16.44 and 24.53 ng/mL hepcidin, there was no 
association between dietary iron intake and iron stores.  
Figure 7.1 Effect of serum hepcidin on the relationship between dietary 
iron intake and natural log-transformed serum ferritin concentration, 
holding CRP, blood donation and menstrual losses at their mean values 
(CRP 0.67 mg/L; blood donation 400 mL/y; menstrual loss 104 
arbitrary units, blood sampling at 11:15). The association between 
dietary iron intake and natural log-transformed serum ferritin is non-
significant at 7.39 and 11.02 ng/mL (hepcidin concentrations >11.02 
ng/mL not depicted). 
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Table 7.6 Change in association between dietary iron intake and natural log-
transformed serum ferritin at different levels of hepcidin concentration
Log-transformed 
hepcidin
Dietary iron intake 
(mg/d)
Change in 
slope 95% CI p-value
0 (1 ng/mL) 3 0.258 -0.044 to 0.560 .094
0 6 0.410 0.028 to 0.792 .036
0 9 0.510 0.116 to 0.905 .011
0 12 0.581 0.197 to 0.965 .003
0 15 0.634 0.268 to 1.001 .001
0 18 0.676 0.330 to 1.022 < .001
0 21 0.708 0.382 to 1.034 < .001
0 24 0.735 0.428 to 1.042 < .001
0.4 (1.49 ng/mL) 3 0.145 0.005 to 0.286 .043
0.4 6 0.254 0.039 to 0.469 .021
0.4 9 0.338 0.084 to 0.592 .009
0.4 12 0.405 0.132 to 0.678 .004
0.4 15 0.460 0.178 to 0.741 .001
0.4 18 0.505 0.222 to 0.788 .001
0.4 21 0.544 0.262 to 0.825 < .001
0.4 24 0.576 0.300 to 0.853 < .001
0.8 (2.23 ng/mL) 3 0.088 0.011 to 0.166 .026
0.8 6 0.162 0.031 to 0.293 .016
0.8 9 0.225 0.057 to 0.393 .009
0.8 12 0.279 0.085 to 0.473 .005
0.8 15 0.326 0.114 to 0.538 .003
0.8 18 0.367 0.143 to 0.591 .001
0.8 21 0.404 0.171 to 0.636 .001
0.8 24 0.436 0.199 to 0.673 < .001
1.2 (3.32 ng/mL) 3 0.053 0.007 to 0.100 .023
1.2 6 0.102 0.018 to 0.185 .017
1.2 9 0.145 0.032 to 0.258 .012
1.2 12 0.184 0.047 to 0.321 .009
1.2 15 0.220 0.064 to 0.377 .006
1.2 18 0.253 0.081 to 0.426 .004
1.2 21 0.283 0.098 to 0.469 .003
1.2 24 0.311 0.116 to 0.507 .002
1.6 (4.95 ng/mL) 3 0.030 0.001 to 0.060 .044
1.6 6 0.059 0.003 to 0.114 .038
1.6 9 0.085 0.007 to 0.164 .033
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1.6 12 0.111 0.012 to 0.210 .028
1.6 15 0.135 0.018 to 0.252 .024
1.6 18 0.157 0.024 to 0.291 .021
1.6 21 0.179 0.031 to 0.327 .018
1.6 24 0.200 0.039 to 0.360 .015
2 (7.39 ng/mL) 3 0.014 -0.008 to 0.035 .219
2 6 0.027 -0.015 to 0.069 .212
2 9 0.040 -0.022 to 0.101 .206
2 12 0.052 -0.028 to 0.132 .201
2 15 0.064 -0.033 to 0.161 .195
2 18 0.076 -0.038 to 0.19 .189
2 21 0.088 -0.042 to 0.217 .184
2 24 0.099 -0.045 to 0.243 .178
2.4 (11.02 ng/mL) 3 0.001 -0.019 to 0.021 .923
2.4 6 0.002 -0.038 to 0.041 .923
2.4 9 0.003 -0.056 to 0.062 .923
2.4 12 0.004 -0.075 to 0.083 .923
2.4 15 0.005 -0.093 to 0.103 .923
2.4 18 0.006 -0.112 to 0.123 .923
2.4 21 0.007 -0.130 to 0.144 .923
2.4 24 0.008 -0.149 to 0.164 .923
2.8 (16.44 ng/mL) 3 -0.009 -0.030 to 0.012 .412
2.8 6 -0.018 -0.061 to 0.025 .416
2.8 9 -0.027 -0.093 to 0.039 .420
2.8 12 -0.036 -0.125 to 0.053 .424
2.8 15 -0.046 -0.159 to 0.068 .429
2.8 18 -0.055 -0.194 to 0.083 .433
2.8 21 -0.065 -0.230 to 0.100 .437
2.8 24 -0.075 -0.267 to 0.117 .441
3.2 (24.53 ng/mL) 3 -0.017 -0.040 to 0.007 .164
3.2 6 -0.034 -0.083 to 0.015 .171
3.2 9 -0.052 -0.127 to 0.024 .178
3.2 12 -0.070 -0.174 to 0.034 .186
3.2 15 -0.089 -0.224 to 0.046 .193
3.2 18 -0.109 -0.277 to 0.059 .202
3.2 21 -0.130 -0.333 to 0.073 .210
3.2 24 -0.151 -0.392 to 0.090 .218
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7.4 Discussion
In this cohort of premenopausal women, usual dietary iron intake was a significant 
positive determinant of iron stores. Each 1 mg/d increase in dietary iron intake 
corresponded to a 3% increase in serum ferritin. Similar associations were 
observed when iron from supplements was included, such that a 10% increase in 
total iron intake corresponded to a 2% increase in iron stores. These 
quantifications of the influence of iron intake on iron stores are unique as most 
cross-sectional work in premenopausal women have not found positive 
associations between dietary iron intake and iron status (Beck, Conlon, Kruger, & 
Coad, 2014). The quantification of a relationship between iron intake and iron 
stores is likely explained by the study sample. Only 3% of the general population 
donate blood per year (Australian Red Cross Blood Service, 2013); in contrast, 
nearly half of this group of women made a blood donation in the last twelve 
months. Studying dietary iron intakes in a group where a large number 
experienced significant blood losses in the past year, likely leading to increased 
iron absorption, is likely to explain the positive influence of iron intake that is 
rarely identified in observational studies. 
This study also established that while dietary iron intake is associated with iron
stores, circulating hepcidin is notably more influential, explaining more variance 
in iron stores than diet and blood loss combined. Furthermore, this study 
demonstrated that increasing concentrations of circulating hepcidin suppressed the 
association between usual iron intake and iron stores, indicating the molecular 
activity of hepcidin in the body can be reflected in free-living women. At low 
hepcidin levels, there was a greater relationship between women’s iron intake and 
iron stores, which diminished at higher hepcidin levels. These findings are 
important as they demonstrate the necessity for an increased understanding of 
determinants of hepcidin. It appears that genetic factors have a significant 
influence on circulating levels of hepcidin (for a review see Ganz, 2011), but 
identifying determinants that can be modified through lifestyle changes or other 
interventions may help prevent or treat iron deficiency related to increased 
hepcidin production. Hepcidin production is upregulated in inflammatory states 
(Ganz & Nemeth, 2011), and given obesity induces an inflammatory response 
(Gregor & Hotamisligil, 2011), researchers have postulated that individuals with 
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excess adiposity are at increased risk of iron deficiency due to dysregulated 
hepcidin production (Tussing-Humphreys, Liang, Nemeth, Freels, & 
Braunschweig, 2009; Tussing-Humphreys et al., 2010). There is evidence of 
higher circulating hepcidin concentrations and impaired iron status in women with 
obesity (Tussing-Humphreys et al., 2010), thus lifestyle changes that reduce 
adiposity and associated inflammation may help improve iron status. Further, 
recent work has shown black soybean extract can inhibit hepcidin production and 
increase circulating iron in animal models (Mu et al., 2014), indicating hepcidin 
can be actively modified and expression is not simply a response to genetic 
influences, inflammation or hypoxic states. 
In this study, the source of dietary iron appeared to influence iron stores. Although 
dietary iron intake was a significant determinant of iron stores, intakes of the two 
major food groups contributing to dietary iron intake were not: cereals 
(contributing 31% of dietary iron; Chapter 5) and vegetables (contributing 16%). 
In contrast, consumption of meat (beef, lamb, chicken, pork; combined 
contribution 14%) was consistently positively associated with iron stores whether 
considered separately as red or white meat, or combined. This finding adds to the 
body of existing evidence supporting the positive effect of meat consumption on 
iron absorption and iron status (Collings et al., 2013; Galan et al., 1998; Heath, 
Skeaff, Williams, et al., 2001; Leonard et al., 2014a; Rigas et al., 2014), which 
may be due to the more efficient absorption of haem iron compared to non-haem 
iron (Institute of Medicine, 2001). The relationship may also represent dietary 
patterns associated with meat intake, rather than meat intake itself. For example, 
Beck et al. (2013) used factor analysis to describe dietary patterns among a cohort 
of premenopausal women, and found that women adhering to a pattern 
characterised by high intakes of beef and poultry as well as broccoli, carrots and 
capsicum were less likely to present with serum ferritin < 20 μg/L (OR 0.59, 95% 
CI 0.42 to 0.82, p = .002) (Beck et al., 2013). 
Other than meat intake, enhancers and inhibitors of iron absorption such as 
phytate, ascorbic acid, calcium, beverage tannins, and alcohol were not associated 
with iron stores in this group of premenopausal women, and there was no 
statistical interaction between phytate and ascorbic acid intakes that might have 
influenced iron stores. The majority of cross-sectional studies in women have 
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found no association between intakes of these food components and iron status 
(Galan et al., 1998; Heath, Skeaff, Williams, et al., 2001; Leonard et al., 2014a;
Pynaert et al., 2009), but as with the present study, these studies did not assess 
whether these components are habitually consumed at the same time as sources of 
iron. Timing of consumption may be an important influence, and it has been 
demonstrated that beverage tannins have no effect on iron absorption if consumed 
one hour prior to food but hinder iron absorption if consumed with or one hour 
following food (Morck et al., 1983). Therefore, further research that can account 
for women’s habitual meal patterns is required. 
The present investigation found dietary iron intake did not predict iron stores 
independently of circulating hepcidin concentrations. Further analysis of the link 
between hepcidin and dietary iron intake indicated that the relationship between 
dietary intake and iron stores was strongest at the lowest levels of circulating 
hepcidin. As hepcidin levels increased, the association between iron stores and 
intake weakened, such that there was no relationship when serum hepcidin was 
greater than 7.39 ng/mL. This value is presented tentatively as it has been noted 
that absolute hepcidin values differ across measurement methods, perhaps due to 
the hepcidin values manufacturers assign to assay standards (Kroot et al., 2012). 
However, these results are in line with the work demonstrating the amount of iron 
absorbed is inversely associated with circulating hepcidin (Roe et al., 2009; Young 
et al., 2009; Zimmermann et al., 2009), and also demonstrate the influence of 
hepcidin in the determination of iron stores. The absence of an association between 
usual iron intake and iron stores at higher levels of hepcidin in this group of 
women perhaps illustrates the systemic control attributed to hepcidin. In normal 
individuals, iron homeostasis is controlled through absorption and hepcidin 
ensures the rate of iron absorption is appropriate; in particular individuals with 
haemochromatosis, excessive iron is absorbed as genetic anomalies cause hepcidin 
levels to remain chronically low despite the presence of iron in the body; in 
individuals with familial iron-refractory iron deficiency anaemia, hepcidin levels 
are chronically high, limiting iron absorption. Interestingly, there was not a 
significant interaction between total iron intake (including supplemental iron) and 
hepcidin in this sample of women. As supplemental iron intakes in this sample 
ranged up to 105 mg/d (section 5.3.2 Dietary iron and zinc intake.), it was 
expected that this variance would be reflected in a similar, if not stronger, 
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interaction as with dietary iron intakes. As only 20% of the cohort reported taking 
supplements containing iron, the study may have been underpowered to detect any 
influence of supplements. It is also possible more information on women’s 
supplemental use was required, such as duration of supplement use. Supplement 
users may have included women who had only been taking iron supplements for a 
short period, before the supplemental iron may have been reflected in iron stores.  
The backwards selection of blood donation and menstrual losses into the 
regression base model to predict serum ferritin is in line with understanding of the 
impact of blood loss on iron stores (Institute of Medicine, 2001). For each 100 mL 
of whole blood donated, serum ferritin decreased by 7%, and serum ferritin was 
negatively associated with the magnitude of menstrual loss. Menstrual losses in the 
current study are similar to those reported in other studies using the same self-
report tool: the median losses of 31 units is comparable to median losses of 38
units in women with low iron stores and 34 units in women with adequate iron 
stores reported by Heath et al. (2001), and mean losses of 46 units in women with 
low iron stores and 39 units in women with adequate iron stores reported by Beck 
et al. (2014). Interestingly, the association between blood donation and serum 
ferritin (adjusting for total iron intake) seemed to decrease when accounting for 
hepcidin concentration. In this cohort, when adjusting for circulating hepcidin 
levels, each 100 mL blood donated corresponded to a 3% decrease in serum 
ferritin, compared to a 7% decrease when not accounting for hepcidin. 
Erythropoiesis down-regulates hepcidin production (Ganz, 2011), but Mast et al. 
demonstrated that some blood donors’ circulating hepcidin concentrations recover 
between donations, indicating the body has sufficient iron for erythropoiesis, 
whereas others still have low hepcidin levels when they present for their next 
donation (Mast et al., 2013). The results of the present study show this inter-
individual difference in donation recovery remains when accounting for total iron 
intake, and therefore supports Mast et al.’s notion that the genetic variation 
affecting hepcidin expression may influence the donation frequency best tolerated 
(Mast et al., 2013).  
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7.5 Conclusion 
In conclusion, this study found dietary iron intake, total iron intake, and intakes of 
meat were positive determinants of iron stores in premenopausal women. There 
was no association between iron stores and consumption of cereals, vegetables, 
and potential enhancers and inhibitors of iron absorption, but further research of 
enhancers and inhibitors is needed that can account for timing of consumption. 
Circulating hepcidin was a major determinant of iron stores, and increased levels 
of hepcidin suppressed the association between dietary iron intake and iron stores. 
The data from this study also support the role of hepcidin in regulating the iron 
status of free-living, premenopausal women, and further research should 
investigate the potential for lifestyle interventions to regulate hepcidin expression. 
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8.1 Introduction
As the activity of over 300 enzymes in the human body relies on zinc, zinc 
deficiency can affect an array of bodily functions including immune function, gene 
expression, appetite regulation, and protein, lipid and carbohydrate metabolism 
(Gibson, 2005, 2012). Deficiency presents as susceptibility to infection, dermatitis
(Shankar & Prasad, 1998), mood disorders including depression (Lai et al., 2012), 
and in children, stunted growth (Brown, Peerson, Rivera, & Allen, 2002). Serum 
zinc is the most commonly used biomarker of zinc status, but as measurement is 
complicated by diurnal variation, fasting status and potential contamination, 
understanding of dietary and lifestyle determinants of zinc status and risk factors 
for zinc deficiency has been limited (Brown et al., 2004). 
The International Zinc Nutrition Consultative Group (IZiNCG) has proposed that 
the main cause of zinc deficiency is insufficient intakes of absorbable zinc (Brown 
et al., 2004). This notion is based on ecological data and food balance sheets
showing increased prevalence of zinc deficiency symptoms in regions where 
traditional diets include few zinc-rich foods and large proportions of zinc-
absorption inhibitors, primarily phytate (Brown et al., 2004). For example, zinc 
supplementation improves children’s growth, and does so to a greater extent in 
children who present with stunting (Brown et al., 2002). Globally, the highest rates 
of stunting occur in parts of South East Asia, Sub-Saharan Africa and South 
America where diets feature unprocessed grains or tubers (Brown et al., 2004). 
IZiNCG acknowledge that these data are limited as deficiency of other nutrients 
also causes stunting, and these regions are largely developing countries with 
economic and social issues that confound any direct associations between zinc 
intake and stunting (Brown et al., 2004). However, in addition to this suggestive 
information, there is also evidence that such diets can compromise zinc absorption. 
A convincing body of isotopic absorption studies has demonstrated that phytate
inhibits zinc absorption from food with a dose-dependent effect (Adams et al., 
2002; Navert et al., 1985). For example, fermenting phytate by increasing the 
leavening time of bread increased absorption from single meals (Navert et al., 
116
Chapter 8: Determinants of Serum Zinc
1985), and a greater proportion of zinc was absorbed from a cultivar of low-
phytate maize compared to a control with normal phytate content (Adams et al., 
2002). There is also some evidence that chicken meat and fish may enhance zinc 
absorption from a meal (Sandström et al., 1989), and it is thought calcium may 
inhibit absorption, particularly in the presence of phytate (Lönnerdal, 2000), 
although this effect has not been demonstrated in absorption studies (Dawson-
Hughes et al., 1986; McKenna et al., 1997). Based on a review of whole-diet 
absorption studies, IZiNCG did not find any influence of calcium or animal tissue 
on zinc absorption, but tentatively suggested that zinc absorption is impaired in 
diets with a phytate:zinc molar ratio > 18 (Brown et al., 2004).  
There is comparatively little research assessing whether consumption of phytate, 
animal tissue, or calcium affects zinc status. Understanding the potential dietary or 
lifestyle risk factors associated with low zinc status has been challenged by the 
lack of a specific and sensitive biomarker at the individual level (Brown et al., 
2004) analogous to serum ferritin as a marker of iron stores or transferrin receptor 
as an inverse marker of cellular iron supply. Serum zinc is useful at a group level 
as it responds to dietary and supplement interventions (Brown et al., 2004; Lowe et 
al., 2012), so has been used to assess relationships between diet and zinc status. A
recent meta-analysis of observational studies found individuals following a 
vegetarian diet had lower zinc intakes and lower serum zinc concentrations 
compared to individuals following non-vegetarian diets (Foster et al., 2013), but 
whether the difference in zinc status is due to meat or phytate intakes remains 
unknown as this study did not account for phytate intake. Cross-sectional studies 
have demonstrated weak negative correlations of -.163 and -.21 between the 
phytate:zinc molar ratio and serum zinc concentration in premenopausal women 
and adolescents (Donovan & Gibson, 1995; Gibson et al., 2001), however only 
one study accounted for known confounders of serum zinc concentration, and did 
so by omitting from analyses women who used oral contraceptives or presented 
with inflammation (Gibson et al., 2001).  
There is also limited research exploring non-nutritional determinants of zinc status. 
Menstrual losses have been proposed as a route of zinc loss, with women losing 
154 μg (24 μmol) per menses, regardless of oral contraceptive use (Hess, King, & 
Margen, 1977), although this amount is considered ‘negligible’ (Brown et al., 
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2004). The role of blood donation has also been considered. One study has 
reported lower plasma zinc levels in male regular blood donors compared to those 
making their first donation (12.5 vs. 16.2 μmol/L) (Qvist, Abdulla, Mathur, 
Robertson, & Svensson, 1983), however as only 1% of body zinc is found in 
whole blood (Gibson, 2005), blood donation is unlikely to be a major source of 
zinc loss. Given the limited amount of research investigating these non-nutritional 
aspects, the aims of this study were to investigate the potential influence of 
absorbable zinc intakes and blood loss on serum zinc while taking into account 
known confounders inflammation and oral contraceptive use.  
8.1.1 Aims and hypotheses.
Aims:
x Identify nutritional determinants of serum zinc after accounting for 
confounders of serum zinc concentration; 
x Investigate whether sources of blood loss are determinants of serum zinc 
concentration in premenopausal women. 
Hypotheses: 
x Dietary zinc intake is not a determinant of serum zinc. 
x Phytate:zinc molar ratio is a negative determinant of serum zinc. 
x Consumption of meat is a positive determinant of serum zinc. 
x Calcium intake is not a determinant of serum zinc regardless of phytate
intake. 
x Menstrual losses and blood donation are not determinants of serum zinc. 
8.2 Methods
See Chapter 3 General Methodology for detail.
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8.2.1 Participants.
See section 3.2 Sampling and timing. 
8.2.2 Demographic and anthropometric information. 
See section 3.4.1 Anthropometry and section 3.4.2 Demographic and medical 
background and blood loss information. 
8.2.3 Assessment of dietary zinc intake and supplement use.
See Chapter 4 Dietary Methodology and section 3.4.3 Use of dietary supplements..  
8.2.4 Estimation of phytate:zinc molar ratios. 
Participants’ zinc and phytate intakes were converted to a molar ratio of 
phytate:zinc using Equation 8.1. Two ratios were calculated; one with dietary zinc 
and one with total zinc, including zinc contributions from supplements. These 
molar ratios were used as continuous variables for inferential analyses and the 
proportion of participants consuming diets with a ratio > 18 (Brown et al., 2004) 
was also explored for descriptive purposes. 
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Equation 8.1 Equation to estimate phytate:zinc molar ratio 
Phytate:zinc molar ratio =  
mg of dietary phytate ÷ 660
mg of dietary/supplemental zinc ÷ 65.4
Where:
660 = molecular weight of phytate 
65.4 = molecular weight of zinc 
(Brown et al., 2004) 
8.2.5 Assessment of blood loss. 
The sources of blood loss included in this study were menstrual losses, nosebleeds, 
and blood donation status. Methods of assessment are described in section 3.4.2 
Demographic and medical background and blood loss information. 
8.2.6 Biochemistry.
Blood samples were analysed for serum zinc concentration and C-reactive protein 
(CRP) by the methods outlined in Section 3.4.4 Biochemical analysis. 
For all participants, serum zinc concentrations were standardised to 08:00 blood 
sampling using the method of Arsenault et al. (2011): 
1) A linear regression model was run with serum zinc concentration as the 
dependent variable and blood sampling time in hours as a covariate. The 
result of interest was the ȕ-coefficient for sampling time. In the present 
study, ȕ = -0.115). 
2) Each participant’s sampling time was centred around 08:00. For example, a 
participant who had blood sampled at 10:00 would have a centred value of 
2 (i.e. 10:00 – 08:00). 
3) Each participant’s centred value was multiplied by the ȕ-coefficient for 
sampling time obtained in step 1. For example, 2 × -0.115 = -0.230. 
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4) The value obtained in step 3 was subtracted from the participant’s raw 
serum zinc concentration. The resulting value was considered the zinc 
concentration standardised to 08:00. These values were interpreted 
according to fasting status.
Standardised serum zinc concentrations were used for all descriptive and 
inferential analyses.
Of the women with complete dietary data and energy intakes within 3 SD of the 
mean, 332 also had complete serum zinc and CRP data available. Six of these 
women had serum zinc concentrations exceeding 18.97 μmol/L, indicative of 
potential contamination (Engle-Stone et al., 2014), and were excluded from all 
analyses. A further five women were missing data on the time of blood sampling. 
Data from 321 women are therefore presented in this chapter. 
The reference values used to categorise biomarker data are presented in Table 8.1.
Serum zinc concentrations were considered low if they met criteria defined by 
IZiNCG; these values represent the 2.5th percentile of serum zinc concentrations of 
non-pregnant females aged 10 years and over in the US National Health and 
Nutrition Examination Survey II 1976 – 1980 (NHANES II) (Brown et al., 2004). 
Provisional reference ranges for women using oral contraceptives were also 
tentatively explored in this study – IZiNCG excluded oral contraceptive users from 
their above analysis of NHANES II, and instead conducted sub-group analyses 
(Brown et al., 2004). The resulting reference ranges are tentative as the 
composition of oral contraceptives (e.g. combined progestin and oestrogen, or 
progestin only) used by women in NHANES II was unknown, and different 
varieties of oral contraceptives may have different effects on serum zinc 
concentrations (Brown et al., 2004). For this study, IZiNCG’s principal reference 
values were used to assess all participants’ serum zinc concentrations, regardless 
of oral contraceptive use, and the provisional oral contraceptive reference values 
were explored in oral contraceptive users only. 
The criterion for severe zinc deficiency used in this study was based on a review of 
clinical zinc depletion-repletion studies in adults that recorded development of 
symptoms such as skin lesions, diarrhoea and alopecia (Wessells et al., 2014). This 
criterion was applied to the whole cohort of women. 
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Table 8.1 Reference values used to interpret serum zinc and C-reactive 
protein concentrations
Classification Serum zinc C-reactive protein
Low serum zinca
AM fasting:
< 10.7 μmol/L - AM nonfasting:
< 10.1 μmol/L
Tentative low serum zinc in oral 
contraceptive usersa
AM fasting: 
< 9.9 μmol/L - 
- AM nonfasting: 
< 9.3 μmol/L
Severe zinc deficiencyb  < 7.65 μmol/L - 
Inflammation/infectionc - PJ/
a Brown et al. (2004)
b Wessells et al. (2014)
c Thurnham (2014)
8.2.7 Statistical analysis. 
The distributions of continuous variables were established by inspecting 
histograms, with normally distributed data presented as mean (SD) and skewed 
data presented as median (interquartile range (IQR; 27th to 75th centiles)). 
Categorical data are presented as n (%) or % (95% CI) where appropriate. 
Differences between groups were assessed using independent samples t-tests for 
normally distributed data, and for skewed data using Wilcoxon rank-sum tests. 
Non-nutritional and nutritional determinants of zinc status were investigated using 
multiple linear regression with serum zinc (μmol/L, standardised to 08:00 blood 
sampling) as the dependent variable. First, a base model of non-nutritional 
determinants was constructed using automated backwards selection, to which 
nutritional determinants could be added. Backwards selection of the base model 
was used to facilitate the exploratory nature of the analysis, and non-nutritional 
predictors were identified using a relatively liberal selection criterion of p  .2 
(Vittinghoff et al., 2012). Based on literature (see Chapter 2), potential non-
nutritional predictors were BMI (kg/m2), whole blood donated (as 100 mL/year), 
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tertiary education (yes/no), have had children (yes/no), current oral contraceptive 
use (yes/no), fasting status at time of blood sampling, and menstrual blood loss 
over the year (blood loss units × frequency of menses). CRP (mg/L) was forced 
into the base model to account for the influence of acute infection and 
inflammation on serum zinc concentration (Thurnham, 2014). Plotting the 
residuals against the fitted values showed heteroscedasticity, so CRP was natural 
log-transformed for these analyses. Presence of collinearity among independent 
variables was determined using criterion of r (Vittinghoff et al., 2012).  
Once the base model was established, nutritional determinants were individually 
and then simultaneously added as independent variables to explore possible 
associations. These determinants were natural log-transformed if residuals did not 
meet the linearity or homoscedasticity assumptions of linear regression; for 
variables where individuals had values of 0, 1 was added to all participants’ values 
prior to log transformation. When individually-added nutritional determinants 
were statistically significant predictors of serum zinc, changes in the fit of the 
model were assessed using the likelihood ratio test.
8.3 Results
8.3.1 Description of participants.
A description of participants included in this study is provided in Table 8.2. When 
assessing the whole cohort using IZiNCG’s principal reference values, 17% (95% 
CI 13 to 22%) of women had low serum zinc concentrations; 25% of oral 
contraceptive users and 12% of non-users. When applying IZiNCG’s provisional 
reference values to participants using oral contraceptive users, 11% (14/122; 95% 
CI 6 to 19%) of oral contraceptive users had low serum zinc concentrations. Of the 
whole cohort, 0.6% (2/326) may have been at risk of severe zinc deficiency 
(Wessells et al., 2014).  
Four percent of women (13/326) consumed diets with a phytate:dietary zinc molar 
ratio > 18 (4 women not consuming any special diet; 4 women consuming 
vegetarian diet; 2 mostly vegetarian but consume some meats; 3 consuming other 
special diet). 
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Three percent of women (10/326) had diets with a ratio > 18 when supplemental 
zinc was included (4 not consuming any special diet; 2 consuming vegetarian diet; 
2 mostly vegetarian but consume some meats; 2 consuming other special diet).  
Women who reported consuming a special diet had lower intakes of dietary zinc 
(7.9 vs. 9.6 mg/d, Z = 3.59, p < .001), higher intakes of phytate (964 vs. 738 mg/d, 
Z = -3.85, p < .001), and accordingly higher phytate:zinc molar ratios (12.4 vs. 8.0, 
Z = -7.02, p < .001). 
Table 8.2 Characteristics of premenopausal women aged 18-50 y (N = 321)
n (%) Mean (SD) Median (IQR)
Age (y) 29.0 (7.3)
Height (m) 1.66 (0.06)
Weight (kg) 66.1 (11.6)
Body mass index (kg/m2) 23.9 (3.9)
Underweight 11 (3%) 
Normal weight 214 (68%)
Overweight 65 (21%)
Obese 26 (8%)
Born in Australia 244 (76%)
Tertiary education 259 (81%)
Currently employed 282 (88%)
Current smoker 24 (8%)
Has children 48 (15%)
Donated blood in previous 12 
months 150 (47%) 
Amount donated (mL/y, n =
150) 840 (478) 
Using oral contraception 122 (38%)
Menstrual blood loss units per 
menses 31 (21 to 48) 
Frequency of menses
1-4 cycles/y 19 (6%) 
4-8 cycles/y 26 (8%) 
8-12 cycles/y 267 (86%) 
Fasting serum zinc (μmol/L) (n
= 140)a 12.61 (1.72) 
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n (%) Mean (SD) Median (IQR)
Non-fasting serum zinc (n =
181)a 11.86 (2.00) 
Low serum zincb 55 (17%)
C-reactive protein (mg/L) 0.65 (0.17 to 2.14)
Elevated CRPc 32 (10%)
Energy intake (MJ/d) 7.6 (2.2)
Dietary zinc intake (mg/d) 8.7 (7.0 to 11.0)
Taking supplements containing 
zinc 48 (15%) 
Supplemental zinc intake 
(mg/d, n = 42) 7.5 (5.0 to 11.0) 
Total zinc intake (mg/d) 9.2 (7.2 to 11.9)
Phytate intake (mg/d) 707 (493 to 1024)
Dietary phytate:dietary zinc 
molar ratio 8 (6 to 11) 
Dietary phytate:total zinc 
molar ratio 8 (5 to 1) 
Calcium intake (mg/d) 823 (340)
On ‘special diet’ 75 (23%)
Vegetarian 15 (5%)
Mostly vegetarian but eats 
some meats 30 (9%) 
Other dietsd 30 (9%)
a Serum zinc standardised to 08:00 sampling time. 
b Low serum zinc defined as – fasting: < 10.7 μmol/L; nonfasting: < 10.1 μmol/L 
(Brown et al., 2004). 
c Elevated CRP defined as  5 mg/L (Thurnham, 2014). 
d ‘Other diets’ include gluten-free or wheat-free (n = 16), vegan (n = 4), weight 
management (including high protein, reduced calories, Lite n Easy, low fat; n = 5).
8.3.2 Non-nutritional determinants of zinc status.
Automated backwards selection of predictor variables for a linear regression 
model retained oral contraceptive use and fasting status as non-nutritional 
determinants of zinc status. This model formed the base model and explained 5% 
of variance in serum zinc concentration (Table 7.2). Providing a fasting blood 
sample increased serum zinc by 0.8 μmol/L, while taking oral contraceptives was 
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associated with a reduction of 0.7 μmol/L. Blood donation, menstrual blood loss, 
demographic information and anthropometric information were not associated 
with serum zinc.
Mean (SD) standardised-serum zinc concentrations were 12.6 (1.7) μmol/L in 
women who provided a fasting blood sample and 11.9 (2.0) μmol/L in non-fasting 
women. Mean concentrations were 11.8 (2.0) μmol/L in women using oral 
contraceptives and 12.4 (1.9) μmol/L in women not taking oral contraception.  
Table 8.3 Non-nutritional determinants of serum zinc (N = 320)a,b
Adj. R2 = .053, p < .001 ȕ&, p-value
Fasting blood sample 0.769 (0.344 to 1.195) < .001
Uses oral contraception -0.657 (-1.133 to -0.182)  .007 
a Serum zinc standardised to 08:00 sampling time. 
b Model adjusted for log-transformed C-reactive protein.
8.3.3 Nutritional determinants of zinc status.
Individual determinants.
Potential nutritional determinants of zinc status were entered separately into the 
base model of fasting status at the time of blood sampling and oral contraceptive 
use (Table 8.4). Intakes of white meat and all types of meat were positive 
determinants of serum zinc, and their additions slightly improved the fit of the 
base model so that the explained variance increased from 5% to 6% (likelihood 
ratio test for white meat Ȥ2 = 4.94, p = .026; likelihood ratio test for all meat Ȥ2 =
4.41, p = .036). For every 10% increase in white meat consumption or total meat 
consumption (e.g. increase in geometric mean of white meat from 60 to 66 g/d, or 
of total meat from 92 to 101 g/d), serum zinc concentration increased by 0.02 
μmol/L. Consumption of a special diet and of the sum of all animal source foods 
(analyses not displayed) and intakes of zinc were not predictors of serum zinc 
concentration, and there was a trend for the molar ratios of dietary phytate:dietary 
zinc or total zinc to be negatively associated with serum zinc concentrations. 
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Table 8.4 Univariate associations between nutritional determinants and 
serum zinc concentration in women aged 18-50 y (N = 313)a
Nutritional determinant ȕ&, p-value for ȕ Adj. R
2
Non-
nutritional 
base 
modelb + 
Dietary zinc intake (mg/d)c 0.244(-0.286 to 0.774) .365 .053
Energy-adj. dietary zinc 
(mg/d)c,d
0.189
(-0.698 to 1.075) .676 .051
Total zinc intake (incl. 
supplements; mg/d)c
0.254
(-0.206 to 0.715) .278 .058
Dietary phytate:dietary zinc 
molar ratio
-0.040
(-0.087 to 0.006) .087 .059
Dietary phytate:total zinc 
molar ratio
-0.043
(-0.090 to -0.003) .068 .064
Phytate (mg/d)c -0.195(-0.560 to 0.171) .295 .053
Red meat (beef + lamb; g/d)c 0.065(-0.088 to 0.217) .407 .052
White meat (chicken + pork + 
fish; g/d)c
0.196
(0.022 to 0.370) .028 .065
Red + white meat (g/d)c 0.177(0.010 to 0.343) .037 .063
Calcium (mg/d)
0.0003
(-0.0003 to 
0.0009)
.344 .053
Energy intake (MJ/d) 0.013(-0.081 to 0.108) .782 .050
a Serum zinc standardised to 08:00 sampling time. 
b Adjusted for log-transformed C-reactive protein.
c Natural log-transformed independent variable. 
d Energy adjusted using the residual method. 
Combining determinants. 
Multiple nutritional determinants were added to the base model to investigate their 
combined effect on serum zinc concentrations (Table 7.4). Due to collinearity, zinc 
intake and meat consumption were not included in the same model. Dietary or 
total intakes of zinc, and dietary intakes of calcium were not associated with serum 
zinc concentration. There appeared to be a non-significant tendency for negative 
associations between intakes of phytate and phytate:zinc molar ratio and serum 
zinc concentration. 
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Table 8.5 Multivariate associations between non-nutritional determinants, 
nutritional determinants and serum zinc concentration in women aged 18-50 
y (N = 320)a,b
ȕ&, p-YDOXHIRUȕ
Model A: Adj. R2 = .055, p < .001
Fasting blood sample 0.803
(0.373 to 1.234) < .001 
Uses oral contraception -0.641
(-1.118 to -0.164) .009
Dietary zinc intake (mg/d)c 0.225
(-0.532 to 0.983) .558
Dietary phytate intake (mg/d)c -0.329
(-0.73 to 0.072) .108
Dietary calcium intake (mg/d) 0.0003
(-0.001 to 0.001) .468
Model B: Adj. R2 = .061, p < .001
Fasting blood sample 0.825
(0.392 to 1.258) < .001 
Uses oral contraception -0.599
(-1.081 to -0.118) .015
Total zinc intake (mg/d)c 0.248
(-0.3 to 0.796) .730
Dietary phytate intake (mg/d)c -0.35
(-0.755 to 0.055) .096
Dietary calcium intake (mg/d) 0.0004
(-0.0004 to 0.001) .612
Model C: Adj. R2 = .058, p < .001
Fasting blood sample 0.802
(0.374 to 1.231) < .001 
Uses oral contraception -0.641
(-1.117 to -0.166) .008
Dietary phytate:dietary zinc molar ratio -0.039
(-0.085 to 0.008) .104
Dietary calcium intake (mg/d) 0.0002
(-0.0004 to 0.001) .432
Model D: Adj. R2 = .064, p < .001
Fasting blood sample 0.821
(0.39 to 1.252) < .001 
Uses oral contraception -0.605
(-1.085 to -0.126) .014
Dietary phytate:total zinc molar ratio -0.042
(-0.089 to 0.004) .073
Dietary calcium intake (mg/d) 0.0003
(-0.0003 to 0.001) .368
a Serum zinc standardised to 08:00 blood sampling. 
b Models adjusted for log-transformed C-reactive protein.
c Natural log-transformed independent variable. 
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8.4 Discussion
In this study of premenopausal women, after accounting for non-nutritional 
determinants of serum zinc concentration, there was no relationship between zinc 
intake and zinc status as measured by serum zinc, and only a trend for negative 
associations with self-reported consumption of the molar ratios of dietary 
phytate:dietary zinc, or dietary phytate:total zinc. Consumption of white meat 
(poultry, pork and fish) and all types of meat were positive determinants of serum 
zinc, with a 10% increase in intakes associated with an 0.02 μmol/L increase in 
serum zinc, but there were no associations with red meat (beef and lamb) alone, or 
with calcium intake. Furthermore, this study supports current understanding that 
oral contraceptive use and timing of blood sampling are important non-nutritional 
confounders of serum zinc concentration, and that blood loss (as blood donation or 
menstrual loss) does not seem to impact zinc status.
There was some suggestion that dietary composition exerted a greater influence on
serum zinc concentration compared to levels of dietary zinc intakes alone. In this 
sample of women, the molar ratios of phytate:zinc were borderline negatively 
associated with serum zinc, while dietary or total zinc intake had no effect. These 
findings are in line with the weak negative correlations between the phytate:zinc 
molar ratio and zinc status yielded in other cross-sectional work (Donovan & 
Gibson, 1995; Gibson et al., 2001), and support the IZiNCG’s approach of 
emphasising intakes of ‘absorbable’ zinc, rather than total zinc intake in their 
estimates of zinc requirements and recommendations (Brown et al., 2004). The 
lack of a relationship between calcium intake and serum zinc is in line with the 
absorption studies that have demonstrated that level of dietary calcium does not 
affect zinc absorption (Dawson-Hughes et al., 1986; McKenna et al., 1997).  
Additionally, the present study indicated that consumption of white meat and all 
meat were positive determinants of serum zinc concentration, but not red meat 
alone. In the current sample, poultry contributed just 5% to dietary zinc intakes, 
while beef contributed 12% (section 5.3.4 Sources of dietary zinc.). As white meat 
was a notably smaller contributor to dietary zinc intakes than red meat, the 
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associations between intake and status are not solely explained by increased zinc 
content and consequent reduction in phytate:zinc molar ratio of the diet. In the 
context of zinc absorption, these positive findings reflect Sandström et al.’s 
observation that chicken and fish increased zinc absorption, while beef had no 
effect (Sandström et al., 1989). Sandström et al. explained their findings in terms 
of the protein source, hypothesising that chicken and fish may be a more potent 
enhancer of zinc absorption than beef (Sandström et al., 1989). Whether 
consumption of white meat in particular affects zinc status has not been tested, but 
the findings of this study warrant further investigation as white meat may add 
another dimension to the notion of ‘absorbable’ zinc. It is also possible the 
influence of white meat and total meat consumption represent particular dietary 
patterns that are protective of women’s serum zinc concentration. 
Although only 15 women in the present study followed a vegetarian diet, and thus 
the study was likely under-powered to detect an influence of vegetarianism on 
serum zinc concentration, the amount of meat usually consumed was positively 
associated with serum zinc concentration, which may relate to vegetarian diets. In 
an eight-week intervention study, Hunt et al. (1998) found that a vegetarian diet 
reduced zinc absorption in comparison to a control omnivorous diet matched for 
zinc but not phytate content (Hunt, Matthys, & Johnson, 1998). Women presented 
with plasma zinc concentrations 5% lower on the vegetarian diet compared to the 
omnivorous diet (Hunt et al., 1998). Hence, the women in the current study who 
consumed little meat may have not only been subject to inhibited zinc absorption 
due to diets with an increased molar ratio of phytate:zinc, but also habitually 
consumed insufficient white meat to enhance absorption. However, diets low in 
meat do not necessarily reduce the quantity of zinc absorbed provided the zinc 
from meat is replaced (Kristensen et al., 2006). Another absorption study 
compared a vegetarian diet to a control omnivorous diet that was matched for 
phytate but not zinc content, finding the proportion of zinc absorbed was not 
affected in the vegetarian diet, but the absolute (mg) amount of zinc absorbed was 
reduced as the vegetarian diet contained less zinc (Kristensen et al., 2006). This 
finding further emphasises the need for those following vegetarian diets to be 
mindful of both phytate and zinc intakes, and to be aware that by not consuming 
meat, particularly white meat, they may miss its zinc absorption enhancement that 
appears to be independent of the phytate:zinc molar ratio.
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In the current study, the associations between serum zinc concentration and 
absolute phytate intake or the phytate:zinc ratios were not as pronounced as 
expected. As the Australian food composition databases used to obtain nutritional 
information from DQES v3.1 did not include values for phytic acid, an external 
database of total phytate values was used, covering 906 food and drink items 
(Hartley, 2014). These phytate values were derived from literature, adjusted for the 
wheat flour processing methods in New Zealand, and where appropriate, 
incorporated into recipes (Hartley, 2014). While this database is anticipated to be 
the most appropriate to the Australian food supply and best efforts were made to 
match DQES v3.1 items with the closest items in the phytate database, 
discrepancies with participants’ actual phytate intakes are still likely as Australian 
products were not directly analysed, and food preparation and processing methods 
that may degrade phytate were not assessed by DQES v3.1 (e.g. soaking legumes) 
(Schlemmer, Frølich, Prieto, & Grases, 2009). Furthermore, Lönnerdal (2000) has 
stated that estimations of total phytate intake may be too broad as different forms 
of phytate have varying impacts on zinc absorption, for instance the 
hexaphosphate and pentaphosphate forms may inhibit absorption, whereas the 
tetraphosphate and triphosphate forms appear to have negligible effect (Lönnerdal, 
2000). Therefore, although the direction of the association between phytate and 
zinc status was as expected, the full effect may have been suppressed by the 
methodological difficulties of estimating phytate intakes. It is also possible women 
in Australia do not consume sufficient phytate to negatively affect zinc absorption 
and therefore zinc status. Only 4% of women in this study had dietary phytate:zinc 
molar ratios associated with impaired zinc absorption (Brown et al., 2004), and the 
median daily intake of phytate in this sample (707 (IQR 493 to 1024) mg/d) is in 
line with the daily intakes of adults following an omnivorous diet in the UK, US 
and Canada, as reviewed by Schlemmer (2009). In comparison, US adults 
following vegetarian diets reported intakes > 1000 mg/d, and adults living in 
Guatemala, Mexico and Nigeria had intakes > 2000 mg/d (Schlemmer et al., 
2009). It is plausible zinc status is not affected by the relatively moderate amounts 
of phytate consumed in the present study.  
It is notable that at most, only 6% of variance in serum zinc concentration could be 
explained in this cohort of women when adjusting for known confounders time of 
day and fasting status of blood sampling, oral contraceptive use, and acute 
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inflammation. There appears to be no suitable published data to compare to this 
adjusted R-squared value. For example, baseline measurements of women in the 
SU.VI.MAX study yielded adjusted R-squared values of just .006 for fasting 
serum zinc levels, but analyses did not account for oral contraceptive use or time 
of sampling (Galan et al., 2005). Researchers of a British study of 189 healthy 
adults found R-squared values of .107 (Ghayour-Mobarhan, Taylor, New, Lamb, 
& Ferns, 2005), although it is unknown whether this R-squared value was 
corrected for their number of predictor variables, which included those unrelated 
to serum zinc including serum lipids and diastolic blood pressure. Nevertheless, it 
appears most of the variance in serum zinc concentrations in healthy populations 
cannot be explained by the confounders acknowledged in the literature. Given zinc 
malabsorption in acrodermatitis enteropathica has been linked to mutations in the 
gene for zinc transporter ZIP4 and associated with low serum zinc concentrations 
(Kasana et al., 2015), further investigation into this and other potential mutations 
in zinc absorption, transport and storage will aid in understanding determinants of 
serum zinc.
The usefulness of serum zinc concentrations to assess the zinc status of a 
population is widely acknowledged (Brown et al., 2004), and in this sample of 
premenopausal women, 17% (95% CI 13 to 21%) were categorised as having low 
serum zinc concentrations. IZiNCG suggest that where 10-20% of a group have 
low serum zinc concentrations, further assessment is required as some members 
may be at increased risk of deficiency (Brown et al., 2004). As oral contraceptive 
use suppresses serum zinc levels (Brown et al., 2004), potentially by inhibiting 
albumin synthesis (Gleichmann et al., 1973; King, 1987), it is expected that the 
proportion of women with low serum zinc levels in the current sample is inflated 
by the rate of oral contraceptive use (38%). Furthermore, in suggesting their 
reference ranges for prevalence of low serum zinc in a sample, IZiNCG proposed 
that a prevalence range of 10-20% should have a confidence interval of 3-4 
percentage points and sample size of 307-683 individuals (Brown et al., 2004). 
The confidence intervals in this study were wider than suggested by IZiNCG and 
the sample size was at the lower end of their recommendations, limiting the 
precision of this estimate. Further, the prevalence of low serum zinc was likely 
elevated due to the number of participants using oral contraception. However,
based on these results a cautious approach may favour further evaluation of zinc 
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status in Australian women, alongside establishment of serum zinc reference 
ranges that apply to women using a variety of oral contraceptives. The present 
study seems to substantiate IZiNCG’s provisional reference ranges for women 
using oral contraceptives (Brown et al., 2004) as a similar proportion of oral 
contraceptive users were categorised as having low serum zinc concentrations 
using the provisional cut-off values (11%) compared to non-users categorised 
using the established cut-off values (12%). This finding is promising but needs to 
be supported by population data including oral contraceptive composition. 
8.5 Conclusion 
In conclusion, this study found that zinc intakes and the molar ratio of phytate:zinc 
were not statistically significant determinants of serum zinc levels in this sample 
of premenopausal women. Intakes of calcium, a proposed inhibitor of zinc 
absorption, were not associated with zinc status alone or in the presence of phytate, 
while consumption of white meats and all meat, potential absorption enhancers, 
were found to be positively associated with zinc status. This study also confirmed 
that serum zinc concentrations are negatively influenced by oral contraceptive use 
and by fasting status, and indicated that blood losses do not affect serum zinc. The 
most variance in serum zinc levels explained by these potential determinants was 
6%, indicating determinants of serum zinc concentration remain largely unknown. 
133
Chapter 9: Discussion
9.1 Chapter Overview
In its entirety, this program of research contributes to the understanding of dietary 
intakes of iron and zinc in the Australian female population, provides estimates of 
biochemical iron and zinc status, and gives insight into determinants of 
biochemical status. In this population of women, 31% were at risk of inadequate 
dietary iron intakes and 19% were at risk of inadequate dietary zinc intakes, and 
prevalence of depleted iron stores and low serum zinc concentrations were 30% 
and 17%, respectively. This research is the first Australian investigation of zinc 
status in premenopausal women, and indicates zinc deficiency may be a problem 
for a segment of the population. It is also the first research to show the relationship 
between hepcidin, dietary iron intake and iron status in a free-living population. 
The findings presented in this thesis contribute information that can be integrated 
in evidence-based approaches to prevent and manage iron deficiency, further
understanding of determinants of zinc status, and provide some guidance as to 
dietary strategies to improve zinc status. The focus of this final chapter is the 
findings and implications of the thesis as a whole. 
9.2 Iron Status and Zinc Status are Only Weakly Associated in 
Premenopausal Women in Australia 
Despite confirming a sizeable positive association between dietary iron and zinc 
intakes, there was only a small positive association between iron and zinc status as 
assessed using serum ferritin and serum zinc in the studied sample of 
premenopausal women (Chapter 6). Each 1 mg/d increase in usual dietary iron 
intake corresponded with a 0.4 mg/d increase in usual dietary zinc intake, and 
women who failed to meet Australian dietary zinc intake recommendations of >6.5 
mg/d were also at increased risk of inadequate dietary iron intakes. These 
associations might reflect the dominance of cereals, vegetables and meat as dietary 
sources of both iron and zinc (Chapter 5). However, although each 1 μmol/L 
increase in serum zinc corresponded to a 6% increase in serum ferritin, having low 
serum zinc concentration did not place women at increased risk of low iron stores. 
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These data provide important evidence that iron deficiency is not a useful proxy 
for low zinc status in premenopausal women in Australia as it is unlikely groups 
with zinc deficiency will be identified. Globally, prevalence of iron deficiency 
may represent regions or populations where zinc deficiency is also an issue 
(Brown et al., 2004), however the findings of this project indicate that this 
relationship may not apply to economically-developed countries where overall 
food restriction is unlikely to be the major cause of insufficiency. Thus, in 
Australia there is a need for zinc-specific assessment of biochemical status. 
Although this study observed broad similarities in the dietary sources of iron and 
zinc, there were also subtle differences (Chapter 5). Cereals provided 31% of 
dietary iron and meat contributed only 14%. In contrast, meat contributed 30% and 
cereals 17% of dietary zinc. Dairy products provided 19% of zinc but did not 
contribute to iron. In conjunction with previous research showing that zinc status 
does not improve following diets maximising iron bioavailability (Heath, Skeaff, 
O'Brien, et al., 2001; Prosser et al., 2010), these dietary contributions data may 
indicate that different dietary strategies are required to boost iron and zinc status. 
Supporting this notion, in Chapter 7 red meat was found to be a positive 
determinant of women’s iron stores but there was no such association with serum 
zinc concentrations in Chapter 8. Similarly, iron status may not respond to diets 
maximising zinc bioavailability. In multivariate models, there was some 
suggestion phytate intake could be a negative determinant of serum zinc 
concentration but there was no association of phytate and iron stores. Taken as a 
whole, the differences in food sources of these two nutrients and in dietary 
determinants of status appear to explain the lack of association between iron and 
zinc status.
9.3 Women’s Main Sources of Dietary Iron are not Necessarily 
Determinants of Iron Status
In the study sample of women, the main dietary sources of iron were cereals, 
vegetables and meat (Chapter 5). Consumption of cereals and vegetables were not 
associated with iron stores, but meat consumption was a consistent positive 
determinant and for each 10% increase in total meat intake, iron stores increased 
by 1% (Chapter 7). This association was observed despite meat contributing 
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similar quantities of dietary iron as vegetables and less iron than cereals. These 
data suggest that the women’s food selection patterns may have contributed to the 
proportion with impaired iron status. This investigation into determinants of iron 
stores reinforces previous research correlating meat consumption with iron status 
(Galan et al., 1998; Heath, Skeaff, Williams, et al., 2001; Leonard et al., 2014a), 
and extends this work by observing the relationship even after accounting for 
blood loss. Whether the positive effect of meat intake on iron stores is due to 
presence of the more bioavailable haem iron or due to dietary patterns that happen 
to be associated with meat consumption cannot be determined from the current 
study. It is important to elucidate the way in which meat consumption influences 
iron status as it will inform dietary guidelines to improve iron status. Data from the 
current study indicate that recommendations to consume a varied eating pattern 
with increased amounts of lean meat could emphasise red, white or all meats, and 
allow for individual preferences. To further inform these recommendations, further 
research is needed to address the association between phytate, ascorbic acid and 
non-haem iron, and its influence on iron status. While the current study observed a 
positive effect of dietary iron intake on iron status, there was no evidence that 
consumption of phytate or ascorbic acid influence iron status. However, as the 
timing of consumption was not assessed, and therefore it was unknown whether 
ascorbic acid, phytate, and iron were consumed simultaneously, these data need to 
be interpreted cautiously.  
9.4 Increased Serum Hepcidin Concentrations Suppress the Influence of 
Dietary Iron Intake on Iron Stores in Premenopausal Women in 
Australia
Clinical studies have shown that iron absorption is impaired at increased levels of 
hepcidin (Roe et al., 2009; Young et al., 2009; Zimmermann et al., 2009), however 
the resulting impact on iron status in a free-living population has only now been 
demonstrated (Chapter 7). As expected from the published clinical work, the 
association between dietary iron intake and iron stores in the study sample of 
women was strongest when circulating hepcidin concentrations were low, and this 
association diminished at higher hepcidin concentrations. Another important 
finding from this study is that the combined effect of diet and blood loss on iron 
stores was far outweighed by the influence of circulating hepcidin. Although it has 
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been suggested that hepcidin holds more influence than dietary aspects (Demeyer 
et al., 2014), the findings of the current study are the first to confirm this notion. 
As hepcidin production is in part driven by genetic influences (Ganz, 2011), it 
seems control of iron status may be pre-determined in at least some individuals. 
However, encouragingly there is some evidence that individuals can manipulate 
hepcidin production: exposure to black soybean extract has reduced hepcidin 
production in animal models (Mu et al., 2014), therefore there is potential that 
other compounds or interventions can also down-regulate hepcidin production in 
humans. Human intervention studies that test the effectiveness of black soybean 
extract in treating iron deficiency could yield valuable insight into the feasibility of 
this dietary strategy. Similarly, exploratory research investigating the potential of 
other compounds to suppress hepcidin production is warranted. Active suppression 
of hepcidin production may be a useful adjunct to dietary strategies for the 
treatment of iron deficiency, notably those increasing iron intake or iron 
bioavailability.  
9.5 Serum Zinc Concentrations of Premenopausal Women in Australia 
are Associated with White Meat Consumption but not Associated with 
Zinc or Phytate Consumption
This study is the first to assess serum zinc concentration and explore its 
determinants in a sample of Australian women. Seventeen percent of women had 
low serum zinc concentrations (Chapter 6), indicating a need for population 
assessment of zinc status in Australia to ascertain whether zinc deficiency is a 
public health issue. This finding again highlights the urgency to implement routine 
testing of zinc status, and for appropriate population reference data (Brown et al., 
2004).  
The proportion of women with low serum zinc concentration also warrants 
investigation into factors associated with low concentrations. Interestingly, 
consumption of white meat and all meats were positively associated with serum 
zinc concentration, but consumption of red meat was not (Chapter 8). Increasing 
consumption of white meat and total meat by 10% were both associated with an 
0.02 μmol/L increase in serum zinc concentration. As zinc intakes were not 
associated with serum zinc, and as red meat provided more than twice the zinc of 
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white meat (Chapter 5), these findings provide weight to the idea that white meat 
enhances zinc absorption (Sandström et al., 1989), rather than increasing the zinc 
content or reducing the phytate:zinc molar ratio of the diet. This distinction 
highlights the importance of distinguishing between dietary determinants of iron 
status and dietary determinants of zinc status, and potentially contributes to the 
lack of association between iron and zinc status. Recommending that women 
consume red meat may help manage iron status, but as the sole strategy is unlikely 
to help improve zinc status. However, much more confirmatory evidence is needed 
before increased consumption of white meat can be confidently recommended as a 
means to increase zinc status. Well-controlled, long-term whole diet interventions 
that measure zinc absorption while manipulating intakes of white meat are needed 
to verify white meat as a zinc absorption enhancer; quantify the amount of white 
meat that should be consumed for such an effect; and establish whether there is a 
ratio of white meat:zinc in a meal that optimises absorption. This work would be 
highly beneficial in a global context as including potentially small quantities of 
white meat in the diet may be a simple, culturally acceptable means to achieve zinc 
adequacy (Brown et al., 2004). 
Negative associations between the molar ratio of phytate:zinc and serum zinc 
concentration in the current study were not as pronounced as expected. Noting the 
best food composition phytate data available was a database that was tailored to 
the New Zealand food supply (Hartley, 2014), the finding indicating a negative 
influence of phytate among Australian women warrants development of a phytate 
database specific for the Australian food supply. Such a database would allow for 
more accurate assessment of phytate in Australian diets and more convincing 
evidence for the role of the phytate:zinc molar ratio.
This study on determinants of serum zinc concentration contributes to 
understanding of serum zinc on an international level. It is worth noting that when 
applying IZiNCG’s provisional reference values for oral contraceptive users, a 
similar proportion of women were identified as having low serum zinc as when the 
standard reference values were applied to women not using oral contraceptives. 
This observation corroborates the validity of IZiNCG’s provisional values. 
Further, lack of an association between blood loss and serum zinc concentrations 
help solidifies the scant research investigating non-nutritional determinants of 
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serum zinc (Hess et al., 1977; Qvist et al., 1983). However, despite accounting for 
the known confounders of serum zinc assessment (e.g. inflammation, oral 
contraceptive use, fasting status), only 6% of variance in serum zinc concentration 
could be explained. Given mutations in the zinc transporter ZIP4 gene are
associated with acrodermatitis enteropathica (Kasana et al., 2015), further research 
exploring genetic links to serum zinc and zinc status may provide valuable insights 
into major determinants of zinc status.
9.6 Importance of Animal Tissue for Iron and Zinc Nutrition 
Animal tissue was a positive determinant of iron stores and serum zinc 
concentrations: a 10% increase in intakes of combined red and white meat 
associated with a 1% increase in serum ferritin and a 0.02 μmol/L increase in 
serum zinc concentration. Although women consumed more iron and zinc from 
red meats, white meat was a positive determinant of iron and zinc status 
independent of red meat. These findings support the inclusion of a variety of 
animal proteins in the Australian Dietary Guidelines, which suggests individuals 
aged 19-50 y consume 2.5 serves of lean meats, poultry, fish, eggs, tofu, nuts and 
legumes/beans per day (National Health and Medical Research Council, 2013). 
The Australian Dietary Guidelines further states: “To enhance dietary variety and 
reduce some of the health risks associated with consuming meat, up to a maximum
of 455g per week (one serve [65 g] per day) of lean meats is recommended for 
Australian adults” (National Health and Medical Research Council, 2013). Within 
the current study population, women’s intake of beef, lamb and pork was 
approximately half this recommendation at 34 g/d. Although these intakes are 
consistent with women’s intakes reported in AHS 2011-13, these findings suggest 
there is scope for future research to investigate barriers to consumption of lean 
meats in the diets of women and to explore strategies to encourage women to 
include meat in their diets in healthful ways.  
9.7 Limitations of this Thesis
The outcomes from this research need to be considered in light of the following 
limitations. First, the study sample of women was a self-selected group that was 
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not representative of premenopausal women in Australia. Women who participated 
in this research program were more likely to fall in the healthy weight range, less 
likely to smoke and more likely to be tertiary educated compared to the general 
population. While lack of representativeness limits confident extrapolation of 
prevalence data and point estimates, this research was still able to identify 
potential risk of low iron and zinc in the Australian population, and identify 
dietary and lifestyle factors associated with impaired iron and zinc status.  
The validity of DQES v3.1 to estimate dietary intakes of iron and zinc has not 
been published, and therefore is another limitation of this research. Although 
DQES v3.1 is an established questionnaire (Hodge et al., 2000; Nutritional 
Assessment Office - Cancer Epidemiology Centre - Cancer Council Victoria, 
2014), evaluation is an important part of FFQ development (Willett, 2013), and 
lack of validation data must be acknowledged. The decision to use the candidate’s 
method of extracting nutritional information rather than Cancer Council Victoria’s 
analysis was informed by inspection of Cancer Council Victoria’s food intake 
data, which indicated standard portions of food may not have been realistic for 
premenopausal women. In contrast, the portion sizes used at Deakin University 
were based on national food composition measures database (Food Standards 
Australia New Zealand, 2015), the Australian Dietary Guidelines (National Health 
and Medical Research Council, 2013) and the packaging of example products, in 
conjunction with a panel of accredited dietitians and nutrition scientists. The 
resulting computations produced intake data similar to national population data 
and while this step does not replace validation, it gives strength to the chosen 
approach. 
An important limitation for the parts of this thesis relating to serum zinc 
concentration is the lack of information collected about participants’ oral 
contraceptives, such as the name or composition. It is possible different varieties 
of oral contraceptives (e.g. combined progestin and oestrogen, or progestin only) 
may have different effects on serum zinc concentrations (Brown et al., 2004), and 
this thesis has not been able to account for or investigate this potential variation. 
This thesis also did not account for women’s stage of the menstrual cycle at the 
time of blood sampling, which can affect zinc metabolism and serum zinc 
concentration (e.g. circulating zinc concentrations are higher during menses and 
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the follicular phase and lower during the ovulatory and luteal phases) (Deuster, 
Dolev, Bernier, & Trostmann, 1987). These data would have been a valuable 
inclusion as the influence of different oral contraceptives on serum zinc 
concentration is yet to be understood, and both oral contraceptive use and 
menstrual cycle phase are likely necessary for correct interpretation of serum zinc 
data.  
As with all cross-sectional studies, causal pathways could not be determined in this 
research. In general, directionality could be inferred from the assessed 
determinants, for example negative associations between blood loss and iron stores 
implied increased blood loss reduced iron stores, rather than reduced iron stores 
increasing blood loss. Nonetheless, stronger study designs are needed to 
substantiate the dietary determinants assessed in this research.
9.8 Concluding Remarks
In summary, in this group of premenopausal women in Australia, while dietary 
intakes of iron and zinc were strongly correlated, iron status was not a useful proxy 
for zinc status. Intakes of dietary iron and meat were positive determinants of iron 
stores, but circulating hepcidin concentrations were a substantially greater 
influence, with increasing concentrations suppressing the effect of iron intake on 
iron stores. Future research in iron nutrition should include measurement of 
hepcidin as manipulation of hepcidin production by the liver may help maintain 
adequate iron status. White meat and total meat consumption were positive 
determinants of serum zinc concentrations, but only a weakly negative effect of the 
phytate:zinc molar ratio was observed. Furthermore, very little variance in serum 
zinc could be explained by the known confounders. Advances in understanding 
other determinants of zinc status are necessary to establish effective strategies to 
improve zinc nutrition. That 17% of premenopausal women in Australia have 
serum zinc concentrations that place them at risk of deficiency suggests population 
assessment of zinc status is needed in this country.  
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           ID No: ___________________
           Date:  ___________________
BACKGROUND QUESTIONNAIRE 
In this questionnaire, we will ask you questions about your general background, 
health status. All responses will remain confidential.
All questionnaires are confidential
Background questionnaire 1
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Appendix A. Background questionnaire
Section 1 – Personal Details
Study ID No: _____________
1. Where were you born?  
Country (please specify): __________________________
Mother’s country of birth: _________________________
Father’s country of birth: _________________________
2. What is your highest level of schooling? (Tick one box)
Never attended school 
Primary school 
Some high school 
Completed high school 
Technical/Trade certificate 
University or Tertiary level 
3. Do you currently work?  (Tick one box)  
YES
NO 
4. What is your current employment status? (Tick one box)
Full time employment 
Part time employment 
Home duties (eg: gardening)  ____________________________________________
5. What is your age? 
Years months
ANTHROPOMETRY Researcher use only
Height: 1) ____________ cm 2) ____________ cm Average: ____________ cm
Weight: 1) ____________ kg 2) ____________ kg Average: ____________ kg
Waist circ.: 1) ____________ cm 2) ____________ cm Average: ____________ cm
Blood pressure:
1) _______________________
Average of BP 2 & 3:
_______________________
2) _______________________
3) _______________________
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Appendix A. Background questionnaire
2 – Health & Medical History Questionnaire
1. Do you follow a special diet?
NO 
YES  Vegetarian (no meat of any kind)
 Mostly vegetarian but eat some meats please specify ______________________
 Vegan
 Other please specify___________________________________________________
2. Do you get nose bleeds?
YES 
NO  If NO, go to Q.5
3. How often do you get a nose bleeds?
 at least once per week - approximately how many times __________________________
 at least once per month - approximately how many times _________________________
 at least once per year - approximately how many times ___________________________
4. How heavy are your nose bleeds?   
 light
 moderate
 heavy
5. Do you donate blood?
NO  If NO, go to Q.8
YES 
6. When did you last donate blood?
Day _________ Month _________ Year _________
7. How many times have you donated whole blood in the past 12 months?
 1 time
 2 times
 3 times
 4 times
 5 times
8. In the last 6 months has your weight been 5 kg’s more/less than your present weight? 
YES  NO 
If YES, please explain: __________________________________________________________
______________________________________________________________________________
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9. Are you a: (Tick one box) Current smoker?  (Go to Q.9 a)
Ex-smoker?      (Go to Q.9 b)
Non-smoker           (If non-smoker, go to Q.10)                                 
a) If you are a current smoker, how many cigarettes do you smoke per day? _____________
• How long have you been smoking? ______________________________________________
b) If you are an ex-smoker, how many cigarettes did you smoke per day? _________________
• At what age did you start smoking? ______________________________________________
• At what age did you stop smoking? ______________________________________________
10. Please write down any operations, illnesses, accidents, falls or admissions to hospital you 
may have had during your lifetime.  Please specify if you were bed-ridden (immobilised) for any 
time and if so, for how long?
11. Have you ever been told by a doctor or nurse that you have 
x Anaemia NO  YES  DON’T KNOW 
x Malabsorption syndrome (chronic bowel disease, Crohn's Disease, Ulcerative Colitis)
NO YES  DON’T KNOW 
Please specify: ________________________________________________________________
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3 – Menstrual Reproductive History
The following questions require you to give information regarding your past menstrual 
reproductive history. The collection of this information is necessary as previous research has 
indicated that menstrual patterns can affect iron status.
1. How many children have you given birth to and what was the year(s) of birth? (if you’ve never 
had children write 0)
Number of children _______________ Year(s) of birth ___________________________
2. Have you had a menstrual period in the last 12 months?
YES 
NO  If NO, go to Q.11
3. When was you last menstrual period (month & year)?  _________ month ________ year
4. Do you use an oral contraceptive pill, an intra-uterine device or depo-provera, and how long
have you been using this contraceptive method.
 Oral contraceptive ___________ months __________ years
 Intra-uterine device ___________ months __________ years
 Depo-Provera ___________ months __________ years
5. What is the frequency of your menstrual periods?
 1 to 4 cycles per year ___________________________________________________
 4 to 8 cycles per year _____________________________________________________
 8 to 12 cycles per year ____________________________________________________
We need to ask the following questions to help us estimate how heavy your periods are.
6. How many ‘heavy’ days do you have during a period?
_______________ HEAVY DAYS
7. How many ‘light’ days do you have during a period?
_______________ LIGHT DAYS
8. On a ‘heavy’ day, how many pads and/or tampons do you use? What absorbency level are they? 
(e.g. super plus, super, regular, mini or light)
_______________ PADS _______________ ABSORBENCY
_______________ TAMPONS _______________ ABSORBENCY
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9. On a ‘light’ day, how many pads and/or tampons do you use? What absorbency level are they? 
(e.g. super plus, super, regular, mini or light)
_______________ PADS _______________ ABSORBENCY
_______________ TAMPONS _______________ ABSORBENCY
10. If you use tampons, which brand of tampons do you usually use?
__________________________________________________________ 
(Heath AL, Skeaff CM, Gibson RS. Validation of a questionnaire method for estimating extent of menstrual blood loss in 
young adult women. J Trace Elem Med Biol. 1998 Apr;12(4):231-5).
If you have had a period in the last 12 months please go to section 4.
11. If you periods have stopped please state the date of your last period 
Day_________ Month_________ Year_________
12.  Give reason(s) why you believe your periods have stopped
 Menopause.
 Medical condition.     If yes, what was it called? _________________________________
 Removal of both ovaries, with hysterectomy     
 Hysterectomy:                                           Date: ________________________________    
i) Were ovaries removed at the time of hysterectomy  one ovary removed
 two ovaries removed
 no ovaries removed
 unsure of ovary status    
 Medication use
i)   What is the name of the medication that caused your periods to stop? _________
ii)  How old were you when you began using it? ________________________________
iii)  How long have you been using it for, in total? _______________________________
              iv)  What was it prescribed for?   
                    Treatment of menopausal symptoms/menstrual irregularities due to menopause
 Other reasons (please specify) ________________________________________
 Don’t know
 Other reason (please specify): ______________________________________________
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OFFICE USE ONLY
    Menopausal status of person at this visit _______________________________
    Age at time of final period if post-menopausal ___________ years    __________ months
    Age at time of hysterectomy ____________ years __________ months
  Menopausal Status Groups
    1. Premenarcheal
    2. Pre-menopausal – not using medication affecting menstruation
    3. Pre-menopausal – using contraceptive pill (>3 months) & getting regular periods
    4. Pre-menopausal – not getting periods due to medication (use > 3 months) or illness
    5. Pre-menopausal when commenced HRT (continuing HRT) and < 55 years
    6. Pre-menopausal when commenced HRT (continuing HRT) and >55 years
    7. Early peri-menopausal – changes in frequency or frequency and flow, but not more than 3 months of   
amenorrhoea, symptoms present such as hot flushes, not using medication
    8. Peri-menopausal/HRT – periods became irregular, now using HRT (> 3months)
    9. Late peri-menopausal – amenorrhoea of at least 3 months, but not 12 months
    10. Postmenopausal – last period was more than 12 months ago – not using medication
    11. Postmenopausal – last period was more than 12 months ago – commenced HRT after periods had stopped 
for more than 12 months
    12. Hysterectomy before menopause
    13. Hysterectomy after menopause
    14. Unknown menopausal status. No periods due to medical condition
    15. Unknown
Background questionnaire 7
165
Appendix A. Background questionnaire
4 – Medications Questionnaire
This section is about the medications you take. If you are unsure how to fill this in, please bring the 
form and all your medication (or a list) with you to the testing site. 
1. If you are CURRENTLY taking any PRESCRIPTION OR NON-PRESCRIPTION 
medications or supplements please specify the NAME of the 
medication/supplement, the DOSE, the DURATION OF USE and the REASON for 
using the PRESCRIPTION OR NON-PRESCRIPTION medication(s). Supplements 
include vitamins, minerals and herbal types/remedies.
Tick if not currently taking any NON-PRESCRIPTION medications or 
supplements and go to Section 5.
Name of 
supplement/ 
medication
eg1. Caltrate
eg2. Glucosamine
Dose (if 
known)
eg1
105mg
eg2 1.5g
Frequency 
(per day)      
eg1 once a day
eg2 twice a day
Duration           
eg1 6 weeks
eg2 2 years
Reason for taking 
supplement/medi
cation
eg1 anaemia
eg2 arthritis
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ID: __ __ __ _ 
Diet checklist Date completed: _ _ /_ _ /_ _ _ _ 
Please complete the following questionnaire about the foods you ate yesterday. Record the number of serves 
you ate of each food item. If you did not have the food, write 0. Please do not leave blank space. 
If you think the reference serve does not match your serve, please make your best guess about the measure of 
your serve. For example, our reference serve for bread is 1 slice. If you had 2 slices of bread on a sandwich and 
2 pieces of toast during the day, then write 4. If you think the list of foods does not adequately describe the 
foods you ate, please add items and the amount at the end of the list. Thank you. 
Foods How many 
serves 
yesterday 
Foods How many 
serves 
yesterday 
Meat, Fish and Poultry 
1. Beef as a steak, roast, casserole, stew, stir-fry 
or curry – medium sized steak or 1/3 cup diced 
cooked meat (100g) ...................................................................  
2. Lamb as a roast, chops, curry or stew – 2 slices 
roast or 2 mid-loin chops or 1/3 cup diced 
cooked meat (100g) ...................................................................  
3. Pork as chops, roast or sweet & sour pork – 2 
slices roast or 1 loin chop or 1/3 cup diced 
cooked meat (100g) ...................................................................  
4. Chicken – ¼ chicken (breast & wing) 130g .................................  
5. Mince as bolognaise sauce or Sheppard’s pie 
or cottage pie or savoury mince – ½ cup (80g) ..........................  
6. Fish (fresh, cooked) – average fillet (100g) ................................  
7. Canned tuna – 1 small can (100g) ..............................................  
8. Canned salmon – 1 small can (100g) .........................................  
9. Prawns or squid or scallops -5-6 clean prawns, 
7-8 scallops, 1 cup fried squid (100g) ........................................  
10. Liver – 1 slice grilled or fried (85g) .............................................  
11. Sausage – any type – 1 average (70g) ........................................  
12. Hamburger – 1 average patty (80g) ...........................................  
13. Pizza – vegetarian or ham and pineapple – 1 
large slice (120g) ........................................................................  
14. Pizza – supreme or 3 toppings or meat lovers – 
1 large slice (120g) .....................................................................  
15. Meat pie – 1 pie (190g) ..............................................................  
16. Pastie– 1 pasty (165g)................................................................  
17. Sausage roll – 1 sausage roll (130g) ...........................................  
18. Ham or Polish sausage – 1 slice (30g) ........................................  
19. Salami, mortadella, devon -2-3 slices (30g) ...............................  
20. Pressed chicken – 2 slices (30g) .................................................  
Pasta and Rice 
21. Brown rice, cooked – ½ cup (90g) ..............................................  
22. White rice, cooked – ½ cup (90g) ..............................................  
23. Pasta, cooked – 1 cup (150g) .....................................................  
Soy Foods and Meat Replacements 
24. Tofu or tempeh, 1/3 cup cooked (100 g) ...................................  
25. Meat replacements including 2 slices 
Sanitarium Deli Slices, 6 slices Sanitarium Deli 
Luncheon or 1/3 can Sanitarium Savoury 
Lentils ........................................................................................  
26. Meat replacements including 1 Sanitarium 
Patty, Schnitzel or Vegie Burger, 4 Sanitarium 
Bacon Style Rashers or 85 g Sanitarium Vegie 
Mince, Nutmeat or Nutolene .....................................................  
27. Meat replacements including 2 Sanitarium 
Vegie Sausages, 2 Sanitarium Vegie Kebabs, 
1/3 can Sanitarium Casserole Mince or 120g 
Sanitarium Vegie Roast ..............................................................  
Eggs, Nuts and Seeds 
28. Egg – one (60g) ..........................................................................  
29. Omelette (with 2 eggs and bacon) – one ...................................  
30. Peanut butter – 2tbs (40g) .........................................................  
31. Almonds, cashews, peanuts or walnuts – 1 
hand-full (30g) ...........................................................................  
Breads 
32. White, light rye – 1 slice (30g) ...................................................  
33. White – 1 roll (90g) ....................................................................  
34. Wholemeal, mixed grain, brown – 1 slice (30g) .........................  
35. Wholemeal – 1 roll (100g) .........................................................  
36. Dark rye, pumpernickel – 1 slice (40g) .......................................  
37. Breads fortified with iron including Burgen 
Pumpkin Seed, Burgen Soy-Lin, Wonder White 
+ Vitamins & Minerals, Wonder Wholemeal, 
Coles Multigrain + 10 Grains and Seeds, Coles 
Wholemeal High in Fibre bread, Coles White 6 
Vitamins and Minerals – 1 slice (30 g) .......................................  
38. Crumpet (white) – 1 crumpet (45g) ...........................................  
39. Crumpet (wholemeal) – 1 crumpet (45g)...................................  
40. English muffin – 1 muffin (70g) ..................................................  
41. Fruit muffin – 1 muffin (70g)......................................................  
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Breakfast Cereals 
42. Cereals including Crunchy Nut Cornflakes, 
granola, Frosties, flavoured Weet-Bix Bites – 1 
cup (30 g) ...................................................................................  
43. Cereals including All-Bran, Sultana Bran, 
Special K Chocolate, Special K Advantage and 
mixes such as Sustain, Just Right, Uncle Toby’s 
Plus, Sanitarium Light n Tasty – 1 cup (30g) ..............................  
44. Cereals including Coco Pops, cornflakes, 
Cheerios, Weet-Bix (2 biscuits), Rice Bubbles, 
Special K original, Special K Forest Berries, 
Nutri-Grain  – 1 cup (30 g) .........................................................  
45. Muesli – ¼ cup (30g) ..................................................................  
46. Porridge (cooked rolled oats) – ¾ cup (190g) ............................  
47. Puffed wheat – 1 cup (12g) ........................................................  
Cakes 
48. Cakes including black forest, chocolate, fruit, 
plain, lamington and sponge – 1 slice (85g) ...............................  
49. Sugar doughnut – one (50g) ......................................................  
50. Chocolate doughnut – one (100g) .............................................  
51. Custard tart – one (135g)...........................................................  
52. Apple pie or other fruit pie – one piece 
(130g) ........................................................................................  
53. Scone – one (40g) ......................................................................  
Biscuits and Snack Foods 
54. Vita-Wheats, Sesame Wheats, Saos,  
Milk Arrowroots, shortbreads, cream 
biscuits – 2 biscuits ....................................................................  
55. Muesli bars (average all brands) 1 bar (35g)  .............................  
56. Chocolate: 
1 row (5 or 6 squares; 30g) ........................................................  
1 small block (50g) .....................................................................  
1 medium block (100g) ..............................................................  
57. Licorice – 1 piece (50g) ..............................................................  
Milk based drinks or additives 
58. Sustagen – one 250 mL ready-to-drink carton 
or made from 15 g (3 teaspoons) Sustagen 
powder ......................................................................................  
59. Sustagen Sport – made from 60 g (3 
tablespoons) of Sustagen Sport powder ....................................  
60. Devondale Smart Plus – 1 cup (250ml) ......................................  
61. So Good Essential Soy Milk – 1 cup (250ml) ..............................  
62. Soy milk not fortified with iron including So 
Good Regular, So Good Light, Soy Life, Aussie 
Soy, flavoured soy milk – 1 cup (250 mL)...................................  
63. Cow’s milk (all types including low fat, full fat, 
A2) – 1 cup (250 mL)  .................................................................  
Milk based Drinks or Additives (continued) 
64. Ovaltine or Ovaltine Light Break – made from 
20g (3 heaped teaspoons) of powder ........................................  
65. Milo or Milo B-Smart – made from 20g (3 
heaped teaspoons) of powder’ ..................................................  
66. Coles MX11 – made from 25g (3 heaped 
teaspoons) of powder ................................................................  
67. Sanitarium Up n Go Energise – carton (350 mL) ........................  
Vegetables 
68. Vegetables including potato, peas,  
carrots, broccoli, cauliflower, celery, 
etc – 2/3 cup (100g) ...................................................................  
69. Salad vegetables including tomato, 
cucumber, lettuce (3/4 cup) ......................................................  
70. Spinach, silverbeet – ½ cup (60g)...............................................  
71. Hot chips – 1 cup (100g) ............................................................  
72. Baked beans – ½  cup (140g) .....................................................  
73. Kidney beans, lentils, chickpeas – ½  
cup (100g) ..................................................................................  
Fruits 
74. 1 average piece of fruit including  
apple, banana, pear, orange, mango, 
pineapple, peach, apricot, plum, etc -  
1 average piece (120g) ...............................................................  
75. Dried fruit including sultanas, raisins, 
apricots, figs, prunes, and dates – 5-6 
apricot halves, 2 small figs, 3-4 
prunes or (30g) ..........................................................................  
76. Berri Fresh orange juice Plus Iron 
1 glass (200ml) ...........................................................................  
77. Sunraysia prune juice, 1 glass (200mL) ......................................  
Vitamin and Mineral Supplements 
Do you take any vitamin or mineral  
supplements? (circle one) 
 
If yes 
Supplement name? ............................................................................  
How often? .........................................................................................  
Number of tablets?.............................................................................  
Amount of iron in supplement? .........................................................  
Additional food eaten but not included on food list 
 ...........................................................................................................  
 ...........................................................................................................  
 ...........................................................................................................  
 ...........................................................................................................  
 ...........................................................................................................  
YES NO
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Appendix B. General description of all 386 women who returned background 
questionnaires and comparison to national data 
Characteristics of participants included in specific analyses are included the 
corresponding chapter.
Table 1. Characteristics of premenopausal women aged 18-50 years (N = 386) 
Thesis sample
National data
n (%) Mean (SD)
Age (y) 28.7 (7.3) - 
Height (m) 1.66 (0.06) 
18-24 y: 1.64a
25-34 y: 1.64 
35-44 y: 1.63 
45-54 y: 1.62
Weight (kg) 66.1 (11.6) 
18-24 y: 66.5a
25-34 y: 69.0 
35-44 y: 72.7 
45-54 y: 73.4
Body mass index (kg/m2) 23.9 (3.9) - 
Underweightb 12 (3%) 
18-24 y: 5%a
25-34 y: 1% 
35-44 y: 0.5% 
45-54 y: 0.7% 
Normal rangeb 262 (69%) 
18-24 y: 55%a
25-34 y: 34% 
35-44 y: 25% 
45-54 y: 21%
Overweightb 73 (19%) 
18-24 y: 28%a
25-34 y: 44% 
35-44 y: 46% 
45-54 y: 45%
Obeseb 34 (9%)
18-24 y: 13%a
25-34 y: 21% 
35-44 y: 29% 
45-54 y: 33%
Born in Australia 293 (77%) 15-49 y: 71%c
Tertiary education 313 (81%) 
20-24 y: 20%d
25-29 y: 42% 
30-34 y: 43% 
35-39 y: 38% 
40-44 y: 33% 
45-49 y: 26%
Currently employed 339 (88%) 
20-24 y: 71%d
25-29 y: 62% 
30-34 y: 51% 
35-39 y: 44% 
40-44 y: 44% 
45-49 y: 48%
Current smoker 27 (7%) 18-24 y: 17%a
169
Thesis sample
National data
n (%) Mean (SD)
25-34 y: 21%
35-44 y: 17% 
45-54 y: 21%
Has children 61 (16%) 
20-24 y: 14%e
30-34 y: 64% 
40-44 y: 84%
a Australian Bureau of Statistics. (2012). Australian Health Survey: First Results, 2011-12.   
Retrieved 26 June, 2015, from 
http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4364.0.55.0012011-
12?OpenDocument
b Categories of body mass index: underweight < 18.50 kg/m2; normal range 18.50 to 24.99 
kg/m2; overweight 25.00 to 29.99 kg/m2; obese > 30.00 kg/m2 (World Health 
Organization. (2000). Obesity: preventing and managing the global epidemic. Report on a 
WHO Consultation. Geneva, Switzerland: World Health Organization.) 
c Australian Bureau of Statistics. (2015). Migration, Australia, 2013-14.   Retrieved 26 
June, 2015, from 
http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4364.0.55.0062011-
12?OpenDocument 
d Australian Bureau of Statistics. (2014). Education and Work, Australia, May 2014.   
Retrieved 26 June, 2015, from 
http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/6227.0May%202014?OpenDo
cument 
e Australian Bureau of Statistics. (2008). Australian Social Trends, 2008. Retrieved 26 
June, 2015, from 
http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4102.02008?OpenDocument 
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Appendix E. Multiple regression analysis excluding disproportionately 
influential participants for Chapter 6
Table 1 Multiple regression analysis of associations between serum ferritin 
and serum zinc concentrations in women aged 18-50 ya,b
Logarithmic scale 
ȕ&,
$QWLORJDULWKPRIȕ
(95% CI) p-value 
Adjusted model
Adj. R2 = 0.173, p < 0.001
0.057
(0.001 to 0.114)
1.059
(1.001 to 1.121) < 0.001 
a Natural log-transformed μg/L serum ferritin was the dependent variable and 
untransformed serum zinc (μmol/L, standardised to 08:00 sampling) was the 
independent variable. 
b Adjusted for fasting status, log-transformed C-reactive protein (mg/L), age 
(years), BMI (kg/m2), oral contraceptive use, blood donation (mL/year), use of 
dietary supplements containing iron and/or zinc. 
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Appendix F. Multiple regression analysis in subsample with serum hepcidin 
data available for Chapter 7 
Table 1 Non-nutritional determinants of natural log-transformed serum 
ferritin in hepcidin subsample (N = 265)a
Adj. R2 = .176, p < .001 ȕ&, p-value
Blood donation (100 mL/year) -0.071(-0.090 to -0.052) < .001 
Menstrual blood loss units per year -0.002(-0.004 to -0.001) < .001 
a Adjusted for log-transformed C-reactive protein
Table 2 Univariate associations between nutritional determinants and natural 
log-transformed μg/L serum ferritin in subsample with hepcidin analysis (N = 
265) 
Nutritional determinant ȕ&, p-value IRUȕ Adj. R
2
Non-
nutritional 
base 
model + 
Dietary iron intake (mg/d) 0.034(0.005 to 0.064) .024 .186
Energy-adj. dietary iron 
(mg/d)a
0.047
(-.003 to 0.096) .064 .181
Total iron intake (incl. 
supplements; mg/d)b
0.264
(0.076 to 0.451) .006 .198
Supplemental iron intake 
(mg/d)
0.013
(0.005 to 0.022) .002 .201
Red meat (beef + lamb; g/d)b 0.094(0.018 to 0.169) .015 .188
White meat (chicken + pork + 
fish; g/d)b
0.120
(0.032 to 0.207) .007 .192
Red + white meat (g/d)b 0.110(0.025 to 0.194) .011 .190
Vitamin C (mg/d) -0.0001(-0.002 to 0.002) .893 .170
Phytate (mg/d)b 0.057(-0.120 to 0.235) .525 .171
Cereals and cereal products 
(g/d)b,c,d
0.106
(-0.074 to 0.285) .246 .174
Iron-fortified breakfast 
cereals (g/d)
0.001
(-0.007 to 0.010) .768 .170
Vegetable products and 
dishes (g/d)c
0.0006
(-0.0004 to 0.002) .216 .175
Energy intake (MJ/d) 0.03(-0.013 to 0.079) .155 .176
a Energy adjusted using the residual method. 
b Natural log-transformed independent variable. 
c Australian Health Survey major food group.
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d Reported analysis was rerun omitting one participant with an outlier Cooks 
distance value who reported in FFQ consuming 0 g/d of any cereals but reported in 
24-hour recall (not used in analysis) consuming pita bread and oats. 
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